Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,41758,0.129644252890437,0.00472305732852576,0.120387060526527,0.138901445254348,2.37749358676996e-161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41465,0.302947467379145,0.0130413457726579,0.277386429664735,0.328508505093554,5.7201199155497e-117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,41905,-0.309542615798682,0.0134017481607063,-0.335810042193666,-0.283275189403697,9.21727997330354e-116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,41786,0.192987216184956,0.00901712872656954,0.175313643880879,0.210660788489032,6.31738472628341e-100
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,41689,0.198251909877778,0.00929415194599666,0.180035372063624,0.216468447691931,2.85134473979383e-99
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39633,0.0848870461101674,0.0041337015663341,0.0767849910401526,0.0929891011801823,5.39513151429381e-92
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,39625,0.18632910466927,0.0091361472081387,0.168422256141318,0.204235953197222,8.71696879669584e-91
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,39655,-0.12321006657647,0.00615282342844365,-0.135269600496219,-0.11115053265672,1.18367017415227e-87
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39308,0.106717738898871,0.00539054125387394,0.096152278041278,0.117283199756464,1.06180212629942e-85
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,39655,-0.0511899861860715,0.00273982679323347,-0.0565600467008091,-0.0458199256713339,1.01529645488995e-76
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39250,0.19525332515257,0.0106636091414125,0.174352651235402,0.216153999069739,9.22977212190364e-74
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,41765,0.119528510701486,0.00671106560429203,0.106374822117074,0.132682199285899,3.87702179057885e-70
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41521,0.151929741488678,0.00868941990882563,0.13489847846738,0.168961004509976,1.12941672183179e-67
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41836,-0.0705150946614937,0.00410175767737416,-0.078554539709147,-0.0624756496138403,1.58161826822788e-65
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,41877,0.0665018227539363,0.00393179306623784,0.0587955083441102,0.0742081371637625,1.64200718196205e-63
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,41903,-0.10740524459714,0.00644340253982713,-0.120034313575201,-0.094776175619079,9.30410966263154e-62
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,41813,0.0598566074769833,0.0036151653857842,0.0527708833208463,0.0669423316331203,5.84570053507466e-61
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,41911,0.0892631919540936,0.00540510121756219,0.0786691935676717,0.0998571903405155,1.154251331128e-60
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,41712,0.180435579384388,0.0109940675844254,0.158887206918915,0.201983951849862,6.19759437695565e-60
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39448,-0.318675099532614,0.0194588836553087,-0.356814511497019,-0.280535687568209,1.44736034624903e-59
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,41750,-0.301306265139845,0.0189542772847851,-0.338456648618024,-0.264155881661666,2.24365162443355e-56
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39581,0.145848358795664,0.00925163020569422,0.127715163592504,0.163981553998825,2.20251181559714e-55
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,41877,0.105023220159514,0.00668673237836235,0.0919172246979237,0.118129215621104,4.29238253005955e-55
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41559,-0.0900401439895332,0.0057721046575425,-0.101353469118317,-0.0787268188607499,2.29942772914296e-54
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,41805,-0.0472637688515641,0.00309298200513844,-0.0533260135816354,-0.0412015241214928,2.86561216373711e-52
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,41765,-0.0781951973624633,0.00512380252307655,-0.0882378503076933,-0.0681525444172333,3.87415568141158e-52
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,39655,-0.0761967039117544,0.00501994729611367,-0.0860358006121372,-0.0663576072113716,1.61343842061127e-51
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,41862,0.194132403156336,0.0128217336133582,0.169001805274154,0.219263001038518,2.33752018883665e-51
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,41802,0.0530915535339761,0.0035252224858464,0.0461821174617172,0.0600009896062351,7.78530281143957e-51
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,41703,0.0668824854487189,0.0044566842993942,0.0581473842219063,0.0756175866755315,1.72873273535778e-50
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,39625,0.145140224564089,0.00969774522318397,0.126132643926648,0.164147805201529,3.77879767579231e-50
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,41740,0.134756062886954,0.00906175966728629,0.116995013939073,0.152517111834835,1.28966038123599e-49
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41411,0.0864498119782781,0.005849487358409,0.0749848167557965,0.0979148072007597,5.06365054461574e-49
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,39655,-0.0772043024184895,0.00529130432355254,-0.0875752588926525,-0.0668333459443266,8.92792118155303e-48
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41465,0.118110211750228,0.00825841365605644,0.101923720984357,0.134296702516098,4.80409499464029e-46
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,41758,0.0810420758678118,0.00568018525749963,0.0699089127631125,0.0921752389725111,7.66265900654671e-46
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,41758,-0.040875943793511,0.002879308990271,-0.0465193894144422,-0.0352324981725799,2.0848244343713e-45
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41689,0.0561882542561527,0.00396812183205621,0.0484107354653225,0.0639657730469829,3.494979223417e-45
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,39633,-0.0863718040510467,0.00613921200719514,-0.0984046595851492,-0.0743389485169443,1.43119457756999e-44
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39408,-0.045983430020981,0.00329518059092052,-0.0524419839791852,-0.0395248760627767,7.06519477891717e-44
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,41740,0.0784374468330998,0.00564224015477098,0.0673786561297487,0.0894962375364509,1.25714380410518e-43
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,41829,0.0901051103683648,0.00652030679157018,0.0773253090568872,0.102884911679842,3.89400422827742e-43
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,41911,0.0427000839356323,0.00312489222291193,0.0365752951787249,0.0488248726925397,3.18713206979547e-42
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39408,0.040994448634876,0.00301795296653758,0.0350792608204623,0.0469096364492896,1.1018131554761e-41
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41521,0.0791811901051988,0.00584920946750491,0.0677167395488892,0.0906456406615084,1.81097262415826e-41
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,39600,0.108566900165444,0.00814936756400147,0.0925941397400011,0.124539660590887,3.52318483266623e-40
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39408,0.108774963050152,0.00820667859062652,0.092689873012524,0.12486005308778,8.68696425690925e-40
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,41758,0.0559120169458688,0.00422875172562582,0.0476236635636422,0.0642003703280954,1.17433765476855e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39308,0.088569714821914,0.00672178258280226,0.0753950209596216,0.101744408684206,2.42256841475488e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,40881,0.057937342711271,0.00443952705723054,0.0492358696790991,0.0666388157434428,1.1434686010016e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,41925,0.0699419252353861,0.00539395816225005,0.059369767237376,0.0805140832333962,3.21731670550502e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,41848,-0.037765501214586,0.0029163398077847,-0.043481527237844,-0.0320494751913279,4.02138945323811e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39589,0.0780506324465943,0.006057980558105,0.0661769905527085,0.0899242743404801,1.03887622658962e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41617,0.098520166293237,0.00770584373536146,0.0834167125719286,0.113623620014545,3.32334945252979e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,41740,0.0534253046268589,0.00423086216790656,0.045132814777762,0.0617177944759557,2.42042512791099e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,41667,0.0947936608168749,0.0075410224006345,0.0800132569116313,0.109574064722119,4.96349761213686e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,41758,-0.0374383851387202,0.00300974112626014,-0.0433374777461901,-0.0315392925312503,2.53301530699985e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,39650,-0.0913864056428661,0.00736691883169698,-0.105825566552992,-0.07694724473274,4.20500175868833e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41586,0.0535302861869625,0.00431788269903139,0.045067236096861,0.0619933362770641,4.26640177852697e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,41777,-0.0254071879894196,0.00205578804742305,-0.0294365325623688,-0.0213778434164704,6.80863572872983e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,41689,0.102646834787193,0.00833151946265368,0.0863170566403916,0.118976612933994,1.0962469447244e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39633,0.0458849134674399,0.00372988513111335,0.0385743386104577,0.0531954883244221,1.488463109124e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41449,0.0778674072946154,0.00634411611012379,0.0654329397187728,0.090301874870458,1.9484820151791e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41614,0.0673435723888136,0.00553843766134215,0.056488234572583,0.0781989102050442,7.80962156450573e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,41802,0.0317228028654334,0.00261764373620257,0.0265922211424764,0.0368533845883905,1.26604084568126e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39401,0.0630765864732837,0.00522998900858494,0.0528258080164572,0.0733273649301101,2.79076537742837e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41455,0.061998169456714,0.00525002794498493,0.0517081146845435,0.0722882242288845,5.12599145527251e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,41809,0.0416809490685136,0.00353392513035468,0.0347544558130185,0.0486074423240088,6.02439723174072e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41689,0.107540866798561,0.00912077135760888,0.0896641549376472,0.125417578659474,6.31737469614697e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,41865,0.180600658287391,0.0155291271595043,0.150163569054763,0.21103774752002,4.11595666925142e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,41862,0.0523267406467639,0.00451988257487594,0.0434677708000071,0.0611857104935207,7.58178678388023e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39408,0.0621628861583958,0.00536888229613419,0.0516398768579728,0.0726858954588188,8.06100993256466e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,41856,0.0392113898614236,0.00340182825093333,0.0325438064895943,0.045878973233253,1.3560190567549e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39308,0.0707599920168672,0.00618301677343119,0.0586412791409421,0.0828787048927924,3.76085644270192e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,39650,0.0243708533213199,0.0021720577564107,0.0201136201187549,0.0286280865238849,4.66038791733972e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,41689,0.0788751022348909,0.00704165588830457,0.065073456693814,0.0926767477759679,5.44797544856815e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,41689,0.0673545473100513,0.00603744719454949,0.0555211508087343,0.0791879438113683,9.01057999465606e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41877,0.0399649797115724,0.00358296552468025,0.0329423672831992,0.0469875921399457,9.17162612882274e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,39625,0.0362429137907673,0.00326660767259151,0.029840362752488,0.0426454648290467,1.87678489754978e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39308,0.0750246711909298,0.0067660366892944,0.0617632392799128,0.0882861031019469,2.0383045614267e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,41765,-0.0454301801525562,0.004101358089071,-0.0534688420071354,-0.0373915182979771,2.16850438781744e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41534,0.0646413987105624,0.00584271169354977,0.0531896837912049,0.07609311362992,2.52394341377357e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,41820,0.0815784204510258,0.00737594984272116,0.0671215587592923,0.0960352821427592,2.60813835690423e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,41703,0.0369883091567087,0.00336377925952898,0.0303953018080319,0.0435813165053855,5.29162964869524e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,41802,0.0636864768710221,0.00581954038203772,0.0522801777222282,0.075092776019816,9.38767433777858e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41689,0.0931383848105417,0.00856634450959722,0.0763483495717311,0.109928420049352,2.03932087992226e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41543,0.169522086036892,0.0156074476206863,0.138931488700347,0.200112683373438,2.3044848681685e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39328,0.0967003432290716,0.00892901826415611,0.0791994674313256,0.114201219026818,3.4338416582219e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,41758,0.0447381739970395,0.00413986147738316,0.0366240455013686,0.0528523024927105,4.15892101329483e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39334,0.145561198403974,0.0134742418635945,0.119151684351329,0.17197071245662,4.59300897808099e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,41877,-0.0424195830590293,0.00393669514959283,-0.0501355055522312,-0.0347036605658273,5.81286484771368e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,41740,0.0320975166663675,0.00297927061540384,0.0262581462601759,0.037936887072559,5.94336714179472e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,39625,0.0392869294859407,0.00372040419000874,0.0319949372735236,0.0465789216983578,6.08242237464016e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,39600,0.0477808969519043,0.0045296674127833,0.038902748822849,0.0566590450809595,6.86498352573106e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41689,-0.022085086080256,0.00209669289238504,-0.0261946041493306,-0.0179755680111813,7.69757898560032e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,41740,-0.0402683558603776,0.00382516753375136,-0.0477656842265303,-0.032771027494225,8.19938298382601e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39250,0.0686857075864927,0.00652239961044768,0.0559018043500153,0.0814696108229702,8.34691047031436e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,41911,0.0344173913859758,0.00328142060370039,0.027985807002723,0.0408489757692286,1.22729982822462e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41466,0.0591271703014571,0.00565212801632517,0.0480489993894597,0.0702053412134544,1.65054450099555e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39650,-0.0298586357512796,0.0028548537599945,-0.0354541491208689,-0.0242631223816904,1.75413706183542e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,41734,0.0579927228306641,0.00555593142507954,0.0471030972375082,0.06888234842382,2.09064626389264e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,41788,0.056724000061435,0.0054458905107388,0.046050054660387,0.0673979454624831,2.6292648038164e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,41840,0.0543313681099498,0.00522283177697922,0.0440946178270705,0.0645681183928291,3.01619635088136e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",41765,-0.0885878844082658,0.00857160467249818,-0.105388229566362,-0.0717875392501694,6.09288169102923e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,41865,0.0269122000209502,0.00260713695662135,0.0218022115859724,0.0320221884559281,6.92433350935488e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41534,0.0912933377518602,0.0088689706241803,0.0739101553284668,0.108676520175254,9.38607062772726e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39625,0.0730440464240331,0.00710934708854514,0.0591097261304846,0.0869783667175816,1.18750244852794e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41547,0.0314309030690135,0.00308547549088454,0.0253833711068798,0.0374784350311472,2.80617028883753e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,41636,0.0469261723642572,0.00461938759702776,0.0378721726740828,0.0559801720544316,3.7349019157578e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,41689,-0.0847579165107786,0.00834515592765963,-0.101114422128991,-0.0684014108925657,3.80795498158381e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,41865,0.0497250810000662,0.00492527709871676,0.0400715378865814,0.0593786241135511,7.02590437991694e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41689,0.0441665005670141,0.00442858540175399,0.0354864731795763,0.0528465279544519,2.42268160541595e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41465,0.069876955402833,0.0070197271310566,0.0561182902259621,0.083635620579704,2.92917113678085e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,41740,0.035240269595618,0.00354683436354796,0.028288474243064,0.042192064948172,3.5142561733928e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,41821,0.0707282244683717,0.00713001961217784,0.0567533860285031,0.0847030629082403,4.11273392070437e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41689,0.0857030658097727,0.0086515442763309,0.0687460390281642,0.102660092591381,4.72037968014409e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,41765,0.0361743664015291,0.00365621643331998,0.0290081821922219,0.0433405506108363,5.32047858949302e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,41758,0.0299834610769905,0.00303330047969069,0.0240381921367968,0.0359287300171843,5.82745551248519e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,41925,-0.0256111413702566,0.00260211080435401,-0.0307112785467905,-0.0205110041937228,8.8358977933798e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41465,0.0633790779179189,0.00644204284636489,0.0507526739390437,0.0760054818967941,9.25913222605897e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41404,0.0884605331023889,0.00903689789476888,0.0707482132286418,0.106172852976136,1.50877012429195e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,41877,0.029476790337299,0.00302723085272619,0.0235434178659556,0.0354101628086423,2.48481307122518e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,41721,0.0208550124195459,0.00214759295301917,0.0166457302316283,0.0250642946074635,3.21914844440754e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,41765,0.0654970485854836,0.00678457704853393,0.0521992775703571,0.0787948196006101,5.60060515277553e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41521,0.0576777905081039,0.00597526145956501,0.0459662780473565,0.0693893029688513,5.67571983360944e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39650,-0.0254407016524553,0.00263772654571548,-0.0306106456820576,-0.020270757622853,6.30061238090171e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39334,0.0477992506324978,0.00497447317959698,0.0380492832004877,0.0575492180645078,8.9707772838569e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41689,0.0378592541451801,0.00394179923169203,0.0301333276510637,0.0455851806392964,9.02272298962973e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41521,0.0938383149673699,0.00983371978409141,0.0745642241905508,0.113112405744189,1.64135973264833e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,41791,0.0330032042459846,0.00346218536762773,0.0262173209254343,0.039789087566535,1.80074273674271e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,39625,0.0282206411536664,0.00297563746535967,0.0223883917215614,0.0340528905857713,2.95179829795576e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,41740,0.0412402547781451,0.0043507340183594,0.0327128161021607,0.0497676934541295,3.00394769741889e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,41740,0.053472443798179,0.00565886093392421,0.0423810763676876,0.0645638112286705,3.97929300963662e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,41802,-0.0337182056984045,0.00356853238315218,-0.0407125291693828,-0.0267238822274262,3.99798610983368e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,41877,-0.0469321781667013,0.00497349343910234,-0.0566802253073419,-0.0371841310260607,4.48863909362165e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,41758,-0.0374646240678383,0.00398992823543438,-0.0452848834092897,-0.0296443647263869,6.98689182194512e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,41689,0.0714543987647817,0.00761228889099158,0.0565343125384382,0.0863744849911252,7.19861227466416e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,41783,0.032381566570691,0.00345575454624499,0.0256082876600508,0.0391548454813311,8.3910191907923e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39589,0.053433161847846,0.00572151330533224,0.0422189957693948,0.0646473279262972,1.15981009505755e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,41877,0.0469399892598598,0.00505140497869884,0.0370392355016101,0.0568407430181095,1.73939084300239e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41689,-0.0404501400314245,0.00437496438645843,-0.049025070228883,-0.031875209833966,2.69114518906942e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,41802,0.0223422866154165,0.00241691202561147,0.0176051390452181,0.027079434185615,2.73006556292867e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,41765,0.0617512965318807,0.00669408280540363,0.0486308942332896,0.0748716988304719,3.26950022945651e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41540,0.0821120221075271,0.00895866816041881,0.0645530325131062,0.099671011701948,5.65921795256855e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,41846,0.0678790687750162,0.00745692835149933,0.0532634892060775,0.0824946483439549,1.00451989052438e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,41911,0.0319794888331146,0.00354524197468412,0.0250308145627337,0.0389281631034955,2.12760608683555e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41622,0.0349868220966461,0.00389207744231361,0.0273583503097114,0.0426152938835808,2.82914457905269e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,41877,0.0386151964128404,0.00430992704790458,0.0301677393989475,0.0470626534267334,3.68840510437473e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,41877,0.0251691813872254,0.00281242536527553,0.0196568276712853,0.0306815351031654,4.0475655794742e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,41745,0.0424863896823068,0.00476252386640153,0.0331518429041598,0.0518209364604538,5.22648808432481e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39625,0.0270068468644646,0.00302841482640381,0.0210711538047131,0.032942539924216,5.50497472821852e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41465,0.0615045664708732,0.00691522298767325,0.0479507294150336,0.0750584035267128,6.66900489847711e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41466,0.0638875406696498,0.00719773492972889,0.0497799802073811,0.0779951011319184,7.8347580325712e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,41736,0.0761807731363566,0.00861216916175255,0.0593009215793216,0.0930606246933916,1.02440308442431e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41865,-0.0442007153239609,0.00499901654512394,-0.0539987877524038,-0.0344026428955179,1.05871306772929e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,39600,0.105936098487806,0.0120109166086004,0.0823947019349496,0.129477495040663,1.31730203925248e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41466,0.0469478382568065,0.00533292788898651,0.0364952995943929,0.05740037691922,1.49554306400701e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41636,0.068694126218559,0.00781249391864692,0.053381638138011,0.084006614299107,1.63924111108644e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41521,0.0613513552013815,0.00698060060783798,0.0476693780100191,0.0750333323927439,1.70034943157102e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,41740,0.0465944914403659,0.00530390994767136,0.03619882794293,0.0569901549378017,1.75664604667273e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,41877,0.116141688196931,0.0132653091829646,0.0901416821983206,0.142141694195542,2.27943168038675e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41689,0.0799171485508694,0.00913858619224047,0.062005519614078,0.0978287774876607,2.49935972939039e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41376,0.0939161877186162,0.0107415182833939,0.0728628118831641,0.114969563554068,2.54491177120632e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39490,0.0247095871610017,0.00282979112455222,0.0191631965568794,0.0302559777651241,2.86881346575003e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,41805,0.0724690527794785,0.00835013514054984,0.0561027879040008,0.0888353176549562,4.46444067816117e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41362,0.0192963618926981,0.00222438982897275,0.0149365578279115,0.0236561659574847,4.63623942766381e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,41925,-0.0263732024203319,0.00304263927028465,-0.0323367753900899,-0.020409629450574,4.90640050341457e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39408,0.0205351607326308,0.00237626028076644,0.0158776905823286,0.0251926308829331,6.31333232973171e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41587,0.0455184254165712,0.00527279671393201,0.0351837438572645,0.055853106975878,6.68493184166271e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41689,0.0631633995256029,0.00734939541584616,0.0487585845105445,0.0775682145406614,9.31444478665595e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41465,0.0774831671723813,0.00903494406048154,0.0597746768138375,0.0951916575309251,1.09436855060795e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,41925,-0.0231579668241112,0.00270105548674777,-0.0284520355781369,-0.0178638980700856,1.11192599111114e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39153,-0.0388460118317872,0.00452977318976977,-0.0477243672837359,-0.0299676563798384,1.12261600687505e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,39598,0.12054338978454,0.0140708248864605,0.0929645730070777,0.148122206562003,1.20484323627248e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41466,0.0464388222303214,0.00542664594876478,0.0358025961707425,0.0570750482899004,1.28258898456878e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,41739,-0.0443588384908316,0.00519016906562578,-0.0545315698594581,-0.0341861071222051,1.40521450040523e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41636,0.0331496912000574,0.0038953945665138,0.0255147178496903,0.0407846645504244,1.9284584726804e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,41888,0.0462350369334057,0.00548109980285535,0.0354920813198092,0.0569779925470022,3.640328977185e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,39598,0.0623401019828813,0.00740090739592077,0.0478343234868766,0.076845880478886,4.11495550462005e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39408,0.0585080842851143,0.00695731106919423,0.0448717545894936,0.072144413980735,4.63203458301769e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39408,0.036190147158143,0.00431577347696529,0.027731231143291,0.0446490631729949,5.67600771022072e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39408,0.0479506397193716,0.00571851049319532,0.0367423591527088,0.0591589202860345,5.69475949124848e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39600,0.0524515134101974,0.00628031413505836,0.040142097705483,0.0647609291149118,7.53341561834414e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,41765,0.0410521979757852,0.00492621337329523,0.0313968197641265,0.0507075761874438,8.62710795673628e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,39633,0.0667222896310227,0.00809569539024335,0.0508547266661457,0.0825898525958997,1.88987428711261e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39160,0.0286631274400057,0.00348118060648951,0.0218400134512863,0.0354862414287252,2.02869886521702e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39589,0.0328351318874362,0.00399586104361078,0.025003244241959,0.0406670195329133,2.31518078826951e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,41786,-0.0392278481610568,0.00478309869345188,-0.0486027216002224,-0.0298529747218911,2.5957974985866e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,41925,-0.0293296008932085,0.00358692128107531,-0.0363599666041161,-0.0222992351823008,3.17636271220743e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39408,0.0302624004433288,0.0037037577204808,0.0230030353111864,0.0375217655754712,3.4071683343e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,41802,0.0241321493586901,0.00295515768727526,0.0183400402916306,0.0299242584257497,3.47238199412055e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41466,0.0555139345305389,0.00679867591140053,0.0421885297441938,0.0688393393168839,3.50058025008852e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41836,0.0374077874148427,0.00459937906588501,0.0283930044457081,0.0464225703839773,4.55032562208572e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,41877,0.0293661366959591,0.00362033393997614,0.0222702821736059,0.0364619912183123,5.43886956467907e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41466,0.044662165099276,0.00551121539543747,0.0338601829242186,0.0554641472743335,5.80226091315375e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,41765,0.0232374878616945,0.00286987809672033,0.0176125267921227,0.0288624489312663,6.12414883933301e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,41877,0.0213620092652593,0.00263832235834208,0.0161908974429088,0.0265331210876098,6.13055813004695e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39633,0.0480089955354771,0.00593749449138471,0.036371506332363,0.0596464847385911,6.82496630688801e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39334,0.0447182153136516,0.0055605635809829,0.0338195106949251,0.0556169199323781,9.76570789665616e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,41721,0.0248785936400726,0.00310976154839223,0.0187834610052239,0.0309737262749214,1.34633981050402e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,39650,0.0593274825851193,0.00741990620667711,0.0447844664200322,0.0738704987502064,1.41655570774941e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,41689,0.0336471960296603,0.00421060868756659,0.0253944030020298,0.0418999890572908,1.44941401202725e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41689,0.0282767638400911,0.00354634115778719,0.0213259351708282,0.035227592509354,1.66977151687813e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,41813,0.0265513329098963,0.00333136661247323,0.0200218543494488,0.0330808114703438,1.71487537843847e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39408,0.0236429636602144,0.00297622371330539,0.0178095651821359,0.029476362138293,2.15289823851665e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41764,0.021891898089966,0.00275746386528578,0.0164872689140058,0.0272965272659261,2.2000675842628e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41750,0.105848471512362,0.013352600478556,0.0796773745743918,0.132019568450331,2.42170357541737e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,41805,-0.0173549104245397,0.00218971857611019,-0.0216467588337156,-0.0130630620153637,2.45108015562659e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,41740,0.0836888060567164,0.0105596755292373,0.0629918420194114,0.104385770094021,2.45820829852503e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39385,0.0336493037700788,0.0042472246606543,0.0253247434351964,0.0419738641049612,2.55365676601201e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,41865,-0.0317047580364867,0.00401828539754382,-0.0395805974156726,-0.0238289186573008,3.25451225861313e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,41925,0.0486580629802062,0.00622651522180549,0.0364540931454674,0.060862032814945,5.92302937935592e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,39598,0.0513399877891038,0.0065785299800427,0.0384460690282201,0.0642339065499875,6.53207098950231e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,41911,0.0380601751018707,0.00489146760868896,0.0284728985888403,0.0476474516149011,7.72809246489856e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39334,0.0580779366304132,0.00746753841809997,0.0434415613309373,0.0727143119298891,8.08229375009161e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39308,0.0446397235003827,0.00574033939166477,0.0333886582927198,0.0558907887080456,8.14083598331332e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,41765,0.0294847076338354,0.00379431278838224,0.0220478545686062,0.0369215606990645,8.37801711147155e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39498,0.0437154026689379,0.00562433337945449,0.0326917092452071,0.0547390960926687,8.38441594861202e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,41865,0.0312788944589626,0.00402738286136308,0.023385224050691,0.0391725648672342,8.65500050675994e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,41689,0.0292548859461592,0.00377165966630823,0.0218624330001951,0.0366473388921234,9.37465603178273e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,41715,0.043880932322093,0.00566959402161366,0.0327685280397303,0.0549933366044558,1.06929605744723e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,41819,-0.0241963376010626,0.00312952531415817,-0.0303302072168126,-0.0180624679853126,1.13831748362561e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39600,0.0527092188279122,0.00684460200862369,0.0392937988910098,0.0661246387648147,1.46766007221788e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39622,-0.0122934319771725,0.00160055754245971,-0.0154305247603936,-0.00915633919395149,1.71598714247322e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41465,0.0536959939157881,0.00700190083416302,0.0399722682808286,0.0674197195507476,1.8610318422882e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41823,-0.0263364682943556,0.00344586468812212,-0.0330903630830749,-0.0195825735056362,2.2695373751328e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,41836,-0.047987740870706,0.00628218112364645,-0.0603008158730531,-0.035674665868359,2.34454693870898e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39598,0.0631871688433761,0.00828959222305137,0.0469395680861955,0.0794347696005568,2.69347099299149e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41636,0.0430844542302226,0.0056620270606298,0.0319868811913882,0.054182027269057,2.94319226013198e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41636,0.0596966411725408,0.00785286954321516,0.0443050168678391,0.0750882654772425,3.11766441046367e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,41764,0.0508220716256351,0.00669157238434874,0.0377065897523115,0.0639375534989586,3.2868066151595e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41765,0.0512746186176166,0.00675290894216227,0.0380389170909786,0.0645103201442547,3.33693600247131e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41465,0.0472790998911668,0.00625371586030007,0.0350218168049786,0.0595363829773549,4.29818941643235e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41836,-0.0349088408149084,0.0046196967576521,-0.0439634464599065,-0.0258542351699103,4.41149702470385e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39530,-0.0339978487138709,0.00449879959154724,-0.0428154959133035,-0.0251802015144383,4.4513485791459e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41465,0.0596155030924802,0.00789833516591589,0.0441347661672851,0.0750962400176754,4.72231696900852e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41465,0.045751487681571,0.00606247283575177,0.0338690409234975,0.0576339344396445,4.76530532019969e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41636,0.0245376554731818,0.00325366382564528,0.018160474374917,0.0309148365714465,4.9513503621534e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39308,0.0482339268064663,0.00642041567873086,0.0356499120761539,0.0608179415367788,6.25928252045158e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,41724,0.053302411802197,0.00709729960902462,0.0393917045685087,0.0672131190358853,6.28298154801159e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,41925,0.041136518356433,0.00548223875031373,0.0303913304058181,0.0518817063070479,6.60211888949008e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41534,0.0571356149689108,0.00761540832985698,0.0422094146423912,0.0720618152954305,6.66304797141248e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39308,0.0416160876682217,0.00554984668930868,0.0307383881571767,0.0524937871792667,6.96066066951297e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39408,-0.0191939013724873,0.00256646130780701,-0.024224165535789,-0.0141636372091855,8.08553985751041e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,39633,-0.0304983160926539,0.004078152576317,-0.0384914951422352,-0.0225051370430726,8.09028662301571e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,39633,0.090923311351884,0.0122317413923362,0.0669490982229051,0.114897524480863,1.13686116868133e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,41758,0.050635055311175,0.00682320333895664,0.03726157676682,0.0640085338555301,1.23361162577442e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41465,0.0449333440680594,0.00609347244189534,0.0329901380819446,0.0568765500541743,1.75697757411819e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41617,0.0181863719087573,0.002469620242214,0.0133459162340179,0.0230268275834968,1.89159717487243e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39612,-0.0392012645417989,0.00532591629630763,-0.0496400604825619,-0.028762468601036,1.96321322848338e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,41740,0.0548624297593253,0.00746326083763139,0.0402344385175678,0.0694904210010829,2.08360436549299e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,41689,0.0425279094207299,0.00578709101192201,0.0311852110373627,0.053870607804097,2.1192328791404e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,41744,-0.0453899278026854,0.00618849447377861,-0.0575193769712915,-0.0332604786340793,2.35467867285198e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39625,0.0452149163686718,0.00618109973219705,0.0330999608935656,0.057329871843778,2.75192489589053e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,41911,0.0372848533447196,0.00511303931140226,0.0272632962943711,0.047306410395068,3.22367970631261e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39407,-0.0243244839127604,0.0033377279905816,-0.0308664307743004,-0.0177825370512205,3.37205746121169e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41466,0.0282498845818856,0.00389608123875759,0.0206135653539207,0.0358862038098505,4.37850993252542e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,41740,0.0567688567622248,0.00783097212819857,0.0414201513909556,0.072117562133494,4.42432234907087e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,41765,0.0539884143481473,0.00745183343586892,0.0393828208138442,0.0685940078824504,4.56557229299749e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,41877,0.024998248378275,0.00346199648132375,0.0182127352748805,0.0317837614816696,5.45113099747005e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39408,0.0291614311468436,0.00403837678345816,0.0212462126512656,0.0370766496424216,5.50454721131365e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39427,0.0420095719545465,0.00581767046884849,0.0306069378356035,0.0534122060734896,5.50583583788459e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39250,0.052744711277976,0.00730484385404885,0.0384272173240402,0.0670622052319117,5.53269981599506e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41604,-0.0212218524678625,0.00294393683399249,-0.0269919686624878,-0.0154517362732372,5.96237034717309e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,41877,0.0495064047037755,0.00687982835908687,0.0360219411199652,0.0629908682875857,6.53913320311509e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,41740,0.0455627065567931,0.00633353964575941,0.0331489688511047,0.0579764442624816,6.6389480771235e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39625,0.0230625563804637,0.00320661910143064,0.0167775829416596,0.0293475298192678,6.79020506766471e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,39633,0.0313798768572306,0.00436386081557519,0.0228267096587033,0.039933044055758,6.8555719446606e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,41744,-0.0267773602609584,0.00372980626490806,-0.0340877805401782,-0.0194669399817386,7.38396292985375e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41667,0.0200574356106201,0.00279592036309489,0.0145774316989541,0.0255374395222861,7.68626255889638e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,41740,0.070572057722152,0.00984253864743501,0.0512806819731794,0.0898634334711247,7.89461630824238e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39408,0.0317053015066937,0.00442584344641431,0.0230306483517216,0.0403799546616657,8.36563338291007e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39600,0.059864995137369,0.00836790311151826,0.0434639050387932,0.0762660852359448,8.95656483060681e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,41636,0.0407685975757811,0.00570198362124929,0.0295927096781325,0.0519444854734297,9.14715165948395e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",41758,-0.0184694636609552,0.00258731769015909,-0.0235406063336671,-0.0133983209882434,9.93332178511259e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,41911,0.0285751527776987,0.00401072751111217,0.0207141268559188,0.0364361786994785,1.09688327845772e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,41740,0.0575019701564557,0.00808162129581775,0.0416619924166529,0.0733419478962585,1.17584359697255e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,39598,0.0296618068148349,0.00416886240998838,0.0214908364912576,0.0378327771384121,1.18802863593267e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39625,0.04558339923407,0.00641452747786037,0.0330109253774636,0.0581558730906763,1.26577689554418e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39476,0.017887644541764,0.00252334895768101,0.0129418805847092,0.0228334084988188,1.43614272797945e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,41765,0.0330533817537035,0.00466381055643205,0.0239123130630967,0.0421944504443103,1.43817171479646e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39489,0.0461088491528805,0.00650692799739868,0.0333552702779791,0.0588624280277819,1.46455450093692e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,41877,-0.0452334262577799,0.00640271147352447,-0.0577827407458879,-0.032684111769672,1.68951288900037e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39250,0.0299514412920203,0.00425048110123005,0.0216204983336093,0.0382823842504312,1.9467997555034e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,41644,0.0545869167197471,0.00774864084456391,0.0393995806644019,0.0697742527750924,1.95177079316495e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,41765,-0.0236107827476708,0.00336978689629883,-0.0302155650644165,-0.0170060004309251,2.56038565806062e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,39650,-0.0205594636333625,0.00293453724827557,-0.0263111566399826,-0.0148077706267424,2.59433313220443e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41832,0.0434215393109109,0.00620202177816915,0.0312655766256993,0.0555775019961224,2.6603937491184e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,41802,-0.0286983231239775,0.00410034165172008,-0.0367349927613488,-0.0206616534866061,2.70230903807015e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,39598,0.0290285240124564,0.00415391780349328,0.0208868451176096,0.0371702029073032,2.94487050096243e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,41899,0.039151328998128,0.00560773414785568,0.0281601700683309,0.0501424879279251,3.055432280587e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,41836,-0.0240203357264609,0.00344089353314735,-0.0307644870514297,-0.0172761844014921,3.0740172380741e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41522,0.0420842708934349,0.00602949532535601,0.0302664600557372,0.0539020817311327,3.10178506631472e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,41884,-0.0282839088215344,0.00406516399018594,-0.0362516302422988,-0.0203161874007699,3.62259906800805e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,41911,0.0195680748057952,0.00282084937823387,0.0140392100244568,0.0250969395871336,4.19187324970507e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,41911,0.056034729316407,0.00810389920455381,0.0401510868754815,0.0719183717573325,4.90797903962782e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41764,-0.0244176953401486,0.00353473172210963,-0.0313457695154835,-0.0174896211648138,5.14361879665602e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39408,0.0172146967923375,0.00249869323486551,0.0123172580520011,0.0221121355326739,5.91114683251805e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41689,0.0396857472270119,0.00576168362555614,0.0283928473209218,0.0509786471331019,5.92202946146974e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,41765,0.0567406336715304,0.0082520689949378,0.0405665784414523,0.0729146889016085,6.43657046962049e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,41810,0.02531520001457,0.00368341666533421,0.0180957033505149,0.032534696678625,6.58018147647424e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41466,0.0390285715829752,0.00567892886453574,0.0278978710084852,0.0501592721574653,6.59830383675869e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41740,0.0738716623160946,0.0107791571795447,0.052744514244187,0.0949988103880022,7.54398018678384e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,41720,-0.0476651529946768,0.00695757053801915,-0.0613019912491943,-0.0340283147401593,7.66965473899908e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41636,0.0423481711113516,0.00619348732597664,0.0302089359524374,0.0544874062702659,8.41585362278741e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39509,0.022252786649531,0.00325559027049147,0.0158718297193678,0.0286337435796943,8.62290033739663e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,39655,0.0540117716038778,0.00790901239988837,0.0385101073000966,0.069513435907659,8.9905457249033e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,41862,0.020898427283357,0.00307075843564705,0.0148797407494888,0.0269171138172252,1.04935486802901e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41689,0.043778923279392,0.00643485715229079,0.0311666032609021,0.056391243297882,1.06620512608755e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39598,0.034757506522179,0.00510970979760299,0.0247424753188771,0.0447725377254809,1.08347118844009e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39600,0.0454096044635919,0.0066806503163883,0.0323155298434708,0.058503679083713,1.12205169074238e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39530,0.0200530202884405,0.00296265635229239,0.0142462138379474,0.0258598267389336,1.36699103387359e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,41819,0.0133165508196807,0.00197115743183937,0.00945308225327559,0.0171800193860859,1.48096616385248e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,41740,0.0407756607726476,0.00603577827830851,0.0289455353471629,0.0526057861981323,1.48175972015572e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39408,-0.0305057554268049,0.00451963986374567,-0.0393642495597464,-0.0216472612938634,1.55848963274289e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,41836,0.0413936995626905,0.00613680706400255,0.0293655577172455,0.0534218414081355,1.59217642829998e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41466,0.0213359426467578,0.00316674299387766,0.0151291263787576,0.027542758914758,1.67990445445702e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39250,0.0561465768136694,0.00833443169165589,0.0398110906980239,0.072482062929315,1.70383930610751e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,39621,-0.025645425027543,0.00382455693594566,-0.0331415566219964,-0.0181492934330895,2.10588490438455e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39598,0.0495258879249937,0.00742835258668468,0.0349663168550917,0.0640854589948956,2.73325832500836e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39600,0.0291611242361422,0.00438328057582228,0.0205698943075305,0.0377523541647539,3.01207209610387e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39616,-0.0523390550765545,0.00788155645064893,-0.0677869057198264,-0.0368912044332826,3.26890790978224e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,41925,0.0442078803793916,0.0066622406421172,0.0311498887208419,0.0572658720379413,3.35706803086165e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,41740,0.046863766683028,0.00709648663911611,0.0329546528703604,0.0607728804956956,4.16170189300131e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,41836,-0.0342181560682118,0.00518849230019878,-0.0443876009766014,-0.0240487111598222,4.41379125259613e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39250,0.0488253442473542,0.00740365129427286,0.0343141877105794,0.063336500784129,4.46111689215048e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41521,0.0382859342281951,0.00580713730358384,0.0269039451131707,0.0496679233432194,4.48053228285145e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41689,0.0692844385403841,0.0105153732096435,0.0486743070494827,0.0898945700312854,4.60145000620859e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41465,0.047027391582074,0.00715039098867459,0.0330126252442718,0.0610421579198762,4.98939426357655e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41466,0.0270347736830409,0.00411560157878315,0.0189681945886259,0.0351013527774559,5.26559856164582e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,41810,0.0320729956741664,0.00488394999840302,0.0225004536772965,0.0416455376710363,5.32530080603859e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39589,0.0398842821526019,0.00607395479483933,0.0279793307547169,0.051789233550487,5.38558370252892e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39655,-0.0190712527012446,0.0029108062220134,-0.0247764328963909,-0.0133660725060983,5.9342338700651e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39598,-0.0260021432764814,0.00397755266394273,-0.0337981464978091,-0.0182061400551536,6.54472390056613e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,39625,0.0471156037030925,0.00724862675930191,0.0329082952548608,0.0613229121513243,8.38237397788615e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41689,0.0743969358876535,0.0114620460686502,0.0519313255930992,0.0968625461822079,8.85068305516409e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,41925,0.0449926753916972,0.00693802007719721,0.0313941560403907,0.0585911947430038,9.18960297852274e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41847,0.0212390014026312,0.00327543739624089,0.014819144105999,0.0276588586992633,9.22918492392346e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,41911,0.0294246765336114,0.00455250017545248,0.0205017761897245,0.0383475768774982,1.05937179427428e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,41802,0.0279896036934734,0.0043339348463876,0.0194950913945537,0.0364841159923931,1.09636712700434e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39633,0.0274941487688101,0.00425758502539442,0.0191492821190371,0.0358390154185832,1.10784552264338e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,39625,0.037620383537462,0.00582779500997414,0.0261979053179127,0.0490428617570113,1.12513409944713e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41534,-0.0273956023126994,0.00424557265051556,-0.0357169247077099,-0.019074279917689,1.13757234101515e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,39625,0.0267259521433064,0.00414549717276138,0.0186007776846941,0.0348511266019187,1.18865952957654e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39655,-0.0446856282831459,0.00697303046504249,-0.0583527679946291,-0.0310184885716626,1.53086634253795e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,41791,-0.0267141881297788,0.0041693347220765,-0.0348860841850487,-0.0185422920745088,1.53149684045765e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,41740,0.0728198714088868,0.0114688362328397,0.0503409523925209,0.0952987904252527,2.2331404875777e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39598,0.0231944103647598,0.00366418971505305,0.0160125985232558,0.0303762222062637,2.54669070487122e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41466,-0.050620174767126,0.00800662161873083,-0.0663131531398384,-0.0349271963944136,2.66234614608379e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41689,0.0361246762022979,0.00573462880584323,0.0248848037428452,0.0473645486617507,3.08381638524796e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39625,0.0567697863650874,0.00901190757341115,0.0391064475212016,0.0744331252089733,3.10147680796806e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,41889,-0.0365577104912347,0.0058063411804359,-0.0479381392048891,-0.0251772817775803,3.14689094013145e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,41636,-0.0233015071098437,0.00370292254226368,-0.0305592352926806,-0.0160437789270069,3.2190785672772e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,39600,-0.0331219136332978,0.00526695553742977,-0.0434451464866601,-0.0227986807799354,3.32438700825102e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39408,0.0470897545806496,0.00753195724553387,0.0323271183794032,0.061852390781896,4.20536037650983e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39308,0.0243960911206659,0.00390219711756779,0.016747784770233,0.0320443974710988,4.20972586335464e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41577,0.0235984542675307,0.00377998641338296,0.0161896808973001,0.0310072276377614,4.42635439619253e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39308,0.0570936006282076,0.00914495495579938,0.0391694889148408,0.0750177123415744,4.45004683622176e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39600,0.0403551391356437,0.00646893166316292,0.0276760330758444,0.053034245195443,4.58604743570235e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39598,0.041742891636187,0.0067056299757062,0.0285998568838028,0.0548859263885712,4.98941606645223e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39308,0.0164799749409108,0.00265805844623587,0.0112701803862885,0.0216897694955331,5.85421422473305e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,41802,0.0373333603660135,0.00602881139351887,0.0255168900347166,0.0491498306973105,6.09770953619716e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39308,-0.0377711462047189,0.00610575955942245,-0.0497384349411869,-0.0258038574682509,6.39030849545843e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,41706,0.021725921538242,0.0035244390742579,0.0148180209526965,0.0286338221237875,7.28441267503288e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,41865,0.041574622054445,0.00675547501988426,0.0283338910154719,0.0548153530934182,7.76249813668322e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41384,-0.0259159435975505,0.00421265842739212,-0.0341727541152391,-0.017659133079862,7.88351193457644e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,39598,0.0359902747982737,0.00585169373296906,0.0245209550816543,0.047459594514893,7.99712491664041e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,39598,0.0435995217583209,0.0070931267333811,0.029696993360894,0.0575020501557479,8.183888480597e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39589,0.0471917127695388,0.00768040481107657,0.0321381193398287,0.0622453061992489,8.30305005346235e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41636,0.0305255925311804,0.0049714820076612,0.0207814877961645,0.0402696972661964,8.48441236474531e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41865,0.034342469829135,0.00559601468876393,0.0233742810391577,0.0453106586191123,8.65160829220132e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,41802,-0.0183042824310546,0.00298591441721753,-0.0241566746888009,-0.0124518901733082,9.02640434561632e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,41740,0.0395354608524417,0.0064551011055192,0.0268834626856241,0.0521874590192593,9.3455534842421e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,41911,0.0227134713609284,0.00371045299892581,0.0154409834830339,0.029985959238823,9.53142001375566e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,41718,0.0547250455801283,0.00896060560531566,0.0371622585937096,0.072287832566547,1.04198644253328e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39334,0.0323485683689325,0.00529840761146441,0.0219636894504623,0.0427334472874028,1.06131291652425e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41689,0.0381042201370451,0.00624558211224262,0.0258628791970496,0.0503455610770406,1.08388441273283e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39600,-0.0248969294844792,0.00408729189028817,-0.032908021589444,-0.0168858373795144,1.15740058312152e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39408,-0.034306499186788,0.00563563617273014,-0.0453523460853391,-0.0232606522882369,1.18637961381795e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,41911,0.0261404610179657,0.00430285921304265,0.0177068569604021,0.0345740650755293,1.27259858541696e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,41865,-0.0189249980443329,0.0031242824106466,-0.0250485915692002,-0.0128014045194655,1.42090129690055e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41465,0.0321858742314105,0.00531587837598764,0.0217667526144747,0.0426049958483463,1.44627472283214e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39427,0.0372695779441983,0.00615564866532931,0.0252045065601529,0.0493346493282438,1.45496435828559e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39589,0.0319728067584504,0.00528709759842985,0.0216100954655279,0.0423355180513729,1.5205779092265e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,41855,0.0420147520033556,0.00695509087592361,0.0283827738865453,0.0556467301201658,1.57397427544292e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39625,0.0494898050892145,0.00819227907999625,0.0334329380924218,0.0655466720860071,1.58076043718334e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39328,0.0296493674265843,0.00492751347168464,0.0199914410220824,0.0393072938310861,1.83363948707963e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39413,0.0298691635690628,0.00496971485470803,0.0201285224538351,0.0396098046842906,1.91228677044773e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41836,0.0276450715347462,0.00460418610377487,0.0186208667713474,0.0366692762981449,1.9714970202215e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,41765,0.0179708782882625,0.00299424276251204,0.0121021624737389,0.0238395941027861,2.00258231898264e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,41758,0.0289022532944383,0.00482490135067503,0.0194454466471152,0.0383590599417614,2.15017920028097e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41465,0.0439148399003503,0.00734285587400653,0.0295228423872975,0.0583068374134031,2.28186173175109e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41521,0.0362287030529724,0.00606924503476658,0.0243329827848299,0.0481244233211149,2.44629902509103e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,41891,0.0436250965956163,0.00732214979124638,0.0292736830047734,0.0579765101864592,2.61861160356575e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41466,0.0376305903240409,0.0063212333529789,0.0252409729522022,0.0500202076958795,2.70054756001857e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41637,0.0322729921317118,0.00542846571335364,0.0216331993335387,0.0429127849298849,2.83283137513279e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41802,0.0237931893849765,0.00400385816058464,0.0159456273902306,0.0316407513797224,2.87668190633287e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,41740,0.0467753272500669,0.00787880673423168,0.0313328660509728,0.062217788449161,2.97873289994726e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,41764,0.0188474004218441,0.00317999022612778,0.0126146195786337,0.0250801812650546,3.16480637041712e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,41848,0.0306613471360029,0.00519404826952635,0.0204810125277312,0.0408416817442745,3.65308603260061e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41466,0.0215448049625511,0.00365048818746206,0.0143898481151255,0.0286997618099767,3.68394377436161e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,41802,-0.0181421043533827,0.00307701855677299,-0.0241730607246578,-0.0121111479821076,3.81517607074591e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39308,0.0147078436179254,0.00249502723630385,0.00981759023476987,0.019598097001081,3.86309241526959e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39633,0.0302098703717977,0.00512977956646564,0.0201555024215251,0.0402642383220704,3.99589493756356e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,41758,0.0151952466757286,0.00258118398148681,0.0101361260720144,0.0202543672794427,4.03026439365882e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,41679,0.0351101903714821,0.00597408807017994,0.0234009777539294,0.0468194029890348,4.27739353439568e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,41925,-0.0171001623680917,0.002916927309647,-0.0228173398949998,-0.0113829848411835,4.67054620518097e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39336,0.0173358869745824,0.00295681721739884,0.0115405252284807,0.0231312487206841,4.67906752330779e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,41903,-0.0277321103424603,0.00473191188107147,-0.0370066576293604,-0.0184575630555602,4.71959296353281e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,39633,0.0177132464028168,0.00302389485794584,0.011786412481243,0.0236400803243907,4.8255401364158e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39625,0.0457813318409645,0.00783195725682954,0.0304306956175786,0.0611319680643504,5.19512899457803e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39334,0.02030924936775,0.00348817636251854,0.0134724236972137,0.0271460750382863,5.97031918358954e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,41911,0.0266863036472821,0.00458658217032732,0.0176966025934405,0.0356760047011236,6.08013793911918e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,41765,0.0426680448268981,0.00733755180828494,0.0282864432826596,0.0570496463711366,6.20319671133429e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41829,0.0641005915887331,0.0110277579114482,0.0424861860822945,0.0857149970951716,6.29062125300188e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41466,0.0268969644265525,0.00463058950736133,0.0178210089921243,0.0359729198609807,6.45103579192871e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39633,0.0177467250667581,0.00306026507270174,0.0117486055242627,0.0237448446092535,6.85095017225555e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,41740,-0.0277579796074026,0.00479471541373481,-0.0371556218183228,-0.0183603373964824,7.23014506852702e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,41750,0.0237437345293363,0.00410612178694289,0.0156957358269282,0.0317917332317443,7.52620960897056e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41601,-0.0355296107991115,0.00614515855080883,-0.0475741215586968,-0.0234851000395262,7.56380225589964e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39259,0.0528865248876578,0.00915082756699485,0.0349509028563479,0.0708221469189677,7.70583088611802e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,41758,0.034599819030484,0.00599236667359153,0.0228547803502446,0.0463448577107234,7.91679885832315e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39308,0.0387217392657227,0.00670709679568914,0.025575829546172,0.0518676489852734,7.9918894334556e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39259,0.0252934603228745,0.00438231632627261,0.0167041203233802,0.0338828003223688,8.06600683793027e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41783,0.0307407802021455,0.00534311226816871,0.0202682801565348,0.0412132802477561,8.94380999704305e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,39633,-0.031689921270815,0.0055171702851463,-0.0425035750297018,-0.0208762675119283,9.49816167938426e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39334,0.0231670063197795,0.0040384832297084,0.015251579189551,0.0310824334500079,9.92308689945942e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39308,0.0193635210957113,0.00337995711570303,0.0127388051489334,0.0259882370424893,1.03794500153537e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,41925,-0.0196825924276763,0.00343679334631968,-0.0264187073864629,-0.0129464774688897,1.0441578801725e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41689,0.0701873441876496,0.0122781847012828,0.0461221021731353,0.0942525862021639,1.11161875589988e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,39576,0.0199470125986874,0.00350795060810475,0.0130714294068021,0.0268225957905727,1.33191548397068e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,41805,0.0237319325745127,0.0042105712248562,0.0154792129737945,0.0319846521752308,1.77325727563986e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41521,0.0345532684754139,0.00613757312403071,0.0225236251523137,0.0465829117985141,1.84183560622164e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39600,0.0182717234044991,0.0032489866979803,0.0119037094764577,0.0246397373325405,1.91335462791271e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41465,0.0368258260146614,0.00655988912835154,0.0239684433230924,0.0496832087062304,2.02039811322331e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39250,0.0296542477528825,0.00528816574778615,0.0192894428872217,0.0400190526185434,2.10189796422087e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,41865,0.0346360552138601,0.00618666381607664,0.0225101941343499,0.0467619162933703,2.20501541615047e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,39589,0.0221685429616904,0.00396467425844589,0.0143977814151364,0.0299393045082443,2.30469521786573e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,41740,-0.0316039768977923,0.00565710301060023,-0.0426918987985687,-0.0205160549970158,2.36157847650507e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",41755,-0.0318961142956325,0.00573096627135262,-0.0431288081874836,-0.0206634204037814,2.66401188845918e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39308,0.0309889270773444,0.00557221719734571,0.0200673813705469,0.041910472784142,2.74154295264956e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,39625,0.0546695366418977,0.00984294183492545,0.0353773706454438,0.0739617026383516,2.85373221810264e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41636,0.031283454349065,0.00565062335780564,0.0202082325677659,0.042358676130364,3.14929552544895e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39474,0.0160502312591113,0.00290205739039983,0.0103621987739276,0.0217382637442949,3.26443452793779e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39308,0.0264294970390375,0.00477890158107264,0.0170628499401351,0.0357961441379399,3.26901560847362e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,41636,0.0395648903993933,0.00716649432509191,0.0255185615222131,0.0536112192765734,3.43882716988594e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,39625,0.0193782817900399,0.00351066377780006,0.0124973807855518,0.0262591827945281,3.46997258514174e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,41765,-0.0419122391361951,0.00760685601017018,-0.0568216769161287,-0.0270028013562616,3.65994402925245e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39334,0.022279227028353,0.00404319624347397,0.014354562391144,0.030203891665562,3.66491998941913e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,41740,-0.033730035798726,0.00613118683412271,-0.0457471619936065,-0.0217129096038454,3.83863368969762e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39328,0.0198499247525469,0.00361676348576019,0.0127610683204569,0.0269387811846369,4.15022593672767e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,41758,0.0137046065585405,0.00250197099638838,0.00880074340561929,0.0186084697114617,4.3924066803469e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41465,0.0375417902257151,0.00686062848302927,0.0240949583989777,0.0509886220524524,4.53152659548e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41251,0.0222781746567425,0.00409557373441953,0.0142508501372802,0.0303054991762047,5.44015140566074e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,41802,0.0486611921080158,0.00895570515970016,0.0311080099950035,0.0662143742210281,5.6226545558923e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39600,0.032690783958762,0.00601671482806884,0.0208980228957471,0.0444835450217769,5.64917905950915e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39598,0.0283704506447657,0.00522450037798987,0.0181304299039056,0.0386104713856258,5.74657670672978e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,41740,0.0424762155563389,0.0078461377475778,0.0270977855710864,0.0578546455415914,6.28390272876551e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41465,0.0479358563670563,0.00886951036139119,0.0305516160587295,0.065320096675383,6.61237643848428e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,41636,0.0510749977427877,0.00945993064289208,0.0325335336827192,0.0696164618028561,6.8154373926625e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,39650,-0.0135063494296938,0.00250337762547772,-0.0184129695756301,-0.00859972928375745,6.98406667182014e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39598,0.0514990649160151,0.00954844544435107,0.032784111845087,0.0702140179869432,7.05493149980959e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41383,0.062622099737266,0.0116437322957249,0.0398003844376453,0.0854438150368867,7.65668574068056e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39600,0.016359015883563,0.00304365071813524,0.0103934604760179,0.022324571291108,7.82340290827248e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41465,0.0330215228682222,0.00614877698330527,0.0209699199809438,0.0450731257555005,7.99192975355121e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41465,0.0282329427758912,0.00527151654774837,0.0179007703423044,0.038565115209478,8.66669215795619e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,39534,0.0142868071035331,0.00267031754137774,0.00905298472243273,0.0195206294846335,8.96174056560735e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41689,0.0725396962413897,0.0135777921840733,0.045927223560606,0.0991521689221734,9.31960372138263e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39408,0.0267701922908672,0.00501501611959418,0.0169407606964626,0.0365996238852718,9.58765382354206e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39192,0.0305897154323938,0.00574841172836888,0.0193228284447908,0.0418566024199968,1.05062105919712e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,41750,0.0437991247918868,0.00823286115235444,0.0276627169332721,0.0599355326505015,1.05447719274911e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,41740,0.0245222872811193,0.00460999778922206,0.0154866916142441,0.0335578829479946,1.05834973022275e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41466,0.0380591553351324,0.00715799443823184,0.024029486236198,0.0520888244340668,1.0724858469737e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,41740,0.0594598869908549,0.0112222301120878,0.0374643159711628,0.081455458010547,1.18707675683945e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39589,0.0408174424124791,0.0077054639201649,0.0257147331289559,0.0559201516960023,1.19859256093269e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,41744,-0.0254354699188092,0.00480659097403715,-0.034856388227922,-0.0160145516096963,1.23071543881603e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,39655,0.0166236914209988,0.0031430871283285,0.0104632406494749,0.0227841421925227,1.25355951348355e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,41765,-0.0269283066883793,0.00509315109141582,-0.0369108828275543,-0.0169457305492043,1.26216208588188e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,41805,0.0141418157633089,0.0026752911074661,0.00889824519267532,0.0193853863339424,1.26952491356802e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41521,0.0213958417716261,0.00405435989496501,0.0134492963774947,0.0293423871657575,1.3326335428833e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41447,0.0415160140657765,0.0078735554365126,0.0260838454102118,0.0569481827213412,1.36505515521318e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39334,-0.0184552178048024,0.00350997775960578,-0.0253347742136297,-0.011575661395975,1.48486035001821e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41465,0.0301027228513615,0.00573069359460805,0.0188705634059297,0.0413348822967933,1.52117286119318e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,41740,0.0504557367407572,0.00960577697082307,0.031628413877944,0.0692830596035704,1.52271844385437e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41465,0.0553408884705134,0.01053626177307,0.0346898153952961,0.0759919615457306,1.52506818947873e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,41805,0.016822438796938,0.00320827491205481,0.0105342199693106,0.0231106576245654,1.60031397049165e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39408,0.0296672333792703,0.00566722713350357,0.0185594681976033,0.0407749985609373,1.68193133528815e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41534,0.0306611046805236,0.00585809612465352,0.0191792362762027,0.0421429730848445,1.68502883929083e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,39627,0.0211323025616748,0.00403984924765592,0.0132141980362691,0.0290504070870804,1.71720887309159e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,41689,-0.0169310416207553,0.00323784666249004,-0.0232772210792358,-0.0105848621622748,1.72956475300808e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41534,0.0265051637979227,0.00508120163832633,0.0165460085868031,0.0364643190090423,1.85333570009116e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41465,0.0291671083616355,0.00559251128497599,0.0182057862430825,0.0401284304801884,1.86280657773704e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,39596,-0.0269746191663006,0.00517583220929331,-0.0371192502965155,-0.0168299880360857,1.90561914132039e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,41911,0.0197059460344243,0.00378381183626049,0.0122896748353537,0.0271222172334949,1.93773567725498e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41465,0.0267520001326886,0.00513939537211271,0.0166787852033477,0.0368252150620295,1.96685772197381e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,39633,-0.0226502489623046,0.00435402019759235,-0.0311841285495856,-0.0141163693750236,2.00533375046359e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41636,0.0240307431964908,0.00462066530285625,0.0149742392028926,0.0330872471900891,2.01534765368977e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,41758,-0.0329815529889273,0.00636417802063691,-0.0454553419093757,-0.020507764068479,2.2232115737303e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41689,0.0298687319317781,0.00576468050595866,0.0185699581400991,0.0411675057234571,2.23580347088604e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,41925,0.0224330468922293,0.00433851292998866,0.0139295615494515,0.0309365322350071,2.36626602332358e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,41740,0.0450047728555063,0.00870707109092438,0.0279389135172945,0.0620706321937181,2.39107255274215e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39308,0.0287528027547873,0.00556225308032105,0.017850786717358,0.0396548187922165,2.39244411220858e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,41636,-0.0185112572136317,0.0035901816111581,-0.0255480131715016,-0.0114745012557618,2.55868941301026e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39090,0.0276416602252387,0.00536044262237034,0.0171351926853929,0.0381481277650846,2.56059157431816e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41689,0.0156141584393476,0.00302850740633694,0.00967828392292718,0.021550032955768,2.56332533330932e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,41740,0.0536043262210395,0.0104075974029499,0.0332054353112577,0.0740032171308212,2.6355226871414e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39408,0.0416071190894746,0.00807799023212043,0.0257742582345186,0.0574399799444307,2.64119618688012e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,41866,0.0279443509142185,0.00543341823379793,0.0172948511759746,0.0385938506524625,2.74163044342014e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,41765,0.0340810493027199,0.00662666495260289,0.0210927859956182,0.0470693126098215,2.74243606860668e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,41865,0.0191074472334366,0.00372916878931979,0.0117982764063699,0.0264166180605034,3.03673329630381e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,39650,0.0112933900163313,0.00220696695558161,0.00696773478339132,0.0156190452492712,3.15389361847503e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,41810,-0.0164847026377546,0.0032238684549976,-0.0228034848095499,-0.0101659204659593,3.2095773996761e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,41865,0.0374676051836368,0.00733116569391752,0.0230985204235585,0.0518366899437152,3.25379737173238e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39578,0.0431576536710506,0.00845923457133157,0.0265775539112407,0.0597377534308605,3.41989045091268e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,41740,0.0477159834986244,0.00936894699198692,0.02935284739433,0.0660791196029188,3.57336001472544e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,39589,0.0122166533423762,0.00239869953489582,0.00751520225398042,0.016918104430772,3.58224921652972e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39554,-0.0149949305254976,0.00294487236874102,-0.02076688036823,-0.00922298068276525,3.6042641221036e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39583,0.0604204373150181,0.0118766732525541,0.0371421577400121,0.083698716890024,3.69157165071091e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,41877,0.0203835352578855,0.0040127082983284,0.0125186269931618,0.0282484435226091,3.83069912110384e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,39600,0.0242643902827261,0.00478299191169972,0.0148897261357946,0.0336390544296575,3.97861237110973e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39625,0.0342282104221237,0.00675038801766332,0.0209974499075036,0.0474589709367438,4.03101613848738e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,41636,-0.0142197529104793,0.00280717580144983,-0.019721817481321,-0.00871768833963765,4.12895492970368e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,41855,0.0194284277996878,0.00383924417797144,0.0119035092108638,0.0269533463885119,4.23797661381446e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41911,-0.0151890576432666,0.00300309611809421,-0.0210751260347313,-0.00930298925180198,4.29766720785641e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41911,0.0211212120278503,0.00417745023001947,0.0129334095770122,0.0293090144786885,4.33818516335914e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39600,0.0281082535290283,0.00556640989212856,0.0171980901404564,0.0390184169176003,4.4978284149909e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,41758,0.0314706178622403,0.00625402085189388,0.0192127369925283,0.0437284987319523,4.91638540139172e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41636,0.03022573318792,0.00602249346883007,0.0184216459890131,0.042029820386827,5.2679037041499e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39476,0.0304860202510952,0.00607987937338347,0.0185694566792636,0.0424025838229268,5.40809577054387e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39598,0.0377934827859894,0.00754815143843939,0.0229991059666482,0.0525878596053306,5.61464409876396e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,41802,0.0134586886410915,0.00268980970218452,0.00818666162480981,0.0187307156573731,5.69983591098187e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41383,0.0404699962794502,0.0080971884355738,0.0245995069457255,0.0563404856131748,5.868540345392e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,41736,0.0496021750384548,0.00994260704747024,0.0301146652254131,0.0690896848514965,6.1516490151446e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,41915,-0.023649928750948,0.00476006356032753,-0.03297965332919,-0.0143202041727061,6.83435874661563e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41455,0.020823575399137,0.00420279992006606,0.0125860875558075,0.0290610632424665,7.33671404275613e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39308,0.0281421581263139,0.00567937197980964,0.017010589045887,0.0392737272067408,7.33789212519487e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39250,0.0192861048483172,0.00389435036412699,0.0116531781346283,0.0269190315620061,7.44558469625062e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39328,0.035383697929815,0.00714726134753985,0.0213750656886369,0.0493923301709931,7.50855630663945e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,41758,-0.0167180453676642,0.00338008873307643,-0.023343019284494,-0.0100930714508344,7.66745213987896e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41287,-0.0167192247725001,0.00338112523156141,-0.0233462302263605,-0.0100922193186397,7.71696372321376e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,41911,-0.0130887412482922,0.00265020322982839,-0.0182831395787558,-0.00789434291782855,7.95713088811796e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,41740,0.0259938141014015,0.00526823377113663,0.0156680759099737,0.0363195522928293,8.15215233906676e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41534,0.0328132684514316,0.00665267551672283,0.0197740244386549,0.0458525124642084,8.22593515475663e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,41925,0.0145787980234284,0.00295830636167714,0.00878051755454119,0.0203770784923156,8.40358113257832e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41689,-0.0127344240484217,0.00259181115404496,-0.0178143739103498,-0.00765447418649355,9.06254746708451e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41465,0.0283411209571707,0.0057692621999291,0.0170333670453096,0.0396488748690317,9.10589923229738e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39598,0.0235263492783044,0.00479447158298046,0.0141291849756627,0.0329235135809461,9.38182624320111e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,41765,0.018605308509855,0.00379901806200455,0.0111592331083261,0.0260513839113839,9.82667370407553e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,41832,0.0316920782884119,0.00649020010730079,0.0189712860781023,0.0444128704987214,1.05668929302145e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39633,0.0123760643599319,0.00253835596332399,0.00740088667181684,0.0173512420480469,1.099783095601e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,41761,0.0206853492521259,0.00424621621734723,0.0123627654661253,0.0290079330381265,1.12055636783191e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41740,0.0319934851382811,0.00656831263905488,0.0191195923657335,0.0448673779108286,1.12394918078823e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39250,0.029414482963683,0.00604220192660231,0.0175717671875425,0.0412571987398236,1.14252354179177e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,41899,0.020299480591868,0.00417718574248192,0.0121121965366034,0.0284867646471326,1.18961017607437e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,41765,0.0194038747591585,0.00399508022071708,0.011573517526553,0.027234231991764,1.20583338415798e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,41721,0.0127712512115782,0.00263174502796415,0.0076130309567685,0.017929471466388,1.23149709492692e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41465,0.0299686363226268,0.00619417358545398,0.017828056095137,0.0421092165501166,1.32541154076248e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41534,0.0309792939426878,0.00640476862369726,0.0184259474402412,0.0435326404451344,1.33392101371571e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41689,0.0542735335913124,0.0112218591512796,0.0322786896548044,0.0762683775278203,1.33708366711541e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39334,0.0291782371781946,0.00603405170708697,0.0173514958323042,0.0410049785240851,1.3459000915469e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41465,0.0235609450667387,0.00487536278682782,0.0140052340045562,0.0331166561289212,1.36279711356975e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41333,0.0209513312928442,0.00433921622948239,0.0124464674830587,0.0294561951026297,1.39257067167627e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,39625,0.0141120060101568,0.002923954522716,0.00838105514563347,0.0198429568746802,1.40928662287224e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,39650,0.0177303730891829,0.00367536059987574,0.0105266663134265,0.0249340798649394,1.42502865887928e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41679,0.0245472067657228,0.00509385119802609,0.0145632584175917,0.034531155113854,1.4590896815946e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,41786,-0.0407326580628316,0.00845792878426277,-0.0573101984799866,-0.0241551176456765,1.48155896422046e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39600,-0.0540666750858805,0.0112386489918255,-0.0760944271098585,-0.0320389230619024,1.52338140022907e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,41848,-0.00993566684670073,0.00206643507094728,-0.0139858795857574,-0.00588545410764406,1.54031266209075e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,41925,0.0161081751552109,0.00335299541678413,0.00953630413831405,0.0226800461721078,1.57130675213129e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39408,0.0351872114195415,0.0073343894412187,0.0208118081147529,0.0495626147243302,1.62753549455082e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41689,0.0107329585523086,0.00223815114406087,0.00634618230994928,0.0151197347946679,1.64091439189903e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,41865,0.0333609151988489,0.00696371942849497,0.0197120251189988,0.0470098052786991,1.68020551201035e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,41840,0.0302273786627395,0.00631012685094748,0.0178595300348824,0.0425952272905965,1.68340506564865e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41467,0.0231047576357838,0.00482696394089916,0.0136439083116215,0.0325656069599462,1.71515253995883e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39600,0.0528806108467222,0.0110504141186063,0.0312217991742539,0.0745394225191905,1.72870244604281e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41667,0.038951673871625,0.00815086690373449,0.0229759747403054,0.0549273730029446,1.78230070867965e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41689,-0.0218851450569795,0.00458266612150109,-0.0308671706551216,-0.0129031194588373,1.81081735778922e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,41689,0.0488082599383272,0.0102312194177153,0.0287550698796051,0.0688614499970492,1.85732122222931e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39328,0.0360740007646465,0.00756470120978261,0.0212471863934726,0.0509008151358204,1.87833064691314e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41465,0.0142713137751521,0.00299303556058654,0.00840496407640248,0.0201376634739017,1.87941070927831e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,41765,0.015941181765429,0.00334467712161041,0.00938561460707255,0.0224967489237854,1.89801716297505e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,41689,0.016469484368739,0.00345945561662896,0.00968895136014622,0.0232500173773317,1.94973336192016e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41614,0.0189693869144957,0.00398549361206212,0.011157819434854,0.0267809543941375,1.96056532446894e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39308,0.0374722514907029,0.0078722190197085,0.0220427022120742,0.0529018007693316,1.96067525055948e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39625,0.0147614869846337,0.00310460813312684,0.00867645504370505,0.0208465189255623,2.01255317275711e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39655,0.0339434356394657,0.00715191168841227,0.0199256887301777,0.0479611825487538,2.10012828925719e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,39589,0.0514579093922332,0.0108563230107763,0.0301795162911117,0.0727363024933548,2.16504869566322e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39408,0.0604243099307403,0.0127605959313945,0.0354135419052072,0.0854350779562735,2.21592457755256e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,41805,-0.0208804970864612,0.00441758594172473,-0.0295389655322416,-0.0122220286406807,2.30581155623679e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39589,0.0581570382932305,0.0123255578702404,0.0339989448675593,0.0823151317189016,2.4062601615697e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41521,-0.0112246595061613,0.00237959271443438,-0.0158886612264527,-0.00656065778586995,2.41793096182378e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,41925,-0.0157274782875783,0.00333671254805033,-0.022267434881757,-0.00918752169339971,2.46004096110208e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,41802,-0.0155695051525571,0.00330933024963498,-0.0220557924418416,-0.00908321786327252,2.56780364117031e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39600,0.0393235992206223,0.00839466281529905,0.0228700601026362,0.0557771383386085,2.84204280478389e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,39600,0.053058200185986,0.0113385783076234,0.0308345867030442,0.0752818136689278,2.91091278405992e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39250,0.0216009332232624,0.00462839332102936,0.0125292823140449,0.03067258413248,3.09285933399054e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",39650,0.00839893559568802,0.00180296084444063,0.00486513234058438,0.0119327388507917,3.22376536271114e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,41740,0.0201375542859386,0.00432506625209875,0.011660424431825,0.0286146841400521,3.25551437949622e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,41636,-0.0169913342663802,0.0036539133869088,-0.0241530045047215,-0.00982966402803896,3.34911510536831e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41689,0.0222103133710766,0.00477800892415253,0.0128454158797376,0.0315752108624155,3.37712540186457e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39565,0.0227581268493055,0.00490444825432638,0.0131454082708258,0.0323708454277852,3.5192990135157e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39427,0.0222546043172976,0.0048040923881675,0.0128385832364893,0.0316706253981059,3.65618842038858e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,41865,-0.0105763945727499,0.0022855777042131,-0.0150561268730076,-0.00609666227249221,3.73702810190319e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41521,0.0177512390117328,0.00384072225657982,0.0102234233888363,0.0252790546346292,3.8401523971281e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39408,0.0271374758525174,0.00587514035395632,0.015622200758763,0.0386527509462718,3.89983053120927e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,41734,-0.0146181900308957,0.00316630902080031,-0.0208241557116644,-0.00841222435012712,3.93412164719992e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,41925,-0.00793003129951509,0.00171869740020723,-0.0112986782039213,-0.00456138439510892,3.9871747070215e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,41925,0.0329110713211312,0.0071449555931092,0.0189069583586372,0.0469151842836252,4.13898498298237e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",41765,0.0364445880311417,0.00791949243217752,0.0209223828640738,0.0519667931982097,4.22596560680583e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39427,0.0259710313380665,0.00565097498216152,0.0148951203730299,0.0370469423031031,4.35863607275306e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41466,0.0264005852495818,0.00574700974909967,0.0151364461413465,0.0376647243578172,4.39389129329883e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,39650,-0.0111576843818918,0.0024286934942826,-0.0159179236306857,-0.00639744513309791,4.394090853191e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41617,0.0341999868619552,0.00745387914227143,0.0195903837431032,0.0488095899808072,4.51231293197626e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,41865,0.0282869057994106,0.00616616743354157,0.0162012176296692,0.0403725939691521,4.52830007615355e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,41877,-0.0164174641277132,0.00358229601590057,-0.0234387643188783,-0.00939616393654811,4.62652946991528e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,41655,0.0333958365050161,0.00729709512918308,0.0190935300518173,0.047698142958215,4.76967480314163e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41751,0.0284726430833131,0.00622298688488462,0.0162755887889393,0.040669697377687,4.79661937342115e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39598,0.0411658449531971,0.0089977447536324,0.0235302652360776,0.0588014246703167,4.81133114958886e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,41802,-0.0135579996930418,0.00296497797643721,-0.0193693565268588,-0.0077466428592249,4.85820491815482e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39308,0.0365672424412507,0.00800091179258787,0.0208854553277785,0.0522490295547229,4.92279747852192e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39625,0.0125271711331867,0.0027525604055738,0.0071321527382621,0.0179221895281114,5.39375280247791e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,41765,0.0140864518014085,0.00309753594061267,0.00801528135780761,0.0201576222450093,5.47372081363675e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,41740,0.045234981481824,0.00995251351607402,0.025728054990319,0.0647419079733291,5.54040420675774e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39600,0.0534438160848586,0.0117633421616517,0.0303876654480212,0.0764999667216959,5.59830751147857e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39308,0.0364298638323882,0.00801891680129663,0.0207127869018468,0.0521469407629296,5.60683351443527e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39427,0.0266407564175741,0.00586559245969154,0.0151441951965786,0.0381373176385695,5.6360060404314e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,41689,-0.0136237269462297,0.00300017968346012,-0.0195040791258115,-0.00774337476664782,5.64957211049093e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,41758,0.0147649745042555,0.0032553226418261,0.00838454212627632,0.0211454068822346,5.7936431099074e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,41877,0.0154808865924863,0.00341420238002764,0.00878904992763211,0.0221727232573404,5.83111116587176e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39250,0.0366784385061261,0.00809999350023889,0.0208024512456578,0.0525544257665943,6.01326432878528e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39583,0.0195193271162449,0.00434001688499885,0.0110128940216472,0.0280257602108427,6.94548688388786e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,39600,0.0461823212729954,0.0102706870253264,0.0260517747033557,0.0663128678426351,6.97824617371985e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39589,0.0385789629567993,0.00858624561893855,0.0217499215436797,0.0554080043699188,7.09067712855289e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,39625,0.0224956918954246,0.00500935384413515,0.0126773583609197,0.0323140254299295,7.16981796402313e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39328,0.0227601581592755,0.00507763163020367,0.0128080001640763,0.0327123161544747,7.45609551208488e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41443,-0.022013003914823,0.00491328759647107,-0.0316430476039063,-0.0123829602257397,7.51820508182822e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,41702,0.0203775900091433,0.00455075526498772,0.0114581096897674,0.0292970703285192,7.60364234613471e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39598,0.0149568273529599,0.00334291945836144,0.00840470521457151,0.0215089494913484,7.74749004700153e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39408,-0.0176000867647976,0.00394164038010944,-0.0253257019098121,-0.00987447161978304,8.08171628899921e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39600,0.052227738689172,0.0116990173388554,0.0292976647050155,0.0751578126733285,8.11365751007755e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41614,0.043105175568741,0.0096604371464596,0.0241707187616802,0.0620396323758018,8.18676423631595e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39598,-0.0340595631262427,0.00763790512616875,-0.0490298571735334,-0.0190892690789519,8.30504000768368e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,41805,0.0171604019679948,0.00386292522741411,0.00958906852226317,0.0247317354137265,8.97121518633727e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39625,0.0164239666675341,0.00369999046099085,0.00917198536399203,0.0236759479710762,9.12893701054926e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39035,0.0593244443902003,0.0133941651168824,0.0330718807611107,0.0855770080192899,9.55791236498819e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41636,0.0113850722138377,0.0025760606154726,0.00633599340751138,0.016434151020164,9.96977063334638e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39408,0.0368923188483905,0.00834734873197701,0.0205315153337156,0.0532531223630655,9.98269185316665e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39427,0.054612088381579,0.0123686798239813,0.0303694759265756,0.0788547008365823,1.01822991613262e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,41802,0.0255403834336774,0.00578700689489233,0.0141978499196884,0.0368829169476663,1.02566353710892e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41521,-0.0164007382089971,0.00372066048915493,-0.0236932327677407,-0.00910824365025342,1.05162536801473e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41557,-0.0195096753462617,0.00442671539439016,-0.0281860375192664,-0.010833313173257,1.05529307341499e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,41612,-0.0165856993556684,0.00376701477712753,-0.0239690483188384,-0.00920235039249843,1.07677149395344e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,41689,-0.0215071452044214,0.00488629466268033,-0.0310842827432749,-0.011930007665568,1.0834421376862e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39598,0.0196943700972529,0.00447447111196757,0.0109244067177965,0.0284643334767093,1.08520434593525e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39308,0.0416078194697243,0.00945889751383068,0.0230683803426162,0.0601472585968324,1.09901816603307e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,41865,0.011226903296847,0.00255406109714528,0.00622094354644223,0.0162328630472517,1.11271341489988e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,39608,-0.00902111530897922,0.00205331712647185,-0.013045616876864,-0.00499661374109439,1.12617353894041e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41466,0.0243011408956581,0.00553692353511646,0.0134487707668298,0.0351535110244863,1.1482019250905e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41466,0.0373871713756337,0.00852198633378483,0.0206840781614154,0.054090264589852,1.15763143414537e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,41819,-0.0106275542614334,0.00242963882821391,-0.0153896463647326,-0.0058654621581341,1.22851494123079e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,39600,0.02716843977168,0.00622694206533333,0.0149636333236267,0.0393732462197334,1.29432767022893e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39633,0.0241501852756664,0.00554295096789633,0.0132860013785896,0.0350143691727432,1.33098843439771e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39633,-0.0102969835565437,0.00236547804185899,-0.0149333205185873,-0.00566064659450008,1.354819081966e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,41865,-0.0601876784023146,0.0138307847955027,-0.0872960166014999,-0.0330793402031293,1.36085203324158e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,39600,0.0137910126562927,0.00317018232619337,0.00757745529695365,0.0200045700156317,1.3722258347978e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39633,0.0202993064489825,0.00467053334026203,0.011145061102069,0.0294535517958961,1.39724820879154e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41534,0.032745738175587,0.00753538165961621,0.0179763901227393,0.0475150862284348,1.39956806186018e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,41877,0.0256209235564363,0.00589714439576484,0.0140625205407372,0.0371793265721354,1.40545361507687e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,41758,0.0123364466827483,0.00284116050253271,0.00676777209778418,0.0179051212677124,1.42218174012993e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,41750,0.0222333772564404,0.00512136705034486,0.0121954978377645,0.0322712566751163,1.42702968737039e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39250,-0.0124080860289124,0.00285899219838149,-0.0180117107377401,-0.00680446132008466,1.43783842789065e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,41865,0.0216651682005562,0.00499348672251243,0.0118779342244318,0.0314524021766806,1.44397498333756e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41466,-0.0212157343606851,0.00490430343951445,-0.0308281691021335,-0.0116032996192368,1.53026236709759e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,41877,0.0181954449150906,0.004208732256412,0.00994632969252304,0.0264445601376581,1.54860713615818e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,41903,-0.0140290917423263,0.00325158088452492,-0.0204021902759951,-0.00765599320865741,1.61086450845788e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39250,0.0168414891630105,0.00390929765079471,0.00917926576745288,0.0245037125585681,1.66170047006115e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41689,0.0151974681696516,0.00352803165598133,0.00828252612392824,0.022112410215375,1.66213543728755e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,41888,0.0090934961978866,0.0021112447731487,0.00495545644251515,0.013231535953258,1.66541515570771e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,41744,0.0126960785689392,0.00294792371268122,0.00691814809208398,0.0184740090457944,1.66845070318912e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39308,-0.0331452284022743,0.00770054200943161,-0.0482382907407603,-0.0180521660637883,1.69025334585519e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39470,-0.00378622632593059,0.000880864605415294,-0.00551272095254456,-0.00205973169931661,1.73607331651159e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39308,-0.0355317978351148,0.00826795085251142,-0.0517369815060372,-0.0193266141641924,1.74235504020607e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39600,0.0232672646870057,0.0054170489219343,0.0126498488000145,0.033884680573997,1.76040810949416e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,41740,-0.0363641004603861,0.00847198844466279,-0.0529691978119251,-0.019759003108847,1.78119198287183e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39328,0.0309226506070367,0.00722072221726415,0.016770035061199,0.0450752661528745,1.86424515581281e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39598,0.0295728336145443,0.00691049977226376,0.0160282540609073,0.0431174131681812,1.88979483078885e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39598,0.0315459712066427,0.00737433826626228,0.0170922682047686,0.0459996742085167,1.90342214903875e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41502,-0.0261375025391226,0.00611143678570679,-0.0381159186391079,-0.0141590864391373,1.90948242804693e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41465,0.0442575998633861,0.0103489592697091,0.0239736396947563,0.0645415600320158,1.91201759069081e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,41740,-0.0286178982206609,0.0066933016548741,-0.0417367694642142,-0.0154990269771077,1.91966569578232e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,41744,0.0260031692781057,0.00608384697379674,0.0140788292094641,0.0379275093467473,1.93235069625201e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,41877,-0.0286217362588716,0.00671277283285028,-0.0417787710112582,-0.0154647015064851,2.02393542946408e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,41740,-0.0155709615306003,0.00365298240138173,-0.0227308070373085,-0.00841111602389214,2.03531987693663e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41534,0.014066485362107,0.00330201326994523,0.00759453935301434,0.0205384313711997,2.05898087697784e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41465,0.0199594133866216,0.00468624180820365,0.0107743794425425,0.0291444473307008,2.06662426750414e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41636,0.0155240368753084,0.00364510607628035,0.00837962896579892,0.0226684447848179,2.06902162240373e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39650,0.0148979140282759,0.00350858513872558,0.00802108715637372,0.021774740900178,2.19271929803007e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39334,0.0369863743399504,0.00871114014629567,0.0199125396532108,0.0540602090266899,2.19579413105904e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39625,0.033388780641801,0.00786550191413346,0.0179723968900994,0.0488051643935026,2.20417929334028e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39334,0.0384806883999591,0.00906759330374759,0.0207082055246139,0.0562531712753044,2.21652597157027e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,41692,-0.0159491609862335,0.00375998092126962,-0.023318723591922,-0.00857959838054508,2.23238812508253e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39598,0.0152883855682278,0.00360872149668074,0.00821529143473356,0.0223614797017221,2.28870172534379e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,39572,0.0207827148200919,0.00490906189535288,0.0111609535052002,0.0304044761349835,2.31913849264389e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39617,0.0179749924469325,0.00424895443114969,0.00964704176187906,0.0263029431319859,2.35110016835141e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39250,-0.0168789589797026,0.00399202352500834,-0.024703325088719,-0.00905459287068628,2.37566017090031e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,39650,-0.0137765733231378,0.00325852790462354,-0.0201632880161999,-0.00738985863007567,2.37831272887081e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,41758,-0.00903884422985545,0.00214268979794998,-0.0132385162338374,-0.00483917222587349,2.47627344688725e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41716,0.030853025692669,0.00734744591277552,0.016452031703629,0.045254019681709,2.69687747595579e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39600,0.0342747871773248,0.00816533075561051,0.0182707388963282,0.0502788354583214,2.7188066953801e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,41765,-0.0229963454123862,0.005479870190066,-0.0337368909849156,-0.0122557998398568,2.72834566696467e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39598,0.0287590589923185,0.00688001037163564,0.0152742386639126,0.0422438793207243,2.9365006933727e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41465,0.0501612204499805,0.0120210423391147,0.0265999774653157,0.0737224634346454,3.0287654572402e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,41836,-0.0161238396862088,0.00386622543567991,-0.0237016415401414,-0.00854603783227614,3.05956904628779e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,41925,0.019524861086809,0.00468556020850723,0.0103411630781348,0.0287085590954831,3.10543776914937e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41617,0.0281717620072928,0.00677105279736665,0.0149004985244541,0.0414430254901314,3.19426319466775e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41786,0.0380039595041721,0.00913430704796825,0.0201007176901543,0.0559072013181899,3.19461296865306e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41614,0.0210737269872836,0.0050680706209057,0.0111403085703084,0.0310071454042587,3.22911332880604e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39650,0.0139933152134124,0.00336667235938372,0.00739463738902029,0.0205919930378045,3.25705983285712e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,41925,-0.0130913212217997,0.00316376380828657,-0.0192922982860414,-0.00689034415755805,3.52660752112794e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,39598,0.0280928330542619,0.00679298896152887,0.0147785746896653,0.0414070914188585,3.56716952726399e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39625,0.0344390048329712,0.00833593540969974,0.0181005714299597,0.0507774382359827,3.63238073583802e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,41786,0.0259358999979207,0.00628491661557658,0.0136174634313906,0.0382543365644508,3.70284108430682e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,41633,-0.0218838998443305,0.00530541065315381,-0.032282504724512,-0.0114852949641491,3.73316657357483e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41465,0.0373994047804923,0.00908697979519183,0.0195889243819163,0.0552098851790683,3.88390305343329e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,41740,-0.0297742428852235,0.00723895183319173,-0.0439625884782793,-0.0155858972921677,3.9282653927594e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41786,-0.0397582235019054,0.00967115835339969,-0.0587136938745688,-0.020802753129242,3.96318960002121e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39328,0.0216681818142919,0.00527119712804364,0.0113366354433263,0.0319997281852574,3.97440369571304e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,41862,-0.0135344407047718,0.0032985530252625,-0.0199996046342863,-0.0070692767752573,4.10008498902699e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,41765,-0.0488158087423195,0.0119054343390078,-0.0721504600467749,-0.0254811574378642,4.15099804397254e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41636,0.0245939718626557,0.00599859515855567,0.0128367253518866,0.0363512183734248,4.15735832681976e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,41899,0.00921542799362099,0.00224824078951872,0.0048088760461643,0.0136219799410777,4.17492116469189e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,39600,-0.0512418848492291,0.0125057597989815,-0.0757531740552328,-0.0267305956432253,4.20699442661202e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,41740,0.0344049385929079,0.00841245967363663,0.0179165176325801,0.0508933595532357,4.34393644546055e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39600,-0.019711134695099,0.00482042633185529,-0.0291591703055354,-0.0102630990846626,4.36159742573239e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41706,0.0844495915043824,0.0206731211757726,0.0439302739998682,0.124968909008897,4.43400013098703e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39308,0.020540751534787,0.00504525166844462,0.0106520582646355,0.0304294448049384,4.70869666055836e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,41871,0.010707351897211,0.00263167910435437,0.00554926085267639,0.0158654429417455,4.75621520420082e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39167,0.0134017094635875,0.00329862996724665,0.0069363947277841,0.019867024199391,4.88358777433697e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,39580,0.0283487886122157,0.00699534118199646,0.0146379198955026,0.0420596573289287,5.10171437578016e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,41706,0.00844173346649704,0.00208443429393375,0.00435624225038688,0.0125272246826072,5.15362722954667e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41465,0.0168290542990569,0.00416470919592518,0.00866622427504355,0.0249918843230703,5.35626198755808e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39600,-0.0386267190523098,0.00956050043935865,-0.0573652999134528,-0.0198881381911669,5.37595209843262e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41466,0.0267213963135649,0.00662034789131783,0.0137455144465819,0.0396972781805478,5.46261710757189e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41521,0.0221720501480566,0.0054959338323132,0.0114000198367227,0.0329440804593905,5.50887777289536e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39589,0.031487370723783,0.00780917864954513,0.0161813805706746,0.0467933608768914,5.56545861941231e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,41758,-0.017210560761393,0.00427752337971395,-0.0255945065856324,-0.0088266149371537,5.76634042087118e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39406,0.0287946985368236,0.00716220417363668,0.0147567783564958,0.0428326187171515,5.85019621968094e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,41740,0.0348726790152395,0.00867600240682934,0.017867714297854,0.051877643732625,5.86618833686353e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39600,0.0287558713491291,0.00715610387529142,0.0147299077535579,0.0427818349447003,5.89925076761833e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,41736,-0.0317725871809748,0.00792105030349101,-0.0472978457758172,-0.0162473285861324,6.07561428179448e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41689,0.0291540469500549,0.00727388773064797,0.0148972269979848,0.0434108669021249,6.15634975894935e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,41728,-0.0131036670872972,0.00327723496387303,-0.0195270476164883,-0.00668028655810602,6.41236276367e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39598,0.0374809449505791,0.0093896924274907,0.0190771477926973,0.0558847421084609,6.60241901901577e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41675,0.045342404699357,0.0113701493651135,0.0230569119437345,0.0676278974549795,6.70387469450289e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,41765,0.0491393290987243,0.0123490132782656,0.0249352630733236,0.073343395124125,6.95149876807027e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,39633,-0.0109547491953302,0.00275294205276404,-0.0163505156187477,-0.00555898277191272,6.95642683045853e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,39630,0.0124981683342112,0.00314285672850819,0.00633816914633516,0.0186581675220873,7.03272019733012e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39334,0.0190252329756937,0.00478469104078258,0.00964723853575988,0.0284032274156276,7.04631764373112e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39576,0.0473668534046123,0.011913692929473,0.0240160152628452,0.0707176915463794,7.0582949808809e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39271,0.0220309452355661,0.00554366581603035,0.0111653602361466,0.0328965302349856,7.11183637416816e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39250,-0.018000233057676,0.00453206061594506,-0.0268830718649284,-0.00911739425042371,7.1814752779702e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,41750,0.0130019987199845,0.00327683925031518,0.00657939378936676,0.0194246036506022,7.29096800046674e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41636,-0.0478634699080763,0.0120735176891793,-0.0715275645788678,-0.0241993752372848,7.39936099391623e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,39650,0.00827533984924851,0.00209118754936104,0.00417661225250087,0.0123740674459962,7.62937070251861e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,41740,0.0102229966452085,0.00258772983620535,0.00515104616624601,0.015294947124171,7.83741024513564e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,41765,0.00745786011046833,0.00188945561433665,0.0037545271063685,0.0111611931145682,7.95164885233609e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41783,0.0279342515818005,0.00708667238524467,0.0140443737067209,0.04182412945688,8.1289769195087e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,41740,-0.0192009971397164,0.00488055159076556,-0.0287668782576169,-0.00963511602181588,8.39085584290166e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39328,0.0276059787870282,0.00701663378619771,0.0138533765660807,0.0413585810079757,8.39437601927709e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39589,0.0245720173145704,0.00624581352281959,0.012330222809844,0.0368138118192968,8.40025193451471e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,39625,0.031829007477208,0.00810141101284123,0.0159502418920392,0.0477077730623768,8.58835436987757e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39165,0.0300228390688458,0.00764408366092088,0.0150404350934409,0.0450052430442507,8.63463977483194e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41521,0.0178176665446788,0.00453856257346985,0.00892208390067793,0.0267132491886797,8.68763955207955e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,41877,0.0259085625005673,0.00660259697345369,0.0129674724325981,0.0388496525685365,8.75312866876578e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41689,0.00838756527428773,0.00213828593420352,0.00419652484324883,0.0125786057053266,8.80586656498911e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39650,-0.00773909161020397,0.00197384924433943,-0.0116078361291092,-0.0038703470912987,8.87841926764498e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,41758,-0.018864472338255,0.0048145540976445,-0.0283009983696382,-0.00942794630687181,8.96572482526005e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41465,0.0216158163177083,0.00551909329366755,0.0107983934621199,0.0324332391732967,9.02883871240298e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41925,-0.0125437313562105,0.00320291553407467,-0.0188214458029969,-0.00626601690942414,9.03487245677921e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39308,0.0159334378209349,0.00407215573229903,0.00795201258562876,0.023914863056241,9.18050959598888e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,41877,-0.0141138147687869,0.00361736454534727,-0.0212038492776676,-0.00702378025990624,9.59969049114844e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39600,0.0171651475882039,0.00440174136976769,0.00853773450345921,0.0257925606729486,9.69138773547137e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39308,0.01697154573958,0.00435548148108802,0.00843480203664747,0.0255082894425125,9.81487246183386e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,39615,0.018607877372479,0.00477605011775921,0.00924681914167099,0.0279689356032871,9.83401385510619e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,41621,-0.0114910050041249,0.00295091141816901,-0.0172747913837361,-0.00570721862451361,9.90754097582091e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41509,0.019826487424498,0.00509148040142418,0.00984718583770658,0.0298057890112894,9.90801947022594e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,39589,0.0169499525554077,0.00436066273420438,0.00840305359636707,0.0254968515144482,0.000102081878460679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41447,-0.0235221956323443,0.00606217859025035,-0.035404065669235,-0.0116403255954537,0.000104910924047148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39308,0.0180340522376857,0.00465158910642346,0.00891693758909575,0.0271511668862757,0.000106399027322189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,41791,-0.0108658079059966,0.00280773171378915,-0.0163689620650234,-0.00536265374696988,0.000109377526103884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,39589,0.0260402284800038,0.00672965315549255,0.0128501082952384,0.0392303486647692,0.000109699959469061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,41905,0.0243279604417132,0.00631210613563081,0.0119562324158768,0.0366996884675495,0.000116666379570921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,41728,0.0264780667397335,0.00687240567754274,0.0130081516117497,0.0399479818677172,0.000117325946308717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39408,0.0224688879002614,0.00583402060500359,0.0110342075144544,0.0339035682860685,0.00011814380700251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39334,-0.0108788843071868,0.00282764541800488,-0.0164210693264764,-0.00533669928789725,0.000120103484981111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,39650,-0.00840232487377623,0.00218660554757809,-0.0126880717470293,-0.00411657800052318,0.000122402208189722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41534,-0.0252198644604006,0.00657257373662338,-0.0381021089841824,-0.0123376199366188,0.000125069011881658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39308,0.0132097482350913,0.00345115143795267,0.00644549141670406,0.0199740050534785,0.000130116784325655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39625,0.0112779340480366,0.00294657122017085,0.00550265445650175,0.0170532136395715,0.000130178916187709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41466,0.0226864311311645,0.00593175480802896,0.0110601917074277,0.0343126705549012,0.000131617230330561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41465,0.0404691860511411,0.0106044089963392,0.0196845444183162,0.061253827683966,0.00013612400688581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41584,0.0196424403118184,0.0051516748100794,0.00954515768406279,0.029739722939574,0.000138022070797288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,41911,0.0388662760430681,0.0102054423555284,0.0188636090262325,0.0588689430599038,0.000140504261851445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,41765,0.0223942569131586,0.00589272884244743,0.0108445083819616,0.0339440054443555,0.000145160113772228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39308,0.0211630096447052,0.00557039053729199,0.0102450441916129,0.0320809750977975,0.000145969115404979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41689,0.0340861862160065,0.0090233574200749,0.0164004056726596,0.0517719667593533,0.000159080012677976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,41802,0.0371047902694243,0.00986155297559716,0.0177761464372539,0.0564334341015948,0.000168903244460105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41676,0.0254484220533731,0.00679026187258363,0.0121395087831092,0.038757335323637,0.000179172843781882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39600,0.0349504762655996,0.00933025541143789,0.0166631756591814,0.0532377768720179,0.000180645191638818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,39600,0.048753600700615,0.0130169427654168,0.0232403928803981,0.074266808520832,0.000181029084787605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,41636,-0.0168027157643731,0.0044866811090271,-0.0255966107380662,-0.00800882079067998,0.000181155004967154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,41794,0.0205316874805922,0.00549430435455894,0.00976285094565671,0.0313005240155278,0.000187085940782105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39250,-0.0125334818209946,0.00335728675137062,-0.019113763853681,-0.0059531997883082,0.000190033801356253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,39630,-0.00584666367390441,0.00156619443361797,-0.00891640476379562,-0.0027769225840132,0.000190135033345518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,41740,0.0348419282157336,0.00933793472830975,0.0165395761482464,0.0531442802832207,0.000191354035975729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41452,0.0236804761499931,0.00634951438163422,0.01123542796199,0.0361255243379962,0.000192689359161341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,41740,-0.0109330136334677,0.00293262903478404,-0.0166809665416444,-0.00518506072529101,0.000193770380956276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41392,-0.0281024817875166,0.00754057718169283,-0.0428820130636345,-0.0133229505113986,0.000194734975157288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41422,0.0282576658026818,0.00758799815519691,0.0133851894184958,0.0431301421868677,0.000196935160814547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39600,0.0197162707418693,0.00530209786128399,0.00932415893375269,0.0301083825499859,0.000201341873288974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,41765,0.0271034355085869,0.00729297304490561,0.0128092083405719,0.0413976626766019,0.000202937025807968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39334,0.0349040889071721,0.00939620045682264,0.0164875360117998,0.0533206418025445,0.000204474733682182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,41888,0.0132844971821691,0.00358415977426528,0.00625954402460912,0.020309450339729,0.000211041102503682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39250,0.0177298016851411,0.00478886052682669,0.00834363505256079,0.0271159683177214,0.000214731667913253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",41877,-0.0289798657366767,0.00783832038949676,-0.0443429737000903,-0.013616757773263,0.000218865371215252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39308,-0.0367628329082445,0.00994439459784732,-0.0562538463200252,-0.0172718194964637,0.00021938997128584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,41789,-0.0108839951178537,0.00294521400876748,-0.0166566145750379,-0.0051113756606694,0.000220355270391401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39542,0.0250203677401295,0.00677351357072908,0.0117442811415005,0.0382964543387585,0.000221956856003233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,41877,0.0161143589300295,0.0043728910141991,0.00754349254219923,0.0246852253178597,0.00022955958647954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39373,0.0259579950735789,0.00704759313486062,0.0121447125292521,0.0397712776179057,0.00023141289651671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41454,0.0157170369987536,0.0042799126495349,0.00732840820566525,0.024105665791842,0.00024137104900749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39589,-0.0165682428906458,0.00451216153851404,-0.0254120795061333,-0.0077244062751583,0.000241887941997205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,41732,-0.0169186854149488,0.00460816199230716,-0.0259506829198708,-0.00788668791002675,0.000242124646714211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,41758,-0.010628094612539,0.00289521486303917,-0.0163027157440958,-0.00495347348098224,0.000242637481503835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41840,-0.0139358635087641,0.00379858577604489,-0.0213810916298121,-0.00649063538771615,0.00024474520354651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39308,-0.0380293279941486,0.0103879263167759,-0.0583896635750293,-0.0176689924132679,0.000252524443158254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41840,0.0269090996937764,0.00735176220278918,0.0124996457763096,0.0413185536112432,0.000252974283846795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39328,-0.0123985134090625,0.00338852393351961,-0.0190400203187609,-0.00575700649936405,0.000254443257846206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39600,0.0195024596601905,0.00533266474444982,0.00905043676106882,0.0299544825593121,0.00025620571318123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39338,0.0155506563368325,0.00425813426616409,0.00720471317515092,0.0238965994985142,0.000261455243239903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39297,0.0311485094879482,0.00854404568374633,0.0144021799478054,0.047894839028091,0.000267992782186248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39334,0.0382891124873176,0.0105053776840245,0.0176985722266295,0.0588796527480056,0.000268951752992528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39244,0.0400626358746662,0.0110044724431596,0.0184938698860733,0.0616314018632591,0.00027331691738613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,41758,0.00971338685413662,0.00267408917878029,0.00447217206372726,0.014954601644546,0.000281854721115169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39334,0.0175262196834268,0.00482742861334878,0.00806445960126318,0.0269879797655904,0.000284134220290645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41640,-0.0228934503459531,0.00630662103269712,-0.0352544275700395,-0.0105324731218668,0.000284433295320533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39485,0.0433375576150363,0.0119389293946271,0.0199372560015672,0.0667378592285054,0.000284790767868966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39408,0.0324915942401319,0.00898733159746036,0.0148764243091096,0.0501067641711542,0.000301404214059938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,41802,0.0133448596042415,0.00369808172065004,0.00609661943176746,0.0205930997767156,0.000309004315482993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,39633,-0.0193000110723668,0.00535237369370992,-0.0297906635120382,-0.00880935863269531,0.000312471034859104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41758,0.0179587648825495,0.00498790205069851,0.00818247686318038,0.0277350529019186,0.000318817481549549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,41858,0.0353798699782928,0.00984365160444676,0.0160863128335772,0.0546734271230085,0.000326593213301994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,41758,-0.0133324348441216,0.00371497215356124,-0.0206137802651016,-0.00605108942314154,0.000333361677213923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39598,0.00887629578629116,0.00247589008027606,0.00402355122895008,0.0137290403436322,0.000338417972519994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,41636,0.0233758182594769,0.00652918274977379,0.0105786200699203,0.0361730164490336,0.000344571685435324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41465,0.0243720073065575,0.00681366798559804,0.0110172180547853,0.0377267965583296,0.000348930642427198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,41703,0.0419910778262977,0.0117474378160591,0.0189660997068218,0.0650160559457736,0.000352175176762437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,41765,-0.01352822101408,0.00379106102719161,-0.0209587006273756,-0.0060977414007845,0.000360372767559296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,41758,-0.0140345023322399,0.00393833209658623,-0.0217536332415489,-0.00631537142293084,0.000367146895609872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39578,-0.0218831644527987,0.0061553284965773,-0.0339476083060902,-0.00981872059950717,0.000379340903799057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,41740,0.0327193562514004,0.00920664147606241,0.0146743389583181,0.0507643735444828,0.000380915035227492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,41805,0.0252889979976787,0.00711604646754317,0.0113415469212941,0.0392364490740633,0.000381034855954811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,41758,-0.0290306728048868,0.00818453049666805,-0.0450723525783562,-0.0129889930314174,0.000390973854526662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,41764,-0.0145959087755835,0.0041178610810111,-0.0226669164943652,-0.00652490105680171,0.000394667838431807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41740,-0.0150773201867749,0.00426185801184578,-0.0234305618899926,-0.00672407848355715,0.000404968225960995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,41836,0.0122374287935879,0.00346120341727504,0.00545347009572877,0.0190213874914469,0.000408240975649291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39308,0.0149088296947648,0.00422196337270281,0.00663378148426729,0.0231838779052623,0.000415331541842958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39373,0.0207142185821591,0.00587435584216055,0.00920048113152442,0.0322279560327938,0.000423303108852141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41689,0.0172183192609482,0.0048834432522787,0.00764677048648199,0.0267898680354145,0.000423559159333577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,41862,0.0194890806058915,0.00553768365164652,0.00863522064866434,0.0303429405631187,0.000434045413933129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,39600,0.0196279158154799,0.00558132724359456,0.00868851441803454,0.0305673172129252,0.000438689757835527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39634,-0.00977652941460693,0.00278018666066783,-0.0152256952695159,-0.00432736355969799,0.000439031229050861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39600,0.0251196587899001,0.00715572911223718,0.0110944297299152,0.039144887849885,0.000449179954654077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41799,-0.0183161734081669,0.00523003409907689,-0.0285670402423576,-0.00806530657397622,0.000463108829548355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,39574,0.0275797546394765,0.0078769277151702,0.0121409763177429,0.0430185329612101,0.000464774967430423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39334,0.0130890552878475,0.00375451530342282,0.00573020529313874,0.0204479052825562,0.000491861837871772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,41765,0.0408829965885904,0.0117466593673661,0.0178595442285528,0.0639064489486281,0.000502299336527488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41636,-0.0151098485885106,0.0043448314306417,-0.0236257181925683,-0.00659397898445282,0.000507459610927203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,41805,0.0157770058540239,0.00453872535899473,0.00688110415039422,0.0246729075576536,0.000510421666751459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,41877,-0.0105424838188158,0.0030354496759141,-0.0164919651836074,-0.00459300245402413,0.000516082614349064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39334,0.0174354680135372,0.00503575240518559,0.00756539329937343,0.0273055427277009,0.000537594316180345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,41819,-0.010316481088368,0.00298437465382984,-0.0161658554098745,-0.0044671067668615,0.000548284688755561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,41764,-0.00886984732408354,0.00256665665513727,-0.0139004943681526,-0.0038392002800145,0.000550396634876963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39308,0.0109476782329569,0.00317079190093539,0.00473292610712359,0.0171624303587903,0.000557226109899576
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39655,-0.0539326701995764,0.015648542612983,-0.0846038137210231,-0.0232615266781298,0.00057001495156988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39334,0.0172715979002674,0.0050146867150962,0.00744281193867883,0.0271003838618559,0.000574934426257433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39600,-0.034489675866024,0.0100147698856708,-0.0541186248419388,-0.0148607268901092,0.00057556526445737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39308,0.015749439996617,0.00457397003056627,0.00678445873670715,0.0247144212565269,0.000576912135282427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39598,0.0154552469274311,0.00449703936607019,0.00664104976993356,0.0242694440849287,0.000590893868776702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39427,0.0265969748510735,0.00774273426852858,0.0114212156847575,0.0417727340173895,0.000594582959643442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39241,-0.0127102994769515,0.00370131488857719,-0.0199648766585627,-0.00545572229534017,0.000597020802877393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,41728,0.0126672462927667,0.00369241228978946,0.00543011820477937,0.0199043743807541,0.000604067390091966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39580,0.0213441273410969,0.00622736338693315,0.00913849510270797,0.0335497595794859,0.000611458900749304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39427,0.0175207173793537,0.00511183321947297,0.00750152426918673,0.0275399104895208,0.000611472514332998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41521,0.0129653552041681,0.00378383075650712,0.00554904692141416,0.0203816634869221,0.000613282004069299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,39589,0.0165753412130895,0.004841316947598,0.00708635999579744,0.0260643224303816,0.00061994406238818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,41802,0.00815952097448453,0.00238435097956043,0.00348619305454608,0.012832848894423,0.000623246694652622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39655,-0.00978593925527888,0.00286071187539168,-0.0153929345310466,-0.00417894397951119,0.000626617637547342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41636,-0.0133522080264124,0.00391798455309705,-0.0210314577504826,-0.00567295830234217,0.000656561838496497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39314,0.0211612836080997,0.00621274075232933,0.00898431173353419,0.0333382554826652,0.000661374416583098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,39643,0.0204680248160005,0.0060249834108784,0.0086590573306788,0.0322769923013221,0.000683214420296263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41521,0.0417971260133549,0.0123299267671179,0.0176304695498038,0.0659637824769059,0.000701291928052522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,41836,-0.0119495261830921,0.00352912605121463,-0.0188666132434728,-0.00503243912271144,0.000711325319934362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,39600,0.0261154603579826,0.00772878259497184,0.0109670464718378,0.0412638742441274,0.000730059243017975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39334,-0.015707242191526,0.00465311030076171,-0.0248273383810189,-0.00658714600203304,0.000739043382648979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39328,0.0250141030777488,0.00741177174288814,0.010487030461688,0.0395411756938095,0.000741000963322064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,41758,0.0202433377150016,0.00600130907900876,0.00848077192014445,0.0320059035098588,0.000745267709952182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39600,0.0110254552696254,0.00328433914498948,0.00458815054544606,0.0174627599938048,0.000790663525308307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,39625,0.0166287560110837,0.00495440899046069,0.00691811438978077,0.0263393976323867,0.000792439553600325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39600,0.0173108183911939,0.00516319885356597,0.00719094863820456,0.0274306881441832,0.000802882680750444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41911,0.0127330618726692,0.00380086064213995,0.00528337501407488,0.0201827487312635,0.000810223632044395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41508,0.0144039242744557,0.00430232960955645,0.00597135823972508,0.0228364903091864,0.000816485658832853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,41765,0.0127578387227646,0.00381158438801162,0.00528713332226182,0.0202285441232674,0.00081883884737358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39600,0.0360977568350584,0.0107973372377019,0.0149349758491628,0.0572605378209541,0.000830918703568276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41465,0.0218264390285191,0.00653197080014053,0.00902377626024368,0.0346291017967946,0.000835708487449772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41281,-0.00849777255368889,0.00254746702445958,-0.0134908079216297,-0.00350473718574811,0.000853067125354589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39600,0.0143564816132434,0.00430899691502535,0.00591084765979375,0.0228021155666931,0.000865875142703732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,41802,-0.00992342001971703,0.00297863500703083,-0.0157615446334975,-0.0040852954059366,0.00086606201948853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39600,0.0140784907217532,0.00422929038073164,0.00578908157551914,0.0223678998679872,0.000875053631369539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39600,0.0369204665473609,0.0111074425246136,0.0151498791991182,0.0586910538956037,0.000890454188331051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,41899,0.0185165139055392,0.00557713598820011,0.00758532736866704,0.0294477004424115,0.000902351186723189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,41769,0.022233616059186,0.00669951196246631,0.00910257261275203,0.03536465950562,0.000906854746202369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,41736,0.00854250989764714,0.00257464748805984,0.00349620082104986,0.0135888189742444,0.00090932371893896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,41689,0.0198413854622289,0.00598598363656349,0.0081088575345645,0.0315739133898934,0.000920102525276766
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,41758,-0.0101004367663023,0.00305164930931224,-0.0160816694125543,-0.0041192041200503,0.00093603981868661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39598,0.0109051998488141,0.00329647775030228,0.00444410345822159,0.0173662962394065,0.000942203785110239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39630,-0.00660852730822715,0.00199909870398292,-0.0105267607680337,-0.00269029384842063,0.000950238098328097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39276,0.014876677843909,0.00450209139762498,0.00605257870456403,0.023700776983254,0.000954958832688812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,39650,-0.0117934557541963,0.00357425326053165,-0.0187989921448383,-0.00478791936355422,0.0009714368274446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39308,0.0115222772163209,0.00349861404527029,0.00466499368759112,0.0183795607450507,0.00099310450694368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39600,-0.0123435417525168,0.00374884433287892,-0.0196912766449594,-0.00499580686007407,0.000995695516087717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41465,0.0139230338568327,0.00423013610130034,0.00563196709828399,0.0222141006153813,0.000999615449469498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,41693,0.0156575955521897,0.0047676510576305,0.00631299947923395,0.0250021916251455,0.00102565460512713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,41758,-0.017532028024986,0.00533877428986118,-0.0279960256331139,-0.00706803041685807,0.00102646690647059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41865,-0.0159123728868666,0.0048494810098927,-0.0254173556662563,-0.00640739010747689,0.00103613933050999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39408,-0.0166235762608748,0.00506663310625243,-0.0265541771491296,-0.00669297537262007,0.00103770912959444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,41862,0.0196811054102024,0.00600285723759671,0.00791550522451283,0.0314467055958919,0.00104583521898015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,39633,0.0295867995861526,0.00905557699340889,0.0118378686790712,0.047335730493234,0.00108931075568264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,39598,0.0106552894470742,0.00326971750857605,0.00424664313026516,0.0170639357638833,0.00112232232653002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41560,0.00843599448339787,0.00258964306040572,0.00336029408500265,0.0135116948817931,0.00112651860417349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41534,0.0129885138136778,0.00399090923163726,0.00516633171966873,0.0208106959076868,0.00113873984857472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39328,0.0153069409532457,0.00470656097043267,0.00608208145119767,0.0245318004552937,0.00114846653780756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39598,0.0137848794361131,0.00424482548052487,0.00546502149428435,0.0221047373779418,0.00116791160316033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39589,0.0217265963518254,0.0066913868219208,0.00861147818086061,0.0348417145227901,0.00116998770327929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39250,-0.00730583602584219,0.00225258970274801,-0.0117209118432283,-0.00289076020845609,0.00118515589590093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,41865,0.0079265418034781,0.00244688462878456,0.00313064793106036,0.0127224356758958,0.00120058563498015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39408,0.0134450130602213,0.00415076657502904,0.0053095105731644,0.0215805155472782,0.0012024292987333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41865,-0.0244882117961214,0.00756206273613738,-0.0393098547589506,-0.00966656883329211,0.00120540892742791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,41836,0.0160832022499658,0.00496807961900387,0.00634576619671817,0.0258206383032134,0.0012096029493284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39573,0.015853113805578,0.00489680883925101,0.00625536848064606,0.02545085913051,0.00120966503262895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39334,0.0193944556917867,0.00599290613401877,0.00764835966910991,0.0311405517144635,0.00121484688020531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,41765,0.0302752337285351,0.00935879203586945,0.011932001338231,0.0486184661188392,0.00121963925429381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39598,-0.010692492829805,0.00330518848997601,-0.0171706622701579,-0.00421432338945197,0.00121975364883286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39250,0.0219487728949125,0.00680101261463327,0.00861878817023128,0.0352787576195937,0.00125351118424922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41689,0.0142542329074812,0.0044182328806146,0.0055944964614766,0.0229139693534858,0.00125741103530927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41689,-0.0113846099624499,0.00353131767682745,-0.0183059926090317,-0.00446322731586806,0.00126768214488494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,39600,0.0231384585860406,0.0071821456085577,0.00906145319326752,0.0372154639788137,0.00127819475880718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39408,0.0231825069075336,0.0071972904789994,0.0090758175686948,0.0372891962463724,0.00128120095146747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39625,0.026707103602293,0.00830323198638235,0.0104327689089836,0.0429814382956024,0.0013015229438725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,41744,0.0137865788493124,0.0042894817531105,0.00537919461321581,0.022193963085409,0.0013119599931789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,41692,-0.0230761843110452,0.00718019510378031,-0.0371493667144546,-0.00900300190763576,0.00131278132812731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39385,-0.0170461615433149,0.00530478341569035,-0.027443537038068,-0.00664878604856182,0.00131578940654743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,41783,-0.0177924951144301,0.00553811071535921,-0.0286471921165342,-0.00693779811232608,0.00131792424355638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,41758,0.017203704381438,0.00535897239927232,0.00670011847886426,0.0277072902840117,0.00132932521146655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41617,-0.0158153572684998,0.00492996955686436,-0.0254780975999539,-0.00615261693704563,0.00133983631021163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39328,0.0427386018841503,0.01332210783898,0.0166272705197495,0.0688499332485511,0.00134009400299953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41764,-0.0120339182104363,0.00375270301565369,-0.0193892161211176,-0.00467862029975511,0.00134572206855523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39600,0.0264551609274721,0.00825628870141201,0.0102728350727046,0.0426374867822397,0.00135804082571491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39250,0.0218414249485996,0.00681732797918412,0.00847946210939869,0.0352033877878005,0.00136021232352206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41689,0.0472501321218382,0.0147525215669081,0.0183351898506983,0.0761650743929782,0.00136399881234329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39600,0.0484581962491818,0.0151556119762044,0.0187531967758211,0.0781631957225426,0.00139076298034264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39328,0.0169441896048799,0.0053075813438496,0.00654133017093464,0.0273470490388251,0.00141478262736079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39589,0.0153945383024357,0.00482310163805884,0.00594125909184038,0.024847817513031,0.00141770636198656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,41740,-0.0171029361246879,0.00535945877411117,-0.0276074753219458,-0.00659839692743,0.00142031860055898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,41866,-0.0143465183521819,0.00449919492039817,-0.0231649403961623,-0.00552809630820145,0.00143253177861248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41466,-0.0110374594136583,0.00346443638768487,-0.0178277547335207,-0.00424716409379599,0.00144632897615277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,41865,0.0104819837938799,0.00329282120519771,0.00402805423169233,0.0169359133560674,0.00145951062979475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39250,0.0129682668207606,0.00407787555400534,0.00497563073491016,0.0209609029066111,0.00147619265140692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39600,0.0167387378619353,0.00528266777947379,0.00638470901416665,0.0270927667097039,0.00153586652777366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39317,0.00917252381680305,0.00289851249931566,0.00349143931814435,0.0148536083154617,0.00155750655098905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,41877,-0.0141963724091144,0.00448685889315114,-0.0229906158396906,-0.00540212897853818,0.00155973636891565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,41740,0.0124376876945831,0.00394547445907106,0.00470455775480385,0.0201708176343624,0.00162302017021931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41740,0.0208783209847676,0.00662416604605825,0.00789495553449346,0.0338616864350418,0.00162608895970317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39393,0.0197606756920264,0.00627411586308175,0.00746340860038617,0.0320579427836666,0.00163965252377582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39600,0.0284350994630026,0.00903911347543948,0.0107184370511412,0.046151761874864,0.00166083729789454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,41829,0.0111947586081473,0.00355927978937579,0.00421857022097073,0.0181709469953238,0.0016632301858712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39598,0.00929721374807359,0.00295846562050139,0.00349862113189085,0.0150958063642563,0.00167910934326817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41521,-0.0115218059185029,0.00367005918865101,-0.0187151219282589,-0.00432848990874696,0.00169671944171027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39600,0.0211865227726062,0.00675297582145723,0.00795069016255007,0.0344223553826624,0.00170926026001667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39600,0.012257188361875,0.00391543105007529,0.00458294350372739,0.0199314332200225,0.00174976291768752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41465,0.0259911458588503,0.008326096404527,0.00967199690597734,0.0423102948117232,0.00180239926338146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39259,-0.0208765573247175,0.00668782479742089,-0.0339846939276624,-0.00776842072177254,0.00180366404001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39589,-0.0159301089884655,0.00511168953818037,-0.025949020483299,-0.00591119749363198,0.00183540810735908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39250,0.00951879802846385,0.00305463502381531,0.00353171338178584,0.0155058826751418,0.00183696441995485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41470,0.0188093037020838,0.0060385409812537,0.00697376337882659,0.0306448440253411,0.00184426761596983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,41877,0.015380751731873,0.00496036052802068,0.00565844509695248,0.0251030583667935,0.00193446742239789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39625,0.0360757768038187,0.0116360255745847,0.0132691666776327,0.0588823869300047,0.00193777953541621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,41819,-0.0094004579568707,0.00304777772364314,-0.0153741022952113,-0.00342681361853015,0.00204408155681659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,41740,0.0128661884813321,0.00417474387301861,0.00468369049021562,0.0210486864724486,0.00206101981766963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39427,0.00965513659918416,0.00313298705100615,0.00351448197921211,0.0157957912191562,0.00206292431123054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,41740,-0.014731364806778,0.00478086420192043,-0.0241018586425421,-0.005360870971014,0.00206512258773777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,41925,-0.0100484237877144,0.00326304668931824,-0.0164439952987781,-0.00365285227665062,0.00207797668820797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39655,0.007217292710711,0.00234520528426293,0.00262069035355567,0.0118138950678663,0.00209278474464874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39629,-0.00655568500109598,0.00213436864680924,-0.0107390475488421,-0.00237232245334988,0.00213514257065749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41534,0.0133535285727627,0.00435123963376545,0.0048250988905824,0.021881958254943,0.00215291636415857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,41925,-0.0208862059510175,0.00681821329854512,-0.0342499040161659,-0.00752250788586907,0.00219350209889378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39408,-0.0173717834215149,0.00567242096943562,-0.0284897285216088,-0.00625383832142113,0.00220036799686981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39600,-0.0152426388317119,0.00498552223287698,-0.0250142624081508,-0.00547101525527307,0.00223816586752883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,41911,0.0192732739936595,0.00630790005258161,0.00690978989059953,0.0316367580967194,0.00225191485171474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39600,0.0219970702161761,0.00720211792358947,0.00788091908594076,0.0361132213464115,0.00226163404130381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41689,0.0255144090243372,0.00836045282067489,0.00912792149581444,0.04190089655286,0.00227931307049253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39328,0.0261960674692488,0.00859041098036636,0.00935886194773076,0.0430332729907669,0.00229816316914521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39308,0.0337877083563825,0.0111089072397404,0.0120142501664912,0.0555611665462737,0.00235974439896915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41877,0.0109624429076162,0.00361084191500629,0.00388519275420392,0.0180396930610286,0.00240220151280632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39650,0.008289578658614,0.00273406008222186,0.00293082089745914,0.0136483364197689,0.00243529277911762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,41689,0.0334283483966914,0.0110264439102433,0.0118165183326144,0.0550401784607683,0.00243694547927582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,39598,0.0355461366811998,0.0117296016063559,0.0125561175327422,0.0585361558296574,0.00244745797538672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41465,0.0245309166066273,0.00809653246423687,0.00866171297672308,0.0404001202365316,0.00245197323665365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,41914,0.0110772695906091,0.00365727244654133,0.00390901559538813,0.0182455235858302,0.00245970297576873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,41703,-0.00933400642005185,0.00308255121047314,-0.0153758067925792,-0.0032922060475245,0.00246645979657286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39600,0.0214969430917386,0.00710442756231279,0.00757226506960558,0.0354216211138717,0.00248507019552671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,39598,0.0124524642490265,0.00411601279829181,0.00438507916437453,0.0205198493336784,0.00248902310419301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39308,0.0109308810590078,0.00362299378099128,0.00382981324826489,0.0180319488697507,0.00255817585084668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39259,-0.0189235852203656,0.00628129491864713,-0.0312349232609139,-0.00661224717981721,0.00259552382718798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39600,0.0189908015926022,0.00630445652493338,0.00663406680373278,0.0313475363814716,0.00259881004467686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,41740,0.0191225508202203,0.00634984956285029,0.00667684567703378,0.0315682559634069,0.00260457502655561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41534,-0.0150651527688687,0.00500512932563905,-0.0248752062471212,-0.00525509929061617,0.00261800679759762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,41705,0.0109360424631334,0.00364180854522996,0.00379809771448263,0.0180739872117841,0.00267911349877384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,39589,0.0272412922576229,0.00907699504150223,0.00945038197627853,0.0450322025389673,0.00269578715955673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41689,0.0145224185231872,0.00484465894860587,0.00502688698391975,0.0240179500624548,0.00272612532110563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41666,-0.0131451646926826,0.00438550952249531,-0.0217407633567734,-0.00454956602859183,0.00272797113259478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,41865,0.0308110746681121,0.0102849136991992,0.0106526438176817,0.0509695055185425,0.00274272713360721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,39630,0.0123481242937428,0.00412975353166288,0.00425380737168354,0.020442441215802,0.00279557346761661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39600,0.0343827239183957,0.0115040804105257,0.0118347263137654,0.056930721523026,0.00280747793877777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,41865,-0.00968140624748524,0.00324136892431643,-0.0160344893391454,-0.00332832315582503,0.00282404926423009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,41814,0.0112917846327004,0.00378333756282893,0.00387644300955568,0.0187071262558451,0.00284460217116026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39600,-0.0134402204341794,0.00450865789374129,-0.0222771899059124,-0.00460325096244649,0.0028795604928797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,41740,0.021219974282278,0.00712038448014839,0.00726402070118715,0.0351759278633688,0.00288613271634558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41758,-0.0114583587462357,0.00384525138899291,-0.0189950514686618,-0.00392166602380963,0.00288895216289454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39655,-0.00912533562319467,0.0030674027306196,-0.0151374449752091,-0.00311322627118025,0.0029368034407967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39406,-0.0123746275856813,0.00417014811301678,-0.0205481178871942,-0.00420113728416841,0.00300957448436271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,41925,-0.00728719376317834,0.00245949574831833,-0.0121078054298823,-0.00246658209647442,0.00305312600476625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39308,0.0169352268110959,0.00571702420252793,0.00572985937414117,0.0281405942480507,0.0030607556598864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,39650,-0.00942661894362985,0.00318262539478036,-0.0156645647173993,-0.00318867316986035,0.00306397475298873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41799,-0.015539651751354,0.00524958323139371,-0.0258288348848857,-0.00525046861782232,0.00308017238496883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,41802,-0.0136072241393745,0.00460768844697822,-0.0226382934954518,-0.00457615478329716,0.00315096871737746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,39589,0.0224477759038429,0.0076119131069644,0.00752842621419264,0.0373671255934931,0.00319442292221639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41447,0.0211966433341207,0.00718833265447469,0.00710751133135027,0.035285775336891,0.00319629724415208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41758,-0.0117564125301508,0.00398759234996925,-0.0195720935360906,-0.0039407315242111,0.00320141777675676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41877,-0.0197796801413145,0.00671566079844736,-0.0329423753062713,-0.00661698497635767,0.00323194568896694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,41758,-0.0164889942018839,0.0056069275346177,-0.0274785721697346,-0.0054994162340332,0.00327909054021953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,39589,0.0105352093895322,0.00358351215302998,0.00351152556959346,0.017558893209471,0.00328989497152423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",41925,0.0158983627933048,0.00541599723606332,0.00528300821062071,0.0265137173759889,0.0033363833193662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41689,0.0109278204381478,0.0037248733910124,0.0036270685917635,0.0182285722845321,0.00335482671331426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39328,0.0231015277296456,0.00787781882136843,0.00766100283976352,0.0385420526195278,0.00336979891788607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41465,0.0179092389241961,0.00611082539076488,0.00593202115829694,0.0298864566900953,0.00338750637672008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,39650,-0.00814450986312765,0.00278547292307261,-0.01360403679235,-0.00268498293390533,0.00346351442221841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,39600,0.0187802368486055,0.00642369025165993,0.00618980395535201,0.0313706697418589,0.00346725597497804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39600,0.0167698569967836,0.00573649895810328,0.00552631903890112,0.028013394954666,0.00346980639773977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39334,0.0269648044512743,0.00922905864568488,0.00887584950573194,0.0450537593968167,0.00348820345857629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39600,-0.0362027046001382,0.0123966304634205,-0.0605001003084423,-0.0119053088918341,0.0035032987840293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,41740,0.0182439841306187,0.00625433053656934,0.00598549627894282,0.0305024719822946,0.00353995497488986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,41787,-0.00661205131807511,0.00227175821342428,-0.0110646974163867,-0.00215940521976352,0.00361404284554165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39600,0.0229932788083202,0.00790314561702979,0.00750311339894185,0.0384834442176986,0.00362868091798236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41636,0.0127817501176757,0.00439881873277175,0.00416006540144309,0.0214034348339084,0.00367021708993022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,41765,0.00786107786584737,0.0027078341268477,0.00255372297722588,0.0131684327544688,0.00370117561423846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39600,0.0296096452130173,0.0102107671296405,0.00959654163892186,0.0496227487871127,0.00374085804905075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41750,-0.0101955002693204,0.00352361789449218,-0.0171017913425251,-0.00328920919611574,0.00381630369005284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39600,0.0151045020383576,0.00522476741196485,0.0048639579109065,0.0253450461658087,0.00384840185852568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,41865,0.00704447936324238,0.00243738862007306,0.00226719766789918,0.0118217610585856,0.00385651843104342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41466,0.022229888247819,0.00769467617565029,0.00714832294354438,0.0373114535520935,0.00387119165540038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39600,0.0112254101069129,0.00389471534738075,0.00359176802604661,0.0188590521877791,0.00395653659829473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,41736,-0.0105776315182044,0.00367274624420443,-0.0177762141568451,-0.00337904887956376,0.00398275954435147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,41827,-0.0130936020139025,0.00455053212820773,-0.0220126449851897,-0.00417455904261536,0.00401636277344861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41521,0.0165951861333162,0.00576748337441183,0.00529091871946899,0.0278994535471634,0.00401661379280712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,41869,0.017514928284283,0.00609518727587066,0.00556836122357648,0.0294614953449895,0.00406509385700097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41466,-0.0104464542384327,0.00363822751610489,-0.0175773801699983,-0.00331552830686714,0.00409450560880542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39600,0.0268677303705845,0.00937467430385356,0.00849336873503148,0.0452420920061374,0.00416494785515085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,41750,-0.0294531172257173,0.0102787669495286,-0.0495995004467934,-0.00930673400464117,0.00417099688539526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,41925,0.0141168297849379,0.00492981732510177,0.00445438782773844,0.0237792717421374,0.00419562748417385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39250,-0.0122012891881791,0.00426159365466202,-0.0205540127513167,-0.00384856562504155,0.00420361759632451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41465,-0.0116428557192911,0.00406957239222315,-0.0196192176080484,-0.00366649383053371,0.00423050112275228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39334,0.00963580967131776,0.00336838630402319,0.0030337725154323,0.0162378468272032,0.00423575693829026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41465,0.0119943299971691,0.00419433490492771,0.00377343358351082,0.0202152264108274,0.00424790983337029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39534,0.00899542817204128,0.00314874908671157,0.00282387996208661,0.0151669763819959,0.0042870745140823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,41819,0.00988699782314916,0.00346313945981672,0.00309924448190839,0.0166747511643899,0.00431142029603137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,41739,-0.0102462791223405,0.00359057675860186,-0.0172838095692001,-0.00320874867548081,0.0043286550562657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,41740,0.0117231335882785,0.00410816435358868,0.0036711314552447,0.0197751357213123,0.0043291969984878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39241,0.0154431160069846,0.0054215310782187,0.00481691509367596,0.0260693169202932,0.00440130288546929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,40938,-0.0152871044617792,0.00538107736607006,-0.0258340160992765,-0.00474019282428189,0.00450600540891246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,41740,-0.00975773935354676,0.00343493611865284,-0.0164902141461063,-0.00302526456098719,0.00450790638182674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39328,0.018069903342207,0.00636076194629986,0.0056028099274593,0.0305369967569548,0.00450797181624426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41614,0.0153900261202163,0.00541866001640091,0.00476945248807053,0.0260105997523621,0.00451565629001691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39328,0.0152493871044705,0.00538282299491235,0.00469905403444229,0.0257997201744987,0.00462034218033421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,39600,0.00778739888289241,0.00275379643008093,0.00238995787993378,0.013184839885851,0.00469424072324376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,41758,0.0126829557988067,0.00449179192635596,0.00387904362314905,0.0214868679744644,0.00475611884946613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41466,0.0125827688504283,0.00445894705173986,0.00384323262901815,0.0213223050718384,0.00478110363017265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,41740,-0.018174885435117,0.00644077652304745,-0.03079880742029,-0.00555096344994404,0.00478196284292014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39250,-0.00955478432238496,0.00338596552520077,-0.0161912767517785,-0.00291829189299146,0.00478316419508764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41466,0.0126477495314067,0.00449207482196943,0.00384328288034661,0.0214522161824668,0.00487648818089782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39259,0.0127386337326979,0.00452707337570695,0.00386556991631225,0.0216116975490835,0.00490374029689725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39308,0.0191147197802653,0.00679541966212327,0.00579569724250371,0.0324337423180269,0.00491889338582018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,41736,0.00813946513354629,0.00289375611430986,0.00246770314949897,0.0138112271175936,0.00491899364587788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39600,-0.01091953507372,0.00388423788246014,-0.0185326413233419,-0.00330642882409817,0.00494378499084815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,41769,0.0140704517265363,0.0050121387413389,0.00424665979351201,0.0238942436595605,0.00500360097046608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,41773,-0.0152542714005852,0.00543766038743442,-0.0259120857599566,-0.00459645704121371,0.00503433699294789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,41758,-0.016226756095988,0.00578980618790553,-0.0275747762242828,-0.00487873596769314,0.00507599615718717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39655,-0.0160959795085714,0.00574755460213466,-0.0273611865287553,-0.00483077248838743,0.00511133753893201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41598,0.00889756808840659,0.00318586961681565,0.00265326363944791,0.0151418725373653,0.00523267434224858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,41689,0.0177397984920227,0.00636082095863117,0.00527258941310567,0.0302070075709398,0.00529610777800518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41802,0.00823190509115273,0.00295431461604993,0.00244144844369485,0.0140223617386106,0.0053372968436823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39334,0.0109807082364124,0.0039472491413818,0.00324409991930402,0.0187173165535207,0.00541420962859932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41431,0.00873001470606729,0.00313938924557449,0.00257681178474129,0.0148832176273933,0.00543041288860101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41657,0.00860716806877596,0.00310017347393314,0.002530828059867,0.0146835080776849,0.00550512199500251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,39598,0.021627409636542,0.00779415979757135,0.00635085643330212,0.0369039628397818,0.00553250728457719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39328,-0.0145666821092671,0.00525354790024578,-0.0248636359937488,-0.00426972822478537,0.00556837479371365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,41705,-0.00688314870721865,0.00248622871486549,-0.011756156988355,-0.00201014042608228,0.00563923909918674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,41865,-0.00893478884299362,0.0032307158013291,-0.0152669918135987,-0.00260258587238858,0.00569009900106454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,41911,0.0181634461862277,0.0065744251745909,0.00527757284402956,0.0310493195284259,0.00573965839855567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41534,0.0128361117521146,0.00466040157088151,0.00370172467318685,0.0219704988310424,0.00589012561237034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41465,0.013256055674435,0.00481306935988059,0.00382243972906899,0.0226896716198009,0.00589221774233455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39600,0.0141503556138653,0.00514650209392642,0.00406321150976951,0.0242374997179611,0.00597820102283826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39408,-0.013526416588723,0.00492040280410297,-0.0231704060847648,-0.00388242709268115,0.00598681501512097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41521,0.0281768225704265,0.0102541787286711,0.00807863226223102,0.0482750128786219,0.00600728292893888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39250,-0.00780049695046723,0.00283909564928757,-0.0133651244230709,-0.0022358694778636,0.00601472435779703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39250,0.0258738858001872,0.00941996051101116,0.00741076319860531,0.0443370084017691,0.00602977519903267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,39589,0.014268109696046,0.00520787689614994,0.00406067097959214,0.0244755484124999,0.00615912969700185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41521,-0.00960491050211988,0.0035071473784113,-0.016478919363806,-0.00273090164043373,0.00617732624315096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,41911,0.0161574205241016,0.0059116896927026,0.00457050872640447,0.0277443323217987,0.00628182768891055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39546,-0.0215594799969527,0.00789234782268208,-0.0370284817294096,-0.00609047826449584,0.00631106108209331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,41737,0.0118932831348266,0.00435405630152276,0.00335933278384203,0.0204272334858112,0.00631230744550954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39308,0.00929216397548308,0.00340224025458661,0.00262377307649333,0.0159605548744728,0.00632094443464743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41466,0.0250555714624034,0.00918035337478816,0.00706207884781859,0.0430490640769882,0.00635629115963588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,39600,0.0200491456893563,0.00735063748688608,0.00564189621505957,0.034456395163653,0.0063910059806011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41744,0.00866238858021543,0.00317748061781056,0.00243452656930673,0.0148902505911241,0.00641566760126691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39308,0.0202343033436133,0.00742966105577985,0.00567216767428481,0.0347964390129418,0.00647088921808058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,39655,-0.0157054021429802,0.00577477176456841,-0.0270239548015343,-0.0043868494844261,0.00654516204735557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41466,0.0188669910960852,0.00694552328437564,0.00525376545870897,0.0324802167334615,0.00660793952496866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,41689,0.0162931061064452,0.00599968487862831,0.00453372374433371,0.0280524884685567,0.00662305474862806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,41836,0.0163050685455089,0.00601201626873631,0.00452151665878577,0.0280886204322321,0.00669488330325649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,39613,0.0139330329732089,0.00513781500343954,0.00386291556646739,0.0240031503799504,0.00670107622542471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,41750,-0.0114144959798516,0.00421119734553066,-0.0196684427770917,-0.00316054918261148,0.00672668135349042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41521,0.0107769122398773,0.00398584882537395,0.0029646485421444,0.0185891759376103,0.00686425854551749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39297,0.0165957151454262,0.00614561066688679,0.00455031823832811,0.0286411120525243,0.00693614803680814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39408,0.0119876887211055,0.00443977295040352,0.00328573373831462,0.0206896437038964,0.00694332442785665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39633,-0.00957164554712411,0.00354914244812576,-0.0165279647454506,-0.00261532634879763,0.00700967540802606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41465,0.0208275816970534,0.00772696595189451,0.00568272843134014,0.0359724349627666,0.00703868772258172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39308,0.0126579899158759,0.00469618059704725,0.00345347594566331,0.0218625038860885,0.0070418257198756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39600,0.0236385556322039,0.00877742382004503,0.0064348049449156,0.0408423063194921,0.00708964952385638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41911,0.0283291298352553,0.0105292397936841,0.00769181983963447,0.0489664398308762,0.00714298078371722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,39598,-0.0115555601771785,0.00429936613541901,-0.0199823178025998,-0.00312880255175725,0.00720465689154199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39650,-0.00447023638400993,0.00166459073010598,-0.00773283421501766,-0.0012076385530022,0.00725324087323633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39308,0.0200715752074872,0.00749758647065565,0.00537630572500214,0.0347668446899723,0.00743819657493487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,39600,0.0252664420606081,0.00944217656977691,0.00675977598384537,0.0437731081373709,0.00746364019449513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,41689,0.0222041137033801,0.00829859431506465,0.00593886884585338,0.0384693585609068,0.00746778384285155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,39598,0.0219707633416426,0.00821525771345674,0.00586885822326742,0.0380726684600178,0.00749771006758332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39522,0.0124654033906029,0.0046624780319927,0.00332694644789725,0.0216038603333086,0.00751630062947786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,41774,0.0116176941305419,0.00435235557140271,0.00308707721059255,0.0201483110504912,0.0076105229586812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,41802,-0.0096840514240521,0.00363197283193286,-0.0168027181746405,-0.00256538467346369,0.00767769725849984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41689,-0.0244354346356643,0.0091836997267,-0.0424354860999963,-0.00643538317133229,0.00780643023620224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39589,0.0159035115398562,0.00597878245718334,0.00418509792377687,0.0276219251559356,0.00782559998896571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39600,0.0123998089164858,0.00466989654109013,0.00324681169594915,0.0215528061370225,0.00793604991745688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,41925,-0.0211285548265119,0.0079691036611424,-0.036747998002351,-0.00550911165067283,0.00802753433400179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41465,0.025870721362504,0.00977382169583503,0.00671403083866734,0.0450274118863407,0.00813226575205673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41488,0.0212068174344285,0.00802941999239744,0.00546915424932954,0.0369444806195275,0.00827274003690972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39408,0.0197165422208595,0.00746619325728369,0.00508280343658351,0.0343502810051356,0.00828353889227556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,41758,-0.0069710898194609,0.00264051097907586,-0.0121464913384496,-0.00179568830047223,0.00829907884558103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,39596,0.00728475736530315,0.00276066838366747,0.00187384733331491,0.0126956673972914,0.00833257236174824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41534,0.0125925190935622,0.0047738587173317,0.00323575600759211,0.0219492821795324,0.00835438579343513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,41732,-0.00813147445908512,0.00308845385797989,-0.0141848440207257,-0.00207810489744453,0.00847677386848939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,41765,0.0106435343891292,0.00404338693685987,0.00271849599288386,0.0185685727853746,0.00849000670391735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,41911,-0.0208422727500134,0.00792076203488657,-0.0363669663383911,-0.00531757916163568,0.00851452056993029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41447,0.0135154389540309,0.00514212340969327,0.00343687707103207,0.0235940008370297,0.00858954269538603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,41758,-0.010706787812295,0.00407472842981912,-0.0186932555347405,-0.00272032008984958,0.00860873789123122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,39633,-0.0135567068493516,0.00516858706953334,-0.0236871375056369,-0.0034262761930662,0.00873037463928114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39334,-0.00839564263646511,0.00320286694226893,-0.0146732618433122,-0.00211802342961802,0.00877212709637404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39625,0.0137076049530598,0.00523055695003309,0.00345571333099496,0.0239594965751247,0.00878755108180853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39250,-0.00957885758569474,0.00366491792039654,-0.016762096709672,-0.00239561846171751,0.00897035380949444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39598,0.0123476864213081,0.00472960794235,0.00307765485430207,0.0216177179883141,0.0090474161221913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,39600,0.00953198093734355,0.0036532482372282,0.00237161439237626,0.0166923474823108,0.0090882423576839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39334,0.0091320502334151,0.00350001248257555,0.00227202576756703,0.0159920746992632,0.00908938940602758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39308,-0.00947030041777826,0.00362976545916516,-0.016584640717742,-0.00235596011781454,0.00909157417558468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39241,-0.0131893248504042,0.00506016484867493,-0.0231072479538071,-0.00327140174700135,0.00916000681407964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39328,0.0128123699871174,0.00492100663307727,0.00316719698628593,0.0224575429879488,0.00923753734231597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39334,0.0162331229240252,0.00624076298855508,0.0040012274664572,0.0284650183815931,0.00930409220077197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41447,-0.0256830272720418,0.00988784115076481,-0.0450631959275408,-0.00630285861654273,0.00940299305847121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41375,-0.0256507873069891,0.00988505362451338,-0.0450254924110353,-0.00627608220294288,0.00947248582146891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,41747,-0.00622323923881143,0.00239925651005988,-0.0109257819985288,-0.00152069647909407,0.00950214444590435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39427,0.0295555827723639,0.0114194847403262,0.00717339268132459,0.0519377728634031,0.00966158987261164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41507,-0.0149203505396447,0.0057719163380136,-0.0262333065621513,-0.00360739451713801,0.00974902632508079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39334,0.0155303105343139,0.00601350697482789,0.00374383686365124,0.0273167842049766,0.00981982449261227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41521,0.0247075748329785,0.00958736359344913,0.0059163421898182,0.0434988074761388,0.00997435744440559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41534,-0.0119047165398317,0.00462329334000184,-0.0209663714862353,-0.00284306159342814,0.0100366727481783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39589,0.023971589749788,0.00931312991354486,0.00571785511924006,0.0422253243803359,0.0100672749497044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,41875,0.0225601850822761,0.00877154737271272,0.00536795223175921,0.0397524179327931,0.0101228464188564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39598,-0.0104881738595732,0.00409053195463039,-0.0185056164906488,-0.00247073122849768,0.0103601541045957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,41925,0.00991186642879089,0.00386851707505382,0.0023295729616854,0.0174941598958964,0.0104124060104582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39308,0.00872173082889946,0.00340398088380401,0.00204992829664361,0.0153935333611553,0.0104142480188392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",41758,-0.0104866165768345,0.00409961223706101,-0.0185218565614741,-0.00245137659219496,0.0105401257265641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,41698,0.00975305368524605,0.00381561995466421,0.00227443857410419,0.0172316687963879,0.0105968717658754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39334,0.0124640730821414,0.00488311314183549,0.00289317132414383,0.022034974840139,0.0107094720733181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41689,0.0167631362305691,0.00656997162215649,0.00388599185114238,0.0296402806099958,0.0107379865409769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39250,-0.0106215541299674,0.00417191574365934,-0.0187985089875397,-0.00244459927239513,0.0109115542791994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,41774,0.00896606746383264,0.003522172875658,0.00206260862754295,0.0158695263001223,0.0109200897512774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,41783,0.0192562895871263,0.00757126720872426,0.0044166058580267,0.0340959733162258,0.0109912273214459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39368,-0.00947532476814852,0.00372764580555986,-0.0167815105470458,-0.0021691389892512,0.0110388783004306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,41877,0.0120224085687431,0.00473233567273755,0.00274703065017747,0.0212977864873087,0.0110813028919031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41617,0.0304939559745479,0.0120105219873569,0.00695333287932831,0.0540345790697675,0.0111305331867434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39241,-0.0184036765376056,0.0072543976578446,-0.032622295946981,-0.00418505712823013,0.0111980726341071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,41911,-0.0162854339954094,0.00641979881643886,-0.0288682396756296,-0.00370262831518926,0.0111999586170418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39241,-0.0133886368703092,0.00528739158595061,-0.0237519243787724,-0.003025349361846,0.0113497786503359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,41750,0.0105580019390241,0.00417319101617188,0.00237854754732724,0.018737456330721,0.0114191627437594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,41849,-0.0113802085927461,0.00450407666317922,-0.0202081988525774,-0.00255221833291488,0.0115272858028808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39250,-0.0125162668107095,0.00495513906361199,-0.022228339375389,-0.00280419424602999,0.0115540723245791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,41689,0.0362048666485279,0.01437360089353,0.00803260889720909,0.0643771243998467,0.0117858789425001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41534,-0.0154541132567349,0.00613548136412149,-0.0274796567304131,-0.00342856978305682,0.0117871695008884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39334,0.0247731585149164,0.00983554004275293,0.00549550003112062,0.0440508169987121,0.0117920043149107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41666,-0.0108069303977334,0.00429085381445674,-0.0192170038740686,-0.00239685692139815,0.0117941937818235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,41709,-0.0196844064023919,0.00781746057683611,-0.0350066291329907,-0.00436218367179311,0.0118139712839109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39250,-0.0149743988630519,0.00595741058419161,-0.0266509236080674,-0.00329787411803633,0.0119660674185994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,41877,-0.0143474496713841,0.0057332678494498,-0.0255846546563057,-0.0031102446864625,0.0123442098632348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39250,-0.0156853939490641,0.00626970179246827,-0.0279740094623019,-0.00339677843582628,0.0123720648276565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39259,-0.0135640903135818,0.00542916092466445,-0.0242052457259241,-0.00292293490123949,0.0124912865758087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39408,0.0155481106420646,0.00623373174472189,0.00332999642240966,0.0277662248617195,0.0126393203200582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39625,0.0222136367242431,0.00890737878287596,0.00475517430980623,0.03967209913868,0.012651249185642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39520,-0.0182963698542059,0.00734276927100407,-0.0326881976253739,-0.00390454208303797,0.012726147366088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41593,-0.028285675701287,0.0113547170175063,-0.0505409210555995,-0.0060304303469746,0.0127473980671239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41636,0.00979672605945728,0.00393734681775041,0.00207952629666647,0.0175139258222481,0.0128531959325351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39334,0.0120121010539649,0.00482941612823471,0.00254644544262485,0.0214777566653049,0.0128875406972563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41925,0.00621785086702991,0.00250890319583021,0.00130040060320269,0.0111353011308571,0.0132127673163707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41466,0.0132577551912356,0.00535745985554202,0.00275713387437319,0.0237583765080979,0.0133500505342098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39308,-0.0114332597484553,0.00462604150133857,-0.0205003010910788,-0.00236621840583167,0.0134702078542737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39589,0.0093609813932718,0.00378858852166994,0.00193534789079871,0.0167866148957449,0.0134948140368254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,39600,0.00821403060655379,0.00332480567036392,0.0016974114926405,0.0147306497204671,0.0135063657830891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39308,0.0209934146809969,0.00851682938583859,0.00430042908475332,0.0376864002772406,0.0137194605042991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39600,-0.0116239903346267,0.00471743834513768,-0.0208701694910965,-0.00237781117815681,0.0137529870327884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,41751,0.0150863654301553,0.0061247985333138,0.00308176030486026,0.0270909705554503,0.0137845160041557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41465,0.0118192776060965,0.00479919317241773,0.00241285898815775,0.0212256962240352,0.013800086955779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39427,0.0196852029870589,0.0079955938115985,0.0040138391163258,0.0353565668577919,0.0138316881059926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39643,0.0303970756071222,0.0123475772853384,0.00619582412785891,0.0545983270863855,0.0138399358453516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41570,-0.010180207424227,0.00413675492098654,-0.0182882470693606,-0.00207216777909337,0.0138712013118788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39241,-0.0214998112067859,0.00873815523232683,-0.0386265954621465,-0.00437302695142531,0.0138919855066141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39308,0.0257035825257918,0.0104467697266546,0.00522791386154889,0.0461792511900348,0.01389260002829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39334,0.0120764566538588,0.00491062762649016,0.00245162650593806,0.0217012868017795,0.0139384567785793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,41786,0.013834488845955,0.00562640172629218,0.00280674146242235,0.0248622362294877,0.0139509625067292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39250,-0.0115236715685665,0.00470864840592267,-0.0207526224441749,-0.00229472069295806,0.0144074713341999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,41740,-0.00881489858635954,0.00360555815123607,-0.0158817925627822,-0.00174800460993686,0.0145059569205291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,39600,0.0280792447904356,0.0115458553255626,0.00544936835233289,0.0507091212285384,0.0150325439179032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,41876,0.00702128020798324,0.00288990525443495,0.00135706590929073,0.0126854945066758,0.0151291511057617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39023,-0.0136300118897518,0.00561268106659048,-0.0246308667802692,-0.0026291569992345,0.0151810899554558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,41805,0.0272027171783116,0.0112073176127088,0.00523637465740232,0.0491690596992208,0.0152279668368712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41293,-0.0127623467791543,0.00525944673684033,-0.0230708623833613,-0.00245383117494721,0.0152566915925576
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39427,-0.0088417038047291,0.00364500554872668,-0.0159859146802334,-0.00169749292922479,0.0152949688360527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39250,0.0174955389207524,0.00721386128606094,0.00335637080007292,0.0316347070414318,0.0153136498543401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,41764,-0.00869488035110549,0.0035856829969835,-0.0157228190251931,-0.00166694167701783,0.0153264681471716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39250,0.031558817366128,0.0130224809900851,0.00603475462556119,0.0570828801066948,0.0153920943988788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,41925,-0.00659476476924138,0.0027227986401858,-0.0119314501040056,-0.00125807943447721,0.015446319298696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39308,0.0163707921550311,0.00676745027765363,0.00310658961083002,0.0296349946992323,0.0155777121613018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39308,0.0229193679160798,0.00947646867454924,0.00434548931396331,0.0414932465181963,0.0155988253909483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41636,-0.0149644863951951,0.00620305869796349,-0.0271224814432035,-0.00280649134718667,0.015860006479785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41911,-0.00660182768520305,0.0027424361257823,-0.0119770024917364,-0.00122665287866974,0.0160851079073891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39600,0.0113275162921822,0.00473339182514002,0.00205006831490776,0.0206049642694566,0.0167230004067989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,41911,0.00873502004546303,0.00365344401598893,0.00157426977412473,0.0158957703168013,0.0168209284539735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41534,-0.00931159107266293,0.00390357165998093,-0.0169625915262255,-0.00166059061910032,0.0170747353794723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39562,0.0116660209881004,0.00489880734169431,0.00206435859837954,0.0212676833778212,0.0172639295531665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41595,-0.00629556448229443,0.00264527440474009,-0.011480302315585,-0.00111082664900386,0.0173303274563769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39600,0.0152349306776315,0.00640204065773534,0.00268693098847027,0.0277829303667928,0.0173437232399397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39600,0.00803253841499847,0.00337869952928316,0.00141028733760347,0.0146547894923935,0.0174519094977042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41534,-0.0155319808914512,0.00653859632638731,-0.0283476296911703,-0.00271633209173203,0.0175429826423824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,41746,-0.0152675199699911,0.00642970905049499,-0.0278697497089613,-0.00266529023102089,0.0175857046200041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,39600,0.0179406865804307,0.00755820146226527,0.00312661171439076,0.0327547614464706,0.0176292895895838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,41740,0.0288678597557106,0.0121972376879883,0.0049612738872536,0.0527744456241676,0.017959275302828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41443,0.029997624216556,0.0126936505513872,0.00511806913583703,0.054877179297275,0.0181327421178461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,41803,0.00729578539946052,0.00308972197973033,0.00123993031918908,0.013351640479732,0.0182250373810568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41614,0.0102475540000017,0.00434193778670492,0.0017373559380601,0.0187577520619434,0.0182830180244434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39600,-0.0128215532008841,0.00543717213285746,-0.0234784105812848,-0.00216469582048352,0.0183847106354148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41636,0.0147117980867809,0.00625860414990537,0.00244493395296633,0.0269786622205954,0.0187553862032904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41534,0.028880029158685,0.0122933771185525,0.00478501000632199,0.0529750483110479,0.0188269990252715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39259,-0.00948704219749452,0.00403992783545608,-0.0174053007549884,-0.00156878364000061,0.0188764976704395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39250,-0.00829504118485133,0.00354080320726699,-0.0152350154710946,-0.00135506689860803,0.0191630579319534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41317,0.0227581281021124,0.00972716172348571,0.00369289112408044,0.0418233650801444,0.0193173453353516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39598,0.0210834951189523,0.00901924260164518,0.00340577961972774,0.0387612106181768,0.0194251919029286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39476,-0.00900693322451669,0.00386233217020628,-0.016577104278121,-0.00143676217091238,0.0197191954467581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39598,0.0142960601515955,0.00614434732878308,0.00225313938718063,0.0263389809160103,0.0199992441548274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41521,0.0182541719823964,0.00786069216795232,0.00284721533320984,0.0336611286315829,0.0202371320279923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39250,-0.010692177463011,0.00460661505801318,-0.0197211429767169,-0.00166321194930518,0.0203030035331457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,41911,-0.0121202974518643,0.00522560763848179,-0.0223624884232887,-0.00187810648044004,0.0203881745482424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,41840,-0.0178276543944349,0.00769578490614005,-0.0329113928104694,-0.00274391597840037,0.0205435592888725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39600,0.0100542572066346,0.00435027298018445,0.00152772216547305,0.0185807922477961,0.020841393497434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,39600,0.0138231409602843,0.0059851310444924,0.00209228411307918,0.0255539978074894,0.0209298270317818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41367,0.0206942847630868,0.00896136819555103,0.0031300030998068,0.0382585664263668,0.0209440771011662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,41888,0.00708960030374198,0.00307900712440994,0.0010547463398985,0.0131244542675855,0.0213189586723307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39408,0.0081973549612055,0.00356007525372365,0.00121960746390714,0.0151751024585039,0.0213214404312191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39241,-0.01328432312808,0.00577478147193799,-0.0246028948130785,-0.00196575144308155,0.0214446635559271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41521,0.023571914404032,0.0102585507739711,0.00346515488704866,0.0436786739210154,0.0215900935292458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39416,-0.00543016398266048,0.00236351399658518,-0.0100626514159674,-0.000797676549353528,0.0216094910771308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,41802,-0.00914196180918271,0.00398520291678722,-0.0169529595260857,-0.00133096409227977,0.0218074773578574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39600,-0.0089526848458631,0.00391697935036294,-0.0166299643725745,-0.00127540531915174,0.0222960530972012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,39600,0.00897477948885975,0.00392677390015676,0.0012783026445525,0.016671256333167,0.0223004073190664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",41802,0.0149778798664619,0.00656044885846469,0.00211940010387108,0.0278363596290526,0.0224428206127241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41465,-0.0116205224353344,0.00509499020655936,-0.0216067032401907,-0.00163434163047805,0.0225780849738942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,41711,-0.0063837443668644,0.00280333741808733,-0.0118782857063156,-0.000889203027413225,0.0227906509070323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,41708,0.0204646137906229,0.00898970547325757,0.00284479106303807,0.0380844365182078,0.0228351485720653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,39600,0.0115513628536445,0.00507517093987708,0.00160402781148541,0.0214986978958036,0.0228619158625225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41287,0.0152823890744102,0.00671718078701096,0.00211671473186872,0.0284480634169517,0.0229153687994372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39633,-0.01002207290237,0.00440899965059219,-0.0186637122175307,-0.00138043358720934,0.0230396249507752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39633,-0.00839922423940128,0.0037004634083789,-0.0156521325198239,-0.00114631595897863,0.0232403670050368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39408,-0.00521361910455176,0.002302224433792,-0.00972597899478407,-0.000701259214319445,0.0235569127984545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,41865,0.0151904271533244,0.00670865900516564,0.00204145550319976,0.0283393988034491,0.0235716449465075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,41717,-0.00935274758914675,0.00414220911008312,-0.0174714774449097,-0.00123401773338384,0.0239674530621241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,41846,-0.00544715231942378,0.00241444521860655,-0.0101794649478926,-0.000714839690954939,0.0240826186359108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,41758,0.0122696103640811,0.00544591024630871,0.00159562628131597,0.0229435944468461,0.0242758443570268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41521,0.0108731438909972,0.00483580379132538,0.00139496845999942,0.0203513193219949,0.0245632274836758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,41786,0.0199475533025405,0.0088746603711244,0.00255321897513671,0.0373418876299444,0.0246119343689288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39250,0.016070906111855,0.00715748723303216,0.00204223113511201,0.0300995810885981,0.0247675167279154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,41740,-0.0123495255748258,0.00550426235596703,-0.0231378797925211,-0.00156117135713037,0.0248728349875088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39250,-0.00976369095268625,0.00435457007913672,-0.0182986483077942,-0.00122873359757828,0.0249708172260895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39328,0.0130971942326719,0.00585741951761159,0.00161665197815319,0.0245777364871906,0.0253722047679613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,41865,0.0141803980809245,0.00634431788222429,0.00174553503176487,0.0266152611300841,0.0254251570655225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39600,0.0186474467993824,0.00834354066641804,0.00229410709320304,0.0350007865055618,0.0254402291504116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39633,0.00560599134452872,0.00250923313608555,0.000687894397801038,0.0105240882912564,0.0254934688921501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39250,0.0182164549596846,0.0081576080053436,0.00222754326921118,0.0342053666501581,0.025565464778712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41534,0.0132065891456123,0.00591447450028508,0.00161421912505349,0.024798959166171,0.0255708075482425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39589,0.0108075230014309,0.00484672420894657,0.00130794355189562,0.0203071024509662,0.0257767706893299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,41911,0.0102520510907549,0.00459816647251403,0.00123964480462743,0.0192644573768824,0.0257909275960058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,39625,-0.00671134632273181,0.00301076214883198,-0.0126124401344425,-0.000810252511021137,0.0258260770480574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39328,0.0118425227581003,0.00531463243534959,0.00142584318481512,0.0222592023313855,0.0258820729824307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,41810,-0.00862761842396845,0.00387509200440346,-0.0162227987525992,-0.00103243809533768,0.0260022368353845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39308,-0.00958324264244909,0.00430805553734331,-0.018027031495642,-0.00113945378925619,0.0261360066986442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,39650,0.00654407863472195,0.0029419902067277,0.00077777782953565,0.0123103794399082,0.0261435962701765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39308,0.00754033862843773,0.00339447395093031,0.000887169684614323,0.0141935075722611,0.0263476192789365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39600,0.00649648617002862,0.00293816471725844,0.000737683324202074,0.0122552890158552,0.0270515210507328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39158,0.00947127248046284,0.00429048192615098,0.00106192790520692,0.0178806170557188,0.0273000256700353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,41911,0.0116642260764167,0.00529599972266571,0.00128406661999188,0.0220443855328415,0.0276499311812977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39328,-0.00896639508798399,0.00408958205199027,-0.0169819759098849,-0.000950814266083054,0.0283650646113962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39250,-0.00825073862114877,0.00376759014635498,-0.0156352153080045,-0.000866261934293007,0.0285513136979518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,41838,0.00969430436000373,0.00442836242281637,0.00101471401128365,0.0183738947087238,0.0286040827462115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39334,-0.0136018244684594,0.00622032244505828,-0.0257936564607736,-0.00140999247614514,0.0287877598566195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39600,-0.00605870194360975,0.00277618737873134,-0.0115000292059232,-0.000617374681296328,0.0291024159175049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,39625,-0.0156005555504293,0.00715227527268523,-0.0296190150848923,-0.00158209601596621,0.0291895511302485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39408,-0.00698371911909447,0.00320610526891885,-0.0132676854461754,-0.000699752792013525,0.0294084975182318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39655,-0.0172801443156494,0.00795598449554027,-0.0328738739269084,-0.00168641470439049,0.0298792564485454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,41728,-0.0162745297844259,0.00749712444591256,-0.0309688936984146,-0.00158016587043733,0.0299664535985318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,41925,-0.00622009902771655,0.00287131213353551,-0.0118478708094462,-0.000592327245986948,0.0303065906973574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,41877,-0.00387834205940535,0.0017904370097705,-0.00738759859855552,-0.000369085520255171,0.0303180212321317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,41758,-0.0124038691767094,0.00573526094097045,-0.0236449806210115,-0.00116275773240732,0.030579259397137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,41774,-0.00727083375246754,0.00336188178032173,-0.0138601220418981,-0.000681545463036946,0.0305800877746515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39241,0.0221243153854573,0.0102296398561068,0.00207422126748797,0.0421744095034266,0.0305813979022085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39462,-0.00313107080317804,0.00144939186806566,-0.00597187886458673,-0.000290262741769346,0.0307739469329445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39554,0.0113657982324329,0.00526182551890795,0.00105262021537331,0.0216789762494925,0.0307905387778383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41534,0.0101834834199125,0.00472734594213139,0.000917885373334947,0.01944908146649,0.031245642945193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,39589,0.00795019761246301,0.00369835157457616,0.000701428526293732,0.0151989666986323,0.0316038984326883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41274,0.014173374316837,0.00659601908618265,0.00124517690791905,0.027101571725755,0.0316709627185635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41585,-0.0270733468940356,0.0126165335565659,-0.0518017526649047,-0.00234494112316651,0.0319024270636557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,41855,0.00466689859149731,0.00217554507249,0.000402830249416917,0.0089309669335777,0.0319579400985525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39259,0.0174815794359361,0.00815016250634782,0.00150726092349437,0.0334558979483778,0.0319804731869275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39241,-0.00774884084517229,0.00361561701476673,-0.0148354501941151,-0.000662231496229505,0.0321229698402516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,41764,0.0243400922910715,0.0113575678797157,0.00207925924682882,0.0466009253353142,0.0321255467799331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41465,0.0120410039992384,0.00562790572666238,0.00101030877498019,0.0230716992234967,0.0324125238948573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39334,-0.0088519802696605,0.00413755962162799,-0.0169615971280513,-0.00074236341126965,0.0324241083964512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,39655,0.0161892020806006,0.00756793417911435,0.00135605108953643,0.0310223530716647,0.0324426265236293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41534,-0.00670613822278823,0.0031365542293008,-0.0128537845122178,-0.000558491933358654,0.0325306348308343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39241,0.0154734669245842,0.00724145051689758,0.001280223911465,0.0296667099377035,0.0326377258035717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41534,-0.0168110723811319,0.00786801728600566,-0.032232386261703,-0.0013897585005608,0.0326464905520356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,41764,0.00749595349228215,0.00351087058759589,0.000614647140594206,0.0143772598439701,0.0327737239528878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39408,0.0135540152084635,0.00636528493008737,0.00107805674549228,0.0260299736714348,0.03324660682027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39250,-0.00819586742554293,0.00385189442462995,-0.0157455804978176,-0.000646154353268228,0.0333807407273847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,41911,0.0153387514667822,0.00721043744045311,0.00120629408349412,0.0294712088500703,0.0334136361385431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41465,0.0130938742775965,0.00616749246278469,0.00100558905053851,0.0251821595046545,0.0337689810311828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39334,0.0116566431849798,0.00549507978788363,0.000886286800727921,0.0224269995692317,0.0339204835299701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39295,0.00859638937380655,0.00405534444662703,0.00064791425841758,0.0165448644891955,0.0340485837941622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,41750,-0.0116777143538285,0.00551352561075745,-0.0224842245509131,-0.000871204156743875,0.0341927456400308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39334,0.0134090427939721,0.00633116884657965,0.000999951854676034,0.0258181337332682,0.0342029766312214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39589,0.0118854171893886,0.00561298729859878,0.000883962084134987,0.0228868722946422,0.0342410937096575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41521,-0.00887410092541987,0.00419138734008348,-0.0170892201119835,-0.00065898173885626,0.0342599950210346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,41726,-0.0142362753038733,0.00672497905026674,-0.0274172342423961,-0.0010553163653505,0.0342849866014402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39250,0.0158088415523276,0.00746766561204994,0.00117221695270972,0.0304454661519455,0.0342853171014595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41466,0.00805182997497724,0.00380501010503317,0.000594010169112238,0.0155096497808422,0.0343543822818397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39241,-0.00599160525273929,0.00283682807852281,-0.011551788286644,-0.000431422218834585,0.0347029064958075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39600,0.00998057615326523,0.00473061634675717,0.000708568113621178,0.0192525841929093,0.0348995372280275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,41748,0.00661128909769157,0.00313475966271525,0.000467160158769678,0.0127554180366135,0.0349612101616827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39427,-0.00795456926981146,0.0037738532242029,-0.0153513215892492,-0.000557816950373771,0.0350702673593155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,41802,-0.00531584210523169,0.00252555461723485,-0.010265929155012,-0.000365755055451395,0.0353256821491472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,41765,0.0152519879783664,0.00725145894396394,0.00103912844819708,0.0294648475085357,0.0354585473444592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39334,-0.00496618699433198,0.00236446726121509,-0.00960054282631356,-0.000331831162350401,0.0357221463140237
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39250,-0.0132651480698522,0.00632448312332097,-0.0256611349915613,-0.000869161148143121,0.0359792161476464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,41707,0.00453895557691708,0.0021648606808668,0.000295828642418145,0.00878208251141601,0.036043669403814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,41805,0.0283490226283006,0.0135214408433112,0.00184699857541066,0.0548510466811906,0.0360481737537771
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39250,0.0159578591156486,0.00761198261978487,0.00103837318087028,0.030877345050427,0.0360691053563629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,39625,-0.0223849485428713,0.0106785204784225,-0.0433148486805793,-0.00145504840516321,0.0360819246817341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,41877,0.00914987901983663,0.0043663976689561,0.000591739588682682,0.0177080184509906,0.0361435736053987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39334,-0.00498051781306404,0.0023783558944545,-0.00964209536619486,-0.000318940259933229,0.0362743647133174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39600,-0.0163526751447187,0.00781602242453714,-0.0316720790968115,-0.00103327119262589,0.0364435729293188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39308,0.00701416038885133,0.00335497775352501,0.000438403991942313,0.0135899167857603,0.0365809322394063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,41765,-0.0122347155532385,0.00588350699527595,-0.0237663892639794,-0.000703041842497625,0.0375913050450069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39308,0.0137228653814476,0.00659981049008079,0.000787236820889209,0.0266584939420059,0.0376152035326312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39427,0.0150305011478669,0.00723266089223735,0.000854485799081685,0.0292065164966521,0.0377197226194654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,41911,0.00520770808051299,0.00250733527983372,0.000293330932038888,0.0101220852289871,0.0378216972879592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41533,0.016401333245182,0.00789783184615668,0.000921582826714904,0.0318810836636491,0.0378500549276725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,41815,-0.00661719969727803,0.00318713056971479,-0.012863975613919,-0.000370423780637037,0.0378924440139939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41740,-0.0185219908534605,0.0089242752361897,-0.0360135703163923,-0.00103041139052872,0.0379631775504947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41636,0.00638590732551287,0.00308386308413992,0.000341535680598614,0.0124302789704271,0.0384018661776202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39241,-0.0107918195322083,0.00521361079368027,-0.0210104966878216,-0.000573142376594922,0.0384827892849189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39250,-0.0115639286767617,0.00559191186831619,-0.0225240759386615,-0.000603781414862005,0.0386665514286755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41408,0.00734866586944333,0.00355674068937794,0.000377454118262579,0.0143198776206241,0.0388368701540396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39250,0.0277440090622438,0.0134343378638362,0.00141270684912494,0.0540753112753627,0.0389323457240583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,39600,-0.0154747040089678,0.00750133685383869,-0.0301773242424916,-0.000772083775443961,0.0391430607941578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41636,0.0210469500895061,0.0102073676956415,0.00104050940604877,0.0410533907729635,0.0392334997040149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39308,-0.00863483092727307,0.00418851557080497,-0.0168443214460508,-0.000425340408495322,0.039274755789823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,41790,-0.00597334653005225,0.00290517726978879,-0.0116674939788383,-0.000279199081266214,0.0397921287012621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39328,0.0087596926681364,0.00426091416080544,0.000408300912957748,0.0171110844233151,0.039823558927937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41925,0.00542281480431604,0.0026379883635016,0.000252357611852909,0.0105932719967792,0.0398344617289575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41386,0.0163245232804966,0.00794518557532987,0.000751959552850045,0.0318970870081431,0.0399337353251063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41465,-0.0119839427912981,0.00583820811814778,-0.0234268307028677,-0.000541054879728432,0.0401243092094356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,41911,-0.0174874007162428,0.00853841022147936,-0.0342226847503424,-0.00075211668214328,0.0405711238264932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41612,0.0101062615609929,0.00493531898668606,0.000433036347088267,0.0197794867748976,0.0406052862936472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,41805,-0.00755392144729018,0.00369083600627184,-0.014787960019583,-0.000319882874997369,0.0407103020459763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,41758,0.00573250134783782,0.00280415942130675,0.00023634888207658,0.0112286538135991,0.0409452515573988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39241,0.0123145901390676,0.00602821435262488,0.000499290007922881,0.0241298902702124,0.0410943009152112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39408,0.0112327769961042,0.00549927305956107,0.000454201799364494,0.0220113521928439,0.0411169507759409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,41740,0.0134695071837504,0.00659593922076104,0.000541466311058779,0.026397548056442,0.0411624422093846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39334,-0.0100116326637104,0.00491015998172483,-0.0196355462278911,-0.000387719099529768,0.0414782048637747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41595,-0.00895139729866661,0.00439754244048195,-0.0175705804820112,-0.00033221411532198,0.0418162700640699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39334,-0.00651268956904651,0.00320182347911175,-0.0127882635881055,-0.000237115549987489,0.0419704454823401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,41765,0.0269490561634249,0.0132637846364725,0.000952038275938857,0.052946074050911,0.0421962492961773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39250,0.00976635518095993,0.00481367039541256,0.000331561205951316,0.0192011491559685,0.0424954341470985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39334,0.0096890624459326,0.00477679862490231,0.000326537141124076,0.0190515877507411,0.0425482638585878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39259,-0.0102381969692572,0.00505783013498781,-0.0201515440338333,-0.000324849904681047,0.0429716784907108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41534,0.0129828210620039,0.0064163338247866,0.000406806765422152,0.0255588353585856,0.0430522694480484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,39598,0.00491804063250272,0.00243130030889688,0.000152692027064832,0.00968338923794061,0.0431176505086694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,41740,0.00793651444297317,0.00392737020131407,0.000238868848397592,0.0156341600375488,0.0433184799176196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41802,0.0206930092814473,0.0102422821762712,0.0006181362159558,0.0407678823469387,0.0433671026342897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39308,0.0106774999607435,0.00528728493702321,0.000314421484178035,0.021040578437309,0.0434635181234527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39427,-0.00729235495848526,0.00361661669264569,-0.0143809236760708,-0.000203786240899712,0.0437883281245523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39308,-0.0103220056327188,0.00512253183625269,-0.0203621680317741,-0.000281843233663563,0.0439274661024902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39334,0.00717200926639986,0.00355973161086155,0.000194935309111213,0.0141490832236885,0.0439545604424545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39094,0.00509312513487189,0.00253221757763818,0.000129978682701066,0.0100562715870427,0.0443161338910651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39408,0.0146645981042505,0.00729322576761311,0.000369875599728791,0.0289593206087722,0.0443803634269634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41465,0.0133305909843722,0.00662996625996226,0.000335857114846209,0.0263253248538983,0.044382479187986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41587,-0.00658583018602878,0.00327750698101397,-0.0130097438688162,-0.000161916503241394,0.0445151322456947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39427,0.00748961995907606,0.00372986241006298,0.000179089635352613,0.0148001502827995,0.0446664833443632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41865,0.0121048279030297,0.00603330528414002,0.00027954954611523,0.0239301062599441,0.0448408437875118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41534,-0.00976464209142029,0.00486764969234632,-0.0193052354884191,-0.000224048694421502,0.0448740334902682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38213,0.0232054040808801,0.0115713328506074,0.000525591693689691,0.0458852164680705,0.0449459412183422
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,39625,0.0140136551552493,0.00700907288833378,0.000275872294115078,0.0277514380163835,0.0455939885756503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,41775,-0.0205697826500476,0.0103076641960666,-0.0407728044743382,-0.000366760825756957,0.0460000627385423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,41736,-0.0188971609966947,0.00947679785814293,-0.0374716847986548,-0.000322637194734542,0.046167778243701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,41750,0.00665152185642826,0.00334098829949266,0.000103184789422651,0.0131998589234339,0.0465142451676256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,41758,0.00564585450514992,0.0028358656536976,8.75578239026217e-05,0.0112041511863972,0.046515260304469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39250,-0.00762160986085022,0.00382945874095744,-0.0151273489931268,-0.000115870728573633,0.0465880724120657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39334,0.013831359384045,0.00696313445983279,0.000183615842772728,0.0274791029253173,0.0470176754329412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39600,0.0124808356988705,0.00628379600070006,0.000164595537498357,0.0247970758602426,0.0470366031056917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,41740,-0.0106383347743965,0.00536464377272144,-0.0211530365689305,-0.000123632979862448,0.0473830900737987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,39589,0.008701395051809,0.00438808118054179,0.000100755937947098,0.0173020341656709,0.0473966115886555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41689,-0.0121061511766764,0.006106155575147,-0.0240742161039646,-0.000138086249388315,0.0474314052833797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39259,-0.00628483203747208,0.00317042999960405,-0.012498874836696,-7.07892382481382e-05,0.0474681832887923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39250,-0.0099427689802992,0.00502411548864806,-0.0197900353380494,-9.55026225490097e-05,0.0478407263000093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,39598,-0.0192003230706108,0.00972095551373776,-0.0382533958775368,-0.000147250263684763,0.0482763533373601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39259,-0.0131004785147995,0.00665141035311564,-0.0261372428069061,-6.37142226927994e-05,0.0489124887876542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,41911,0.00753386229102448,0.00383198060400483,2.31803071750131e-05,0.0150445442748739,0.0493136820267677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39334,-0.00918506502149933,0.00467676996599048,-0.0183515341548407,-1.85958881579913e-05,0.0495586168680715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41521,0.0108780297741437,0.00554788847728063,4.16835867368508e-06,0.0217518911896137,0.0499294873503036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41689,-0.00774780127981843,0.00396480304859164,-0.015518815255058,2.32126954211763e-05,0.0507052994654502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,41740,0.0181773878857043,0.00931768556112795,-8.52758141064967e-05,0.0364400515855151,0.0510963603879711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,41805,-0.0139796934598665,0.0071848169103462,-0.0280619346041451,0.000102547684412028,0.0517087101939838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,41879,0.00430219113599122,0.00221359950151098,-3.64638869703093e-05,0.00864084615895274,0.0519735755089612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,41636,-0.00763663263674094,0.00393209491754694,-0.0153435386751329,7.02734016510709e-05,0.0521430870144125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41521,-0.0292470127769145,0.0150698181749934,-0.0587838563999015,0.000289830846072571,0.0523082100244753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39308,0.0158791871335593,0.00818856761392813,-0.000170405389739829,0.0319287796568584,0.0525044611465437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39250,-0.00722680098077412,0.00372763461176346,-0.0145329648198305,7.93628582822659e-05,0.0525630955187666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39589,0.0109229935719206,0.00564539743467424,-0.00014198540004089,0.0219879725438821,0.0530344162319719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39250,-0.017246987399934,0.00894442133040017,-0.0347780532075184,0.000284078407650289,0.0538518827023019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39655,-0.00550570213942084,0.00286363986237261,-0.0111184362696711,0.000107031990829475,0.0545529771598231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39250,0.0116949834855424,0.0060914906159538,-0.000244338121727014,0.0236343050928119,0.0548986523067738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39334,0.00688813362682868,0.0035928321246572,-0.000153817337499426,0.0139300845911568,0.0552406022548241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39250,-0.0143278643022053,0.00747575056184402,-0.0289803354034196,0.000324606799008946,0.0553182090815364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39308,-0.0117047821701256,0.00610839588203479,-0.0236772380989138,0.000267673758662634,0.0553688627683168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,41911,-0.00941187847101041,0.00491655222100624,-0.0190483208241826,0.000224563882161815,0.0556000677163458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39600,0.0242944685651394,0.0127364938959275,-0.000669059470878544,0.0492579966011573,0.0564858851692137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,39625,0.0110236682839095,0.00578270479612043,-0.00031043311648651,0.0223577696843056,0.0566350682223669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,41769,-0.0193648946190963,0.0101706076009011,-0.0392992855168625,0.000569496278669951,0.0569312182141609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41458,0.016296542684791,0.00856636362133195,-0.000493530013019668,0.0330866153826016,0.0571428400572648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39241,-0.00903510937030719,0.00474930095278479,-0.0183437392377654,0.000273520497150995,0.0571447720146598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39328,0.0168968602601491,0.00889203550907767,-0.000531529337643118,0.0343252498579413,0.0574304993394351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41625,0.020871623349469,0.010987965278517,-0.000664788596424219,0.0424080352953622,0.0575210352742597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39600,-0.0143907577985604,0.00758435419068693,-0.0292560920123067,0.000474576415186001,0.0577977772059845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41466,0.0139312602428427,0.00735918297227073,-0.000492738382807965,0.0283552588684933,0.0583743831399758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39633,0.013070831876664,0.00691153094759322,-0.000475768780618684,0.0266174325339467,0.0586287551508036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,41866,0.00632636114339252,0.00335447189976063,-0.000248403780138315,0.0129011260669234,0.0593237258172838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39334,-0.00867475071873145,0.00460518808538043,-0.0177009193660771,0.000351417928614189,0.0596338105499126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39250,0.0137260559147028,0.00728722592194789,-0.000556906892315077,0.0280090187217206,0.0596493487979734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39427,0.00847680204820502,0.00450406150179915,-0.000351158495321323,0.0173047625917314,0.0598580424592938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41636,-0.0123808635163307,0.00657859934344246,-0.0252749182294779,0.000513191196816514,0.0598595212158673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39600,0.0130634156120983,0.00694959897029953,-0.000557798369688748,0.0266846295938854,0.0601703921825034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39241,0.0185123431763829,0.00985901875771928,-0.000811333588746851,0.0378360199415127,0.0604486613770722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,41740,-0.00980885764378106,0.00523169887991361,-0.0200629874484117,0.000445272160849625,0.0608300806845025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39414,-0.0109041284573512,0.0058178014165357,-0.0223070192337611,0.000498762319058798,0.0609202110321175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,41740,0.0146977773214815,0.00785814951082947,-0.000704195719744236,0.0300997503627073,0.0614523690196592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39433,0.00495349060421747,0.00264878088608898,-0.00023811993251694,0.0101451011409519,0.0614965940292093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,39650,-0.00303072288102963,0.00162137469786295,-0.00620861728884101,0.00014717152678175,0.0616171965995613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39427,-0.0107466305005633,0.00575254508695407,-0.0220216188709933,0.000528357869866682,0.0617678308971222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41465,0.0148955560113,0.00797504980481604,-0.000735541606139454,0.0305266536287394,0.0618169033584837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39427,0.0174932741898216,0.00937409924927059,-0.000879960338748733,0.035866508718392,0.0620504000261391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39308,0.00777995623015662,0.00417060360207822,-0.000394426829916686,0.0159543392902299,0.062148913577232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39600,0.0157830621716336,0.00846115191974046,-0.000800795591057731,0.0323669199343249,0.0621580949282919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39408,0.00588994418002689,0.00315830491921538,-0.000300333461635252,0.012080221821689,0.0622215560942349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41415,-0.00609464378373128,0.00326832760126741,-0.0125005658822154,0.000311278314752843,0.0622380134049186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,41865,-0.0156865300205413,0.00842247933424328,-0.0321945895156581,0.000821529474575554,0.0625603839918702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,39598,0.00946337561525732,0.00508128005087301,-0.000495933284453791,0.0194226845149684,0.0625733847396469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41877,0.00529626571326462,0.00285588369692874,-0.00030126633271571,0.0108937977592449,0.0636883456205344
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,41765,0.00773925521530528,0.00417401476498991,-0.000441813724074955,0.0159203241546855,0.0637398555330926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39250,-0.0120413966558054,0.00650068796497424,-0.0247827450671549,0.000699951755544114,0.0640066020817326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39241,-0.00859442023864576,0.00464071406661058,-0.0176902198092025,0.000501379331910979,0.0640591405313545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41504,0.0103619575609796,0.00559700986778157,-0.000608181779872232,0.0213320969018315,0.064143761271823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,41758,-0.00718331667179993,0.00388236131888442,-0.0147927448568134,0.000426111513213524,0.0643007577674047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,39625,-0.01066775895152,0.00577419822939656,-0.0219851874811372,0.000649669578097277,0.064703292256209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39250,0.00921254527300202,0.00498785202939815,-0.000563644704618352,0.0189887352506224,0.0647753673093683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39250,0.0132857309511266,0.00719469563616316,-0.000815872495753203,0.0273873343980064,0.0648327392890126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39372,0.00888727575701899,0.00481484138995731,-0.000549813367297333,0.0183243648813353,0.064947420024233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,41878,-0.00685696056947097,0.00372282729690929,-0.0141537020714132,0.000439780932471236,0.0655165862782713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41521,0.0144740612833422,0.00786554042981886,-0.000942397959102805,0.0298905205257871,0.0657637824098811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41534,0.0169525280722141,0.00922960678202634,-0.00113750122055757,0.0350425573649857,0.0662689784150861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,41736,-0.00852921414008493,0.00466534167360633,-0.0176732838203533,0.000614855540183486,0.0675410343455207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41622,0.009185474363504,0.00503751019287991,-0.000688045614540628,0.0190589943415486,0.0682633915867717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39598,0.0214774547863417,0.0117819910156506,-0.0016152476043334,0.0445701571770169,0.0683448590342547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41689,-0.00524063074044271,0.0028754089646805,-0.0108764323112165,0.000395170830331076,0.0683915247961935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39408,-0.0176018329350005,0.00967462168561591,-0.0365640914388077,0.00136042556880667,0.0688808193795813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39385,0.0169590379067242,0.00933951606231617,-0.00134641357541549,0.0352644893888639,0.0694231498753484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,41765,-0.00552435521265203,0.00305082125127509,-0.0115039648651512,0.000455254439847143,0.0701982515996782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39334,0.00809782308655615,0.00447783855328397,-0.000678740477880439,0.0168743866509927,0.0705687727723627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41740,-0.0236407245554068,0.0130751429873212,-0.0492680048105564,0.00198655569974289,0.0706190465046145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39498,-0.0214696858776019,0.0118837322221723,-0.0447618010330596,0.00182242927785572,0.0708452137355118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,41740,-0.013209034581097,0.00731495200703261,-0.0275463405148809,0.0011282713526869,0.0709789924852857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41465,0.00913172405353253,0.00506286758399982,-0.000791496411107104,0.0190549445181722,0.07130700697595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39600,0.0123237319443822,0.00684349028711295,-0.00108950901835921,0.0257369729071236,0.0717623734167916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,41855,-0.00487637634845896,0.00270958867232762,-0.0101871701462211,0.000434417449303182,0.0719348572450387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39328,0.0109387844043859,0.00608162353019335,-0.000981197714793054,0.0228587665235649,0.0721002806020015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39328,0.0043393535726516,0.00241403177916998,-0.000392148714521564,0.00907085585982477,0.0722757519730759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39408,0.00766952134784118,0.00426693087380851,-0.00069366316482351,0.0160327058605059,0.0722948469148176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41598,0.00788135624818523,0.00438628482705237,-0.000715762012837412,0.0164784745092079,0.0723876994532908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39328,0.0165806505814775,0.00924110265147906,-0.00153191061542145,0.0346932117783765,0.0728048371725549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39308,0.0151883703574325,0.00847707306677406,-0.00142669285344465,0.0318034335683096,0.0732092886593356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39600,-0.0115302459027446,0.00644820781223309,-0.0241687332147214,0.0011082414092323,0.0737822491809796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39600,-0.0232225883600825,0.0129880516876121,-0.0486791696678023,0.00223399294763728,0.073804120714577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39655,0.00515925756860954,0.00288997813898489,-0.000505099583800847,0.0108236147210199,0.074252440924307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39221,-0.00792566236086772,0.00444616141249068,-0.0166401387293494,0.000788814007614014,0.074682375637956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39427,-0.0116615876399654,0.006556940972679,-0.0245131919464162,0.00119001666648546,0.0753481208431803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,41925,0.00757043193201398,0.00426267353489809,-0.000784408196386272,0.0159252720604142,0.0757586813718845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39107,-0.0208176390011214,0.0117264560930426,-0.043801492943485,0.00216621494124209,0.0758820710239811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,39589,-0.00768234735851933,0.00432794228400186,-0.016165114235163,0.000800419518124314,0.0759160316732634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,41877,0.00891433195778337,0.00503856425064673,-0.000961253973484219,0.018789917889051,0.0768800104336161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41534,0.00944494410994341,0.00533878409910478,-0.00101907272430196,0.0199089609441888,0.0768975882901612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39328,0.0157334835844545,0.00889397809975586,-0.00169871349106702,0.033165680659976,0.0769216010243256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39241,-0.00575151590328336,0.00325540837785067,-0.0121321163238707,0.000629084517303959,0.0772975766526153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39625,-0.00734331799061033,0.00415742759869807,-0.0154918760840585,0.000805240102837892,0.0773710372825163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,41911,0.00897901778604709,0.00508423111573393,-0.000986075200791412,0.0189441107728856,0.0774100025990733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39241,-0.0130748002344151,0.0074049011572112,-0.0275884065025491,0.00143880603371883,0.077475630539895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39589,-0.0116592902535872,0.00661480526007843,-0.0246243085633409,0.00130572805616653,0.0779948907954289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39250,-0.00811536126864142,0.00461919040672353,-0.0171689744658195,0.0009382519285367,0.078967071483542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39259,-0.00543413382246038,0.0030942057176881,-0.0114987770291291,0.000630509384208301,0.0790780295560173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39408,-0.0121805668275424,0.006936798620015,-0.0257766921227718,0.00141555846768698,0.0791278461293658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39589,-0.00833584163890236,0.00474821643749482,-0.0176423458563922,0.000970662578587489,0.0791891664034885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39241,-0.00492137081715312,0.00280432718989303,-0.0104178521093435,0.000575110475037208,0.0793017110474177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39334,0.00641564907118301,0.00365608300080844,-0.000750273610401542,0.0135815717527676,0.0793241753625749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41636,0.0148895209866908,0.00849650154214065,-0.00176362203590489,0.0315426640092864,0.079723469718153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39241,0.0277665744960135,0.0158503531949424,-0.0033001177660736,0.0588332667581006,0.0798378148312083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39427,-0.00704432460420301,0.00402414208917925,-0.0149316430989943,0.000842993890588325,0.080057659268647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39625,0.0137465250183771,0.00785486831536287,-0.00164901687973415,0.0291420669164883,0.0801350274137517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,39566,0.0174281306790328,0.00999734897061369,-0.00216667330336999,0.0370229346614357,0.0813135785043762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41447,0.00765859339234069,0.00439647532675597,-0.000958498248101024,0.0162756850327824,0.081535028040064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,41706,-0.00657654238617205,0.00378535696547609,-0.0139958420385052,0.000842757266161092,0.0823464578789649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,41765,-0.00641716715426722,0.00369484616911441,-0.0136590656457315,0.000824731337197013,0.08244786089158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41534,0.00885632073192302,0.00509944680243666,-0.00113859500085284,0.0188512364646989,0.0824600860093594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41466,0.00947597367658866,0.00546259273363803,-0.00123070808134188,0.0201826554345192,0.0828174487618466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,41925,-0.0076094552019496,0.00439046331332143,-0.0162147632960596,0.000995852892160399,0.0830871385239347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41299,0.00684633658429996,0.00395185124715372,-0.000899291860121335,0.0145919650287213,0.0832199175647302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39328,-0.0111474808220651,0.00644835299492564,-0.0237862526921194,0.00149129104798912,0.0838856574560741
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39625,0.013943292113536,0.00807029532048413,-0.00187448671461293,0.0297610709416848,0.0840646287653272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39334,0.00740031372119448,0.00428369611551425,-0.000995730665213451,0.0157963581076024,0.0840970907274071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41466,-0.0136494353173452,0.00790546184774739,-0.02914414053893,0.00184526990423972,0.0842666018554211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39598,0.016758072909227,0.00970783263593897,-0.00226927905721337,0.0357854248756674,0.0843318860562605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,41744,0.00666541410102087,0.00386345789392397,-0.000906963371070119,0.0142377915731119,0.0845067092953386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39625,0.0101064584791058,0.00586481782813221,-0.00138858446403335,0.0216015014222449,0.0848741023846665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41866,-0.0064095995693632,0.00372439220063891,-0.0137094082826155,0.000890209143889056,0.0852780094695582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39308,0.0118633341284687,0.00689757511445531,-0.00165591309586369,0.0253825813528011,0.0854743838504434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41614,0.00598069896849977,0.00348193994751589,-0.000843903328631376,0.0128053012656309,0.0858871563428164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39600,0.00992346154781996,0.005777348421404,-0.00140014135813187,0.0212470644537718,0.0858886499450093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41465,0.0056412378323176,0.00328944108772812,-0.000806066699629524,0.0120885423642647,0.0863778721660876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39250,-0.00789392720308732,0.00460343626618208,-0.0169166622848042,0.00112880787862956,0.0864127983533347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,41758,-0.0224725947884236,0.0131200377713906,-0.0481878688203491,0.00324267924350186,0.0867645657181813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39334,0.0118844096538479,0.00694181826447015,-0.00172155414451362,0.0254903734522094,0.086925107802009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39334,0.0193323361961352,0.0113083814947971,-0.00283209153366707,0.0414967639259374,0.0873765056526075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39427,0.00970311887144543,0.00568818656366342,-0.00144572679333488,0.0208519645362257,0.088067121038127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41534,-0.00675979155803849,0.0039641274500803,-0.0145294813601959,0.00100989824411891,0.088173550500904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39241,-0.00558323914009884,0.003275806798845,-0.012003820465835,0.000837342185637353,0.0883381968328038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39334,-0.00569416411004336,0.00334090226808388,-0.0122423325554878,0.000854004335401041,0.0883392200083521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39600,0.00500985917612479,0.00294109034689757,-0.000754677903794436,0.010774396256044,0.0885211109731079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39410,-0.00971673557649759,0.00572007426246439,-0.0209280811309278,0.0014946099779326,0.0894030022281448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41534,-0.0132025800035039,0.00777254914759653,-0.0284367763327931,0.00203161632578527,0.089415521859287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41740,0.0186187991946111,0.01098012961782,-0.00290225485631599,0.0401398532455382,0.0899699637540845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,41689,0.00567134019447969,0.00335167499992893,-0.000897942805381022,0.0122406231943404,0.0906523638874701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,41758,-0.0215485985404432,0.0127571932470497,-0.0465526973046606,0.00345550022377426,0.0912176010365045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41465,0.0105104289449265,0.00623145123044047,-0.00170321546673685,0.0227240733565898,0.091690232285407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39241,0.00797053099052564,0.00472706180463623,-0.00129451014656137,0.0172355721276127,0.0917964013664648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39334,0.0143650256982912,0.00852877188716292,-0.00235136720054815,0.0310814185971305,0.0921524342706008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,41740,0.00804001479310013,0.0047903701032281,-0.00134911060922695,0.0174291401954272,0.0932986156853337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39655,0.0074171780203765,0.00441994442620458,-0.00124591305498448,0.0160802690957375,0.0933527848174368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,41925,0.00311913164725153,0.00185917818490566,-0.000524857595163561,0.00676312088966662,0.0934303496560088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39589,0.00524810217889234,0.00313479891866514,-0.000896103701691322,0.011392308059476,0.0941309241741445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39308,0.00539120498348622,0.00322161179542576,-0.000923154135548273,0.0117055641025207,0.0942680281228629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41465,0.00643766127824242,0.00385008189409096,-0.00110849923417586,0.0139838217906607,0.0945320285405065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41805,-0.0216385044686832,0.012955654395595,-0.0470315870840494,0.00375457814668306,0.0949039505570079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41466,0.00690200664734781,0.00413395162257671,-0.00120053853290255,0.0150045518275982,0.0950247247343552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41534,-0.00868842437689814,0.00520786687365373,-0.0188958434492595,0.00151899469546317,0.095275056746693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,39598,0.0247192979009898,0.0148437520390448,-0.00437445609553804,0.0538130518975177,0.0958814323821955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41696,0.00483226493091231,0.00290406115092097,-0.000859694924892796,0.0105242247867174,0.0961427420923002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,39598,0.00878588682820773,0.00528142439550594,-0.00156570498698391,0.0191374786433994,0.0962318939854449
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41689,-0.00463068742581473,0.00278542478582384,-0.0100901200060295,0.000828745154399992,0.0964423536602274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41173,0.00507136662420565,0.0030538429185693,-0.000914165496190168,0.0110568987446015,0.0968085388625522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,39650,0.00738218789640566,0.00444691904672538,-0.00133377343517609,0.0160981492279874,0.0969291529667976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,41802,0.012461692656454,0.00752342419733869,-0.00228421877032978,0.0272076040832379,0.0976674884828745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,38782,0.0101450796758302,0.00612848470104431,-0.00186675033821665,0.022156909689877,0.0978746633647626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41465,0.0151851517618662,0.00917747654358993,-0.00280270226357008,0.0331730057873024,0.0980278661453487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39408,0.00767775050006822,0.00464106211207723,-0.00141873123960314,0.0167742322397396,0.0980937972573346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41534,-0.00852369046800532,0.00515598793152467,-0.0186294268137937,0.00158204587778303,0.0983218853063024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39334,-0.0082276156487551,0.00498015090455004,-0.0179887114216732,0.00153348012416299,0.0985471670987056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39589,-0.0096136358687992,0.0058285596554195,-0.0210376127934214,0.00181034105582302,0.0990939605906038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41521,-0.00525045618750427,0.00318377137352366,-0.0114906480796106,0.000989735704602098,0.0991451018065758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41585,0.0121232479530314,0.00736526522211148,-0.00231267188230712,0.0265591677883699,0.0997873621504228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39308,-0.0473520461120307,0.0287711975208428,-0.103743593252883,0.00903950102882122,0.0998313612902336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39427,-0.0295265179066177,0.017958024083437,-0.0647242451101541,0.00567120929691873,0.100164680492872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,41805,0.00699204345220274,0.00425341304841678,-0.00134464612269416,0.0153287330270996,0.100227575715119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,41766,0.00996727200983876,0.00608602087135254,-0.00196132889801221,0.0218958729176897,0.101501479158991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41636,-0.00756179638629488,0.00462692115399102,-0.0166305618481173,0.00150696907552752,0.102219151834307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,41836,0.00817626163039677,0.00501617973073689,-0.00165545064184754,0.0180079739026411,0.103129982688372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39328,0.00762912736592048,0.00468129352172981,-0.00154620793666995,0.0168044626685109,0.103193222903415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,41765,0.010140876913919,0.00623295544232637,-0.00207571575304072,0.0223574695808787,0.103765854493653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39427,0.00929497097605535,0.00572340909645401,-0.00192291085299452,0.0205128528051052,0.104399153538059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,41765,-0.00450744946526033,0.00278733709677015,-0.00997063017492983,0.000955731244409157,0.105877043575844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41521,0.0040490045255207,0.00250430246352109,-0.000859428302980628,0.00895743735402203,0.105941706345765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,39589,0.00784636730590641,0.00485342818415963,-0.00166635193504647,0.0173590865468593,0.10597932425675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,41765,-0.0152476901166328,0.00943515447758688,-0.0337405928927031,0.00324521265943751,0.106107264482134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39259,-0.0123208744048139,0.00764432616656806,-0.0273037536912873,0.00266200488165946,0.107042208776137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,41925,-0.00279313013446453,0.00173597628249921,-0.00619564364816298,0.000609383379233909,0.107647047762505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,41636,0.00680190245500299,0.00423698362975756,-0.00150258545932183,0.0151063903693278,0.108437868351192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41466,0.00662833466815291,0.00413824030970519,-0.00148261633886927,0.0147392856751751,0.109240358148448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41617,0.0124149903015868,0.00775459939654029,-0.00278402451563215,0.0276140051188058,0.109404708183333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39327,-0.0122781176870692,0.00768281797182337,-0.027336440911843,0.00278020553770462,0.110044202160329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,41785,-0.00922255888193576,0.0057722908717632,-0.0205362489905916,0.00209113122672011,0.110127173828874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39427,0.00862585188688507,0.00540219413417337,-0.00196244861609474,0.0192141523898649,0.110354823176303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39250,-0.0116750482427959,0.00733521292891752,-0.0260520655834743,0.0027019690978824,0.111494378420373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,39553,-0.00492152839962767,0.00309216588829838,-0.0109821735406925,0.00113911674143716,0.111500765345491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,39655,0.00374506309375739,0.00235353810488175,-0.000867871591810835,0.00835799777932561,0.11158233889862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41689,-0.0160341296586383,0.0100832210336839,-0.0357972428846588,0.00372898356738218,0.111818539356713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39408,0.0133909840937059,0.00842795171130508,-0.00312780126045206,0.0299097694478639,0.112117268399051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39259,-0.0111728873272222,0.00703931872330232,-0.0249699520248948,0.00262417737045033,0.112494422442309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39589,-0.00824942277524061,0.00520653890271443,-0.0184542390245609,0.00195539347407966,0.113123524075992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39589,-0.00823039152594879,0.00519794405322222,-0.0184183618702643,0.00195757881836676,0.113360549599217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39427,-0.0140795216009701,0.00889835657189701,-0.0315203004818882,0.0033612572799481,0.113619233562982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39334,-0.00780815791608222,0.00493512905760936,-0.0174810108689966,0.00186469503683214,0.113642782878271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,39633,-0.00546878366731233,0.00346179623339769,-0.0122539042847718,0.00131633695014715,0.114192064394401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41689,0.00363338338315856,0.00230706519101098,-0.000888464391222958,0.00815523115754008,0.115305056553693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39259,-0.00974545594502248,0.00618958825024249,-0.0218770489154978,0.0023861370254528,0.1154034742981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39328,-0.00616590676500383,0.00391749645433446,-0.0138441998154994,0.00151238628549171,0.115530668075997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41689,-0.0117225828917565,0.00745906970876052,-0.0263423595209272,0.00289719373741409,0.116070350497542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,41908,0.010172605222739,0.00647306724938258,-0.00251460658605081,0.0228598170315289,0.116083872250995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39259,-0.00939751795509261,0.00598573211867345,-0.0211295529076926,0.00233451699750735,0.116447960394129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39122,-0.00777195602696192,0.00495629949972426,-0.0174863030464215,0.00194239099249762,0.116888677671297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39334,-0.00928940619475368,0.00592424932729255,-0.0209009348762471,0.00232212248673972,0.116903390331234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41465,0.00734456301871908,0.00468467967466661,-0.00183740914362747,0.0165265351810656,0.116956284928929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39427,0.0120593512126838,0.00770347186806612,-0.00303945364872585,0.0271581560740934,0.117508142528896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39619,0.00803268476061045,0.00514236433320276,-0.00204634933246696,0.0181117188536879,0.118302428884113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39600,-0.0163019419695139,0.0104388667367725,-0.0367621207735879,0.00415823683456012,0.11839729512537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39334,0.0161079404461661,0.0103300175696833,-0.00413889399041317,0.0363547748827454,0.118946993511097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,39589,-0.00892483939615801,0.00572483382095213,-0.0201455136852242,0.00229583489290816,0.119032475510289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39259,0.0108617027805017,0.00696813310821581,-0.00279583811160125,0.0245192436726047,0.119080993397437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39241,0.010283168516397,0.00659740267960625,-0.00264774073563125,0.0232140777684253,0.119104428129073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39334,0.0152793055575746,0.0098051715547486,-0.00393883068973262,0.0344974418048819,0.119193884074003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,41786,-0.00962138457268189,0.00618017731382746,-0.0217345321077837,0.00249176296241994,0.119538728069314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39625,-0.00471454758454699,0.00302883943548769,-0.0106510728781029,0.00122197770900888,0.119605472897064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,41765,-0.00658194462013398,0.00422939697695207,-0.01487156269496,0.00170767345469207,0.119675752332578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39427,0.0217266074572323,0.0139619987488088,-0.0056389100904329,0.0490921250048976,0.119707733066115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39600,0.00489737937046857,0.0031483435079333,-0.00127337390508069,0.0110681326460178,0.11984589813434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41466,0.0111215111161326,0.00719158777700761,-0.0029740009268023,0.0252170231590675,0.12201783051353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39334,0.00948626807029384,0.00613706244426278,-0.00254237432046121,0.0215149104610489,0.122198223991423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39600,0.0198304799112032,0.0128386518349756,-0.00533327768534897,0.0449942375077553,0.12247373031848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39328,0.00990880462498524,0.00642910833710148,-0.00269224771573366,0.0225098569657041,0.123287664424562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,39650,0.00356599181020993,0.00231679587691114,-0.000974928108535896,0.00810691172895576,0.123786260396864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,41758,0.00742872632771198,0.0048299917798176,-0.00203805756073051,0.0168955102161545,0.124062588219078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,41764,0.00397217056055967,0.00258487587662529,-0.00109418615762589,0.00903852727874523,0.124391601902958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39241,-0.010699216047458,0.00696406239734045,-0.0243487783462453,0.00295034625132925,0.124483041170055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41534,0.0079481090572301,0.0051745070458336,-0.00219392475260376,0.018090142867064,0.124559701556957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,41689,-0.00541278625982223,0.00352434071870089,-0.012320494068476,0.00149492154883151,0.124604386100551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,41685,0.00534869140542786,0.00348280914927209,-0.00147761452714544,0.0121749973380012,0.124626191870047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,41829,0.013792894594311,0.0089980505219212,-0.00384328442865451,0.0314290736172766,0.125330353038464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41521,-0.00857371775686543,0.00560355743847812,-0.0195566903362826,0.00240925482255169,0.12602906742764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,41911,0.0124698772023616,0.00815034607992659,-0.00350480111429456,0.0284445555190177,0.126045117159414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39625,0.0146485293935813,0.0095819083564854,-0.0041320109851301,0.0334290697722927,0.126350280658884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,41802,0.00488381498148415,0.00319653578454985,-0.00138139515623355,0.0111490251192018,0.12657469081808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39650,-0.00318275921988154,0.00208828543624999,-0.00727579867493153,0.000910280235168454,0.127511945171675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",41911,-0.0108019055155899,0.00711275521269032,-0.0247429057324629,0.00313909470128311,0.128870125862703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39250,-0.00833765652777656,0.00549079631204962,-0.0190996172993938,0.0024243042438407,0.128923481344279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41855,0.00497323666696747,0.00327585570425932,-0.00144744051338079,0.0113939138473157,0.12900072052375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39259,-0.00681132251819247,0.00448954928062262,-0.0156108391082128,0.00198819407182786,0.129258313723704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,41911,0.00450064801668071,0.00296760986690875,-0.00131586732246045,0.0103171633558219,0.129393929989538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39585,-0.0143893984116961,0.0094895611944361,-0.0329889383527908,0.00421014152939869,0.129462251337673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41708,0.0104171860350137,0.00687199591839221,-0.00305192596503499,0.0238862980350625,0.129571424666219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39328,0.0132539766647589,0.00875086165422814,-0.00389771217752831,0.030405665507046,0.129905462697187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39427,0.00958845464710275,0.00633516748313871,-0.00282847361984911,0.0220053829140546,0.130174732140109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,39567,0.0143462117964343,0.00950249714075516,-0.00427868259944577,0.0329711061923145,0.131140959294176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41521,0.0079164804669055,0.0052467565241989,-0.00236716232052434,0.0182001232543353,0.131365863045146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,39636,0.00578120131293476,0.00383674837399414,-0.00173882550009376,0.0133012281259633,0.131891295981805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,41758,0.0144709007953385,0.00960739615317525,-0.00435959566488501,0.033301397255562,0.132033414968958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,41764,0.00827210465081668,0.00549546173119586,-0.0024990003423272,0.0190432096439606,0.132280960049327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,41722,0.00281977269595579,0.001873348407152,-0.000851990182062121,0.0064915355739737,0.132295544297444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39598,0.00895311690851514,0.00595049725720497,-0.0027098577156066,0.0206160915326369,0.132455716931564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,39600,0.00569153333771251,0.00378486968723951,-0.00172681124927693,0.0131098779247019,0.132672039441158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41534,0.00508748444584706,0.00338399381694244,-0.00154514343536012,0.0117201123270542,0.132761245018741
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39328,0.0148043363706644,0.00985109138085827,-0.00450380273581782,0.0341124754771466,0.132917016436651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39250,0.00708895445740724,0.00471953990969142,-0.00216134376558795,0.0163392526804024,0.133115511176163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41534,0.010585224180667,0.0070489142646212,-0.00323064777799053,0.0244010961393246,0.133203794372121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39250,-0.00656184393968216,0.00437531031572087,-0.0151374521584951,0.00201376427913074,0.133710456296373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39576,-0.00588868216558336,0.00393657479187535,-0.013604368757659,0.00182700442649232,0.134711120122565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39259,-0.012118038763564,0.00810597300232319,-0.0280057458481175,0.00376966832098942,0.134956630777931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,41818,-0.00602300994206465,0.00403961701275122,-0.013940659287057,0.00189463940292773,0.135989193789079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39328,0.0124391807891664,0.0083444598571836,-0.00391596053091344,0.0287943221092463,0.136066702500262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41465,0.00622963922887885,0.00417919685637072,-0.00196158660960776,0.0144208650673655,0.13608299024807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39600,0.00422693335276954,0.00283862586210708,-0.00133677333696034,0.00979064004249942,0.136495681282857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39589,0.00457814793054746,0.00307513911588656,-0.00144912473659019,0.0106054205976851,0.136578947781584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41465,-0.0198260686115055,0.0133236383502204,-0.0459403997779374,0.00628826255492645,0.136765610862151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41424,-0.00758119545023953,0.00510977817144389,-0.0175963606662695,0.00243396976579049,0.137922577774089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40174,-0.00496923227456996,0.00335018808100361,-0.011535600913337,0.00159713636419711,0.138030013511884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41534,-0.00542760320590449,0.00366497301042022,-0.0126109503063281,0.00175574389451914,0.138647061569946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39334,0.00580706595545775,0.00393434094885752,-0.00190424230430299,0.0135183742152185,0.139974677609783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41689,-0.0109319728569454,0.00740962048904289,-0.0254548290154695,0.00359088330157865,0.140135660206471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41466,0.00756112932036882,0.00513190408862377,-0.00249740269333377,0.0176196613340714,0.140679130605363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,41689,0.0141084358409434,0.00958770978820101,-0.00468347534393053,0.0329003470258174,0.141176581209389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,41744,0.0474883103102405,0.0323270230604091,-0.0158726548881614,0.110849275508642,0.141857447513854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41534,0.0128191651948719,0.00873176089289195,-0.00429508615519629,0.0299334165449402,0.142099294212875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39259,-0.00481599223025892,0.00328883746231718,-0.0112621136564006,0.00163012919588275,0.143129237326257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,41925,-0.00671091489654152,0.0045836552911998,-0.0156948792672931,0.00227304947421009,0.143191100286649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,39583,-0.00388628512122317,0.00265472494328796,-0.00908954601006757,0.00131697576762123,0.143246467398631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39600,0.00390085132515412,0.00266518886950016,-0.0013229188590662,0.00912462150937443,0.143323548544933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39241,0.00576485044122353,0.00393953191139493,-0.00195663210511054,0.0134863329875576,0.143405583325234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39241,-0.00631877526168083,0.00432214764667475,-0.0147901846491633,0.00215263412580169,0.143783712520719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,41759,0.0064347993417172,0.0044047264057675,-0.00219846441358709,0.0150680630970215,0.144070841787921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,39650,-0.00481806407929456,0.00329937978320407,-0.0112848484543745,0.00164872029578542,0.144237755502431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41466,0.00978059250613033,0.00670439422636769,-0.00336002017755034,0.022921205189811,0.144635449518763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39334,-0.00543822595584546,0.0037284452696963,-0.0127459786844502,0.0018695267727593,0.144710720481591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,41805,0.0145382529609122,0.00998754190558564,-0.00503732917403569,0.03411383509586,0.145516284177141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39600,0.0120532547840807,0.00828272120614448,-0.0041808787799625,0.0282873883481239,0.145634454809838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41534,0.00500496187907336,0.00344523780047724,-0.00174770420986204,0.0117576279680088,0.146326091298425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,41877,0.00837137041185326,0.00577741437725506,-0.00295236176756665,0.0196951025912732,0.147366179316845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39314,-0.00700343952348112,0.00483469212937743,-0.0164794360970609,0.00247255705009863,0.147484104902452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,41745,0.0146030635202368,0.0100895332094392,-0.00517242157026404,0.0343785486107377,0.147823389753678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,41888,0.0074046888518133,0.00512797190785294,-0.00264613608757847,0.0174555137912051,0.14876817864914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41373,-0.0104700424901187,0.00725832023101813,-0.0246963501429142,0.00375626516267686,0.149189171091152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41689,0.00363324185444865,0.00251888286788298,-0.001303768566602,0.0085702522754993,0.149212908648871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39427,0.00579825203471762,0.00402850890771131,-0.00209762542439655,0.0136941294938318,0.150093104971843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,41728,0.0103395414068204,0.00719486888511328,-0.00376240160800168,0.0244414844216424,0.150721495101709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,41636,0.0149105862615246,0.0103769288340176,-0.00542819425314985,0.0352493667761991,0.150771033174301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39241,-0.0065117446568867,0.00453335110428808,-0.0153971128212913,0.00237362350751793,0.150915496438786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39600,0.0226522104511277,0.015786109262463,-0.00828856370329971,0.0535929846055552,0.151330986642793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39427,-0.00422743267567131,0.00294611403643518,-0.0100018161870843,0.00154695083574165,0.151339290726216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41429,-0.00740263050696605,0.00517188690208491,-0.0175395288350525,0.00273426782112037,0.152362587587462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41740,0.00585412926738882,0.00409069785699059,-0.00216363853231275,0.0138718970670904,0.152430132869822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,41740,0.0130070838437485,0.00909290348776841,-0.00481500699227755,0.0308291746797746,0.152607267349875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39334,-0.00525427061842155,0.00367384119609531,-0.0124549993627684,0.00194645812592525,0.152693188452113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,39650,-0.00325047154822183,0.00227550071322409,-0.00771045294614105,0.0012095098496974,0.153186525216752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,41765,-0.0117599692722969,0.00824003746072649,-0.0279104426953208,0.00439050415072703,0.153553391993539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,41805,0.0164338253146852,0.01151959626926,-0.00614458337306441,0.0390122340024349,0.153719635519753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,41740,-0.0127503970349853,0.00894176912783482,-0.0302762645255415,0.00477547045557097,0.153910361506778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41740,0.022996511101316,0.0161435047057076,-0.00864475812187094,0.0546377803245029,0.154323944936976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,41706,0.0123152128889588,0.00865192141554968,-0.00464255308551855,0.0292729788634362,0.154641761412084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,39588,0.0149656759140771,0.0105185665796938,-0.00565071458212286,0.035582066410277,0.154826406457398
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41689,0.00575740023390361,0.00404677257906826,-0.00217427402107017,0.0136890744888774,0.154842895410219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39600,0.00776047492421691,0.00545998582034143,-0.00294109728365229,0.0184620471320861,0.155247423436338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,39589,0.00611578694333364,0.00430455561256639,-0.00232114205729649,0.0145527159439638,0.155411773970158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41466,0.0110599730104821,0.00779154165675959,-0.00421144863676665,0.0263313946577309,0.155782024734961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39259,0.00486604994969772,0.00343437665137999,-0.00186532828700707,0.0115974281864025,0.156551467155551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,41925,-0.0045724279754662,0.00322742351837142,-0.0108981780714742,0.00175332212054179,0.156581612241365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39250,-0.00540688476135103,0.00381852896960191,-0.0128912015417708,0.0020774320190687,0.156816423473848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39408,-0.00376697450913979,0.00266194804932835,-0.00898439268582335,0.00145044366754377,0.157062281985084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39328,-0.00626264065923846,0.00442685674277332,-0.0149392798750742,0.00241399855659725,0.157187722078468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41521,0.00924982093670171,0.00654126074064541,-0.0035710501149633,0.0220706919883667,0.15736453036612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,41765,0.0037297910477568,0.00264379769819491,-0.00145205244070523,0.00891163453621883,0.158336008028157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39250,-0.00768244224733476,0.00544741683268748,-0.0183593792394022,0.00299449474473269,0.15848301691054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39250,0.00852514910388837,0.00605772800058963,-0.0033479977772673,0.020398295985044,0.15936232470581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,41765,0.00698496727583609,0.00496433753649697,-0.00274513429569798,0.0167150688473701,0.159442372860693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41534,-0.00525520662960452,0.00373814901982071,-0.0125819787084531,0.00207156544924407,0.159798267766283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,41740,0.0052396646473996,0.00372818750198276,-0.00206758285648662,0.0125469121512858,0.159920434415298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,41827,-0.00362611806655109,0.00258291208728415,-0.00868862575762802,0.00143638962452585,0.160375821714281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,41844,0.00758371764741219,0.00540336067137817,-0.00300686926848902,0.0181743045633134,0.160485670414527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,41689,-0.0124428758798308,0.00887654394072285,-0.0298409020036476,0.00495515024398594,0.16100755517736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,41925,-0.00463471707715026,0.00333464124008164,-0.0111706139077103,0.00190117975340976,0.16459164303693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,41787,-0.00552213727202145,0.00398762644504761,-0.0133378851043148,0.00229361056027186,0.166131523310835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39625,0.00444646563571461,0.00321478138751689,-0.00185450588381849,0.0107474371552477,0.166652534871715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41591,0.00836242813760342,0.00604773813773434,-0.00349113861235589,0.0202159948875627,0.166769449455271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,41925,0.00850733183388438,0.00615427532080462,-0.00355504779489267,0.0205697114626614,0.16688895805808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39334,0.00635863862481009,0.00461194846793474,-0.002680780372342,0.0153980576219622,0.168006284533326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39625,-0.00509527555078132,0.00369752693078288,-0.0123424283351158,0.00215187723355311,0.168224287367015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41534,0.00977141566320502,0.00710435574822136,-0.00415312160330885,0.0236959529297189,0.169027592033199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39427,0.00975068573162283,0.00709758667894093,-0.00416058415910139,0.023661955622347,0.169531297292234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,41865,0.004042040148971,0.00294700241251291,-0.0017340845795543,0.00981816487749631,0.170218417545758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39440,0.00581079706546795,0.00423716228036833,-0.00249404100405398,0.0141156351349899,0.170282160846069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39250,-0.00752977117785144,0.00549590589114961,-0.0183017467245047,0.0032422043688018,0.17069419409028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41609,0.00409663884458475,0.00299103059463216,-0.00176578112089429,0.00995905881006378,0.170822561023641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39250,-0.0101270671518425,0.00740213542913865,-0.0246352525929542,0.00438111828926929,0.171300944171768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39334,-0.00430481705179037,0.00314921325820189,-0.0104772750378661,0.00186764093428533,0.171669606170054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39328,0.00747554297342984,0.00548049383922267,-0.00326622495144659,0.0182173108983063,0.172587603531512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41614,-0.00483522269489017,0.00354485577395256,-0.0117831400118372,0.00211269462205685,0.172587655242285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39250,-0.00578926517597999,0.00424736460973315,-0.014114099811057,0.00253556945909698,0.172903371661127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,41824,-0.0163848489636433,0.0120347446056184,-0.0399729483906553,0.00720325046336881,0.173390890522106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39241,-0.00739464539582219,0.00543247958269165,-0.0180423053778978,0.00325301458625345,0.173481981841751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39466,-0.00478988233139476,0.00352739964627698,-0.0117035856380976,0.00212382097530812,0.174521242505518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39533,-0.00448900561600292,0.00331319278675607,-0.0109828634780448,0.00200485224603896,0.175481193205934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39633,0.0053887413508244,0.0039776137733078,-0.0024073816448589,0.0131848643465077,0.175519425553972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39600,0.00699527061264913,0.00517586513804599,-0.00314942505792102,0.0171399662832193,0.17655761515688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39600,-0.0108662066563991,0.00804306090121231,-0.0266306060227753,0.00489819270997699,0.176721970192498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39427,-0.00518189746663247,0.00383709717789896,-0.0127026079353144,0.00233881300204949,0.176892423652517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41447,0.00529390044450047,0.0039224431293593,-0.00239408808904376,0.0129818889780447,0.177154098151229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,41865,0.00885797755180093,0.0065660851082717,-0.0040115492604116,0.0217275043640135,0.177343912310287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39241,-0.00488356760806968,0.00362080003585521,-0.0119803356783459,0.00221320046220653,0.177444778531251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39625,-0.00702363459037274,0.00522936137468294,-0.0172731828847513,0.00322591370400582,0.179262331501014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,41805,0.00686489095886599,0.0051198521243619,-0.00317001920488333,0.0168998011226153,0.179996203639327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39334,0.00871190868829245,0.00650461030900136,-0.00403712751735021,0.0214609448939351,0.18048717394203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39427,-0.00598806710684059,0.00447090031601143,-0.014751031726223,0.00277489751254182,0.180487291463589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,41707,0.00456488694389968,0.00341199123814338,-0.00212261588286134,0.0112523897706607,0.180953790283214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39241,-0.0082052783980498,0.00614178977582028,-0.0202431863586575,0.00383262956255794,0.181585972314673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41521,-0.00873211596044872,0.00655249609417062,-0.0215750083050231,0.0041107763841257,0.182673593359128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39334,0.017719472308111,0.0133290566643637,-0.00840547875404186,0.0438444233702638,0.183748634775015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39650,-0.00263434069509577,0.00198441181708907,-0.00652378785659034,0.00125510646639881,0.184365099325462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,41891,-0.00552236791747475,0.00416013089464708,-0.013676224470983,0.00263148863603353,0.184382497521736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,41805,0.00410310476864442,0.00309146347540929,-0.00195616364315779,0.0101623731804466,0.184453236722115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39241,0.00823673989122142,0.00621088832588003,-0.00393660122750345,0.0204100810099463,0.184809398668828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41465,0.0093635276905053,0.00706895747360601,-0.00449162895776248,0.0232186843387731,0.185328012811496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39600,0.0108522144378035,0.00819726634783598,-0.00521442760395505,0.026918856479562,0.185569703934777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,41802,-0.00549698837836487,0.00415639901462126,-0.0136435304470225,0.00264955369029279,0.186012555265114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39241,-0.011333606122872,0.00858025989216425,-0.028150915511514,0.0054837032657699,0.186565414055473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,41865,0.0045703882595662,0.00346268920954188,-0.00221648259113588,0.0113572591102683,0.186892652941781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39308,0.00259562921164149,0.00196680909033869,-0.00125931660542235,0.00645057502870533,0.186958105952801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39598,-0.00846931777096889,0.00641883801077516,-0.0210502402720882,0.00411160473015042,0.187047121298107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39589,0.00653995222751775,0.00495745937050507,-0.00317666813867219,0.0162565725937077,0.187124902595652
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39600,0.00593308869194758,0.00449933442964224,-0.00288560679015122,0.0147517841740464,0.187310529199058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41521,-0.00448787444585436,0.0034036615905906,-0.0111590511634119,0.00218330227170321,0.187345283328839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39334,-0.00397509134546286,0.0030195284531503,-0.00989336711363744,0.00194318442271172,0.188047479685761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,41911,0.0122363213325153,0.00932278621957533,-0.00603633965785232,0.030508982322883,0.189368169478201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41466,-0.0121436935882273,0.00926297584785001,-0.0302991262500133,0.00601173907355871,0.189883632591472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39250,-0.00654239544387368,0.0049951069123449,-0.0163328049920697,0.00324801410432232,0.190305005152012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39241,-0.00733876487229026,0.00561313991195349,-0.0183405190997191,0.00366298935513858,0.191096331401601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,41925,-0.0058661654325,0.00449725085463208,-0.0146807771075789,0.00294844624257888,0.192123445670943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39625,0.00472639604008995,0.00362722176076452,-0.00238295861100852,0.0118357506911884,0.192590107521254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39334,0.0128948740433066,0.00990363668036331,-0.00651625385020544,0.0323060019368187,0.1929326203775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41521,0.0081836138768228,0.00628537000578873,-0.00413571133452311,0.0205029390881687,0.192936216323945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41636,-0.0147330156031038,0.0113202407409435,-0.0369206874553529,0.0074546562491454,0.193118756383547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,41815,0.00561160188840816,0.00431266571621159,-0.00284122291536656,0.0140644266921829,0.193215764749282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39334,0.00694230454301358,0.00533535049508627,-0.0035149824273555,0.0173995915133827,0.193221366697854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41534,-0.00383518117489441,0.00295488457660933,-0.00962675494504869,0.00195639259525987,0.194340601963424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41466,-0.00630081324838873,0.00485562540121055,-0.0158178390347614,0.00321621253798395,0.194437202063729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41466,-0.00645381529474095,0.00497668075971716,-0.0162081095837866,0.00330047899430468,0.194719415888319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39250,-0.00695106439960468,0.00536289638990752,-0.0174623413238234,0.00356021252461407,0.19495535112295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39655,0.00670632877207927,0.00518571009134869,-0.00345766300696417,0.0168703205511227,0.19595768461277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41521,-0.00380864275822381,0.00294553908702361,-0.00958189936879007,0.00196461385234246,0.196027047773562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41689,-0.00544251020645639,0.00423342240265361,-0.0137400181156575,0.00285499770274469,0.198603596549285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39250,0.00961681402457032,0.00748400051574328,-0.00505182698628651,0.0242854550354272,0.198826142337017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39250,-0.00543733967193631,0.00423902774985332,-0.0137458340616488,0.00287115471777619,0.199630177195252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39427,-0.0101924763158505,0.00795643487732226,-0.0257870886754021,0.00540213604370118,0.200208600370135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39408,0.0102834328752077,0.00804050679699785,-0.0054759604469081,0.0260428261973235,0.200940953034194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39334,0.0122380914887236,0.00956900768550404,-0.00651716357486436,0.0309933465523115,0.200949337205621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39328,0.00552686398282587,0.00432347500519482,-0.00294714702735597,0.0140008749930077,0.201157800701583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39589,0.00596051350878709,0.00466899111875413,-0.003190709083971,0.0151117361015452,0.201764468332377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39385,-0.00400478610453696,0.00314133763067656,-0.010161807860663,0.00215223565158911,0.20238396284353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41466,-0.00741510917288253,0.00583252245407238,-0.0188468531828644,0.00401663483709935,0.203631305672102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,41765,-0.0113895767663526,0.00896305568173471,-0.0289571659025527,0.00617801236984738,0.20384903843164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39595,0.00841252168281527,0.0066237792918762,-0.00457008572926208,0.0213951290948926,0.204094192020431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39250,0.0153465225035118,0.0120893849716574,-0.00834867204093669,0.0390417170479603,0.204318590351381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39250,-0.00900200530303425,0.00713115377165223,-0.0229790666954726,0.00497505608940411,0.206850849736644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41454,-0.0115775522270933,0.00923972813017657,-0.0296874193622393,0.00653231490805281,0.210221690375348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41636,-0.00688948459845271,0.00550502646608785,-0.0176793364719849,0.00390036727507947,0.210778281076789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39600,-0.0105677192440809,0.00845051150534143,-0.0271307217945501,0.00599528330638831,0.211128236396079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39224,-0.00359344393340857,0.00287549626705672,-0.00922941661683973,0.0020425287500226,0.211444788266802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39241,-0.00702959380908177,0.00562905452746882,-0.0180625406829207,0.00400335306475711,0.211763723000039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41786,0.0102017046361287,0.00819296254449559,-0.00585650195108267,0.0262599112233401,0.213088099636138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41534,-0.0087208632713191,0.00701879968951709,-0.0224777106627726,0.0050359841201344,0.214074421906862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41534,-0.00851214978379903,0.00685095866960339,-0.0219400287762217,0.00491572920862361,0.214083620305381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41646,-0.00938108107203438,0.00756805379740542,-0.024214466514949,0.00545230437088023,0.215159291927286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39334,-0.00626801882880884,0.00505823552743216,-0.0161821604625759,0.00364612280495819,0.215309267827518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41556,0.00608840691920077,0.00491956832633558,-0.00355394700041696,0.0157307608388185,0.21589067620363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,41750,0.00675017249837297,0.0054556886265339,-0.00394297720963347,0.0174433222063794,0.216008095380295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39408,-0.00432571476264671,0.00349766826486436,-0.0111811445617809,0.00252971503648744,0.216209592259536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39250,-0.00481428201188902,0.00389575470739803,-0.0124499612383892,0.00282139721461113,0.216568919303473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",41716,0.00902838626230687,0.00731057903394641,-0.00530034864422809,0.0233571211688418,0.216861731394763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39250,0.00787520450752974,0.00638929575214928,-0.00464781516668284,0.0203982241817423,0.217766350659474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39241,-0.010298682837778,0.00837851490337612,-0.0267205720483952,0.0061232063728392,0.219032405222956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39427,-0.00691220175579027,0.00562372819980031,-0.0179347090273989,0.00411030551581835,0.219055865708211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,41740,0.0137988583448434,0.0112358299804961,-0.00822336841692909,0.0358210851066158,0.219426900433703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,39598,0.0050643051355251,0.00412945577613283,-0.00302942818569525,0.0131580384567455,0.220079854980354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39408,0.0049626376331004,0.0040531109618105,-0.00298145985204817,0.012906735118249,0.220827259172584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,41689,-0.00395352428820612,0.00322955796183057,-0.010283457893394,0.00237640931698179,0.220910567400505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39250,0.00630386402612482,0.00514973222999783,-0.00378961114467092,0.0163973391969206,0.220935959343895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41465,-0.00966467992410436,0.00791999487450489,-0.025187869878134,0.00585851002992523,0.222377834732779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41502,-0.00478215401096333,0.00393291214419381,-0.0124906618135832,0.00292635379165653,0.224033045998451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39259,-0.00796993957237481,0.00656287376889771,-0.0208331721594143,0.0048932930146647,0.224622752333903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,41765,0.0106183147513885,0.0087520933346398,-0.00653578818450556,0.0277724176872825,0.22506311629086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39241,-0.00523213707333288,0.00431450861963326,-0.0136885739678141,0.00322429982114832,0.225277447739125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39328,0.00478497234041492,0.0039524693671067,-0.00296186761911421,0.0125318122999441,0.226064459837894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39250,-0.00800808142160637,0.00663146106880385,-0.0210057451164619,0.00498958227324918,0.227232094404186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39259,-0.00987765167471213,0.00818731557850112,-0.0259247902085743,0.00616948685915006,0.22766775313583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39600,-0.0130473875747188,0.0108354552826266,-0.0342848799286669,0.00819010477922939,0.228562007121303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39600,-0.0101406246449909,0.00842767742775595,-0.0266588724033925,0.00637762311341079,0.22890448706405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39589,0.00678133704461232,0.00564163655487213,-0.00427627060293706,0.0178389446921617,0.229383255593804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39600,0.0109675995889237,0.00913084888171544,-0.00692886421923852,0.028864063397086,0.229715465540263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,41865,0.00454411914231332,0.00379407980887808,-0.00289227728308771,0.0119805155677144,0.231060387128367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39600,-0.0128149655095583,0.0107093525965824,-0.0338052965988599,0.00817536557974327,0.231482675517922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41534,0.0103055221977118,0.00861557247798616,-0.00658099985914103,0.0271920442545647,0.231659721207646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39589,0.00448774311981674,0.00375185306206725,-0.00286588888183507,0.0118413751214686,0.231667571928729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39241,-0.0051570205900666,0.00431234614914833,-0.0136092190423973,0.00329517786226413,0.231772565443917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39259,-0.0108629883488047,0.00909140620734197,-0.028682144515195,0.00695616781758556,0.232166998063857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39427,0.0095771940139893,0.00802989233480773,-0.00616139496223385,0.0253157829902124,0.233015880789433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41466,0.00925924745358727,0.00776467807129522,-0.00595952156615135,0.0244780164733259,0.233093861844553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39633,-0.00787448959792122,0.00662935685528574,-0.0208680290342813,0.00511904983843883,0.234929490779542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41521,-0.00637407185843948,0.00536803259108133,-0.0168954157369589,0.00414727202007992,0.235086570022429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39221,-0.00987136654546694,0.00831893754642959,-0.0261764841364689,0.00643375104553506,0.235406510051114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39308,0.00735486806122471,0.00619945010759617,-0.00479605414966379,0.0195057902721132,0.235500852118826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39241,0.00757919727258465,0.0063967076458946,-0.00495834971336876,0.0201167442585381,0.236099621974331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39598,-0.0308649795185969,0.0260663116876882,-0.0819549504264657,0.0202249913892719,0.236401198352011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39334,0.00358823542278968,0.00303163045979086,-0.00235376027840041,0.00953023112397978,0.236597963603843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39589,0.0138052700420118,0.0116654052617279,-0.00905892427097487,0.0366694643549986,0.236661674436961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41465,0.00588956364784664,0.00498604185385455,-0.00388307838570828,0.0156622056814016,0.237541053661993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39259,-0.00623923620947834,0.0052938789545619,-0.0166152389604197,0.00413676654146298,0.238593548290609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,39589,0.00664862103889633,0.00564830790212138,-0.00442206244926158,0.0177193045270542,0.239181244404053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39408,-0.0122031031083283,0.0103771558610472,-0.0325423285959807,0.00813612237932417,0.239637420844101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39400,-0.00788785034326549,0.00671065098694195,-0.0210407262776717,0.00526502559114073,0.239851626999104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39488,0.00421264249926965,0.00358440853733454,-0.00281279823390605,0.0112380832324454,0.239913006347241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39250,0.0126486546830437,0.0107655260592073,-0.00845177639300264,0.03374908575909,0.24005214369155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39241,0.00963404639064973,0.0082001985523758,-0.00643834277200684,0.0257064355533063,0.240078917162523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,41744,0.00684060987075466,0.00582329635743681,-0.00457305098982148,0.0182542707313308,0.240137164493847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39241,-0.0147840640374405,0.0126181666223977,-0.03951567061734,0.00994754254245902,0.241364184413169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39600,-0.00272526305232262,0.00232693001149536,-0.00728604587485352,0.00183551977020827,0.241550219321733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39408,0.010655128878564,0.00910167293158,-0.00718415006733283,0.0284944078244608,0.241754015150296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39259,-0.00519462994287242,0.004440043951155,-0.0138971160871362,0.00350785620139137,0.242047202251067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41593,-0.0043274374574485,0.00371360936010023,-0.011606111803245,0.00295123688834796,0.243922406979714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39241,-0.0053403591976167,0.00458673288071417,-0.0143303556438165,0.00364963724858308,0.244326253929399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39314,0.0107341805402328,0.00922004824141783,-0.00733711401294618,0.0288054750934117,0.244360088738925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,41694,0.00484211604250533,0.00416236678834394,-0.0033161228626488,0.0130003549476595,0.244725617434133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41802,0.00571812795975822,0.004924683866811,-0.00393425241919133,0.0153705083387078,0.245615827424233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41466,0.00852700938241043,0.00735088611511692,-0.00588072740321874,0.0229347461680396,0.246071356485606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,41758,-0.00356847048519025,0.00308110254367151,-0.00960743147078641,0.0024704905004059,0.246811722969468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41636,0.00765201426943345,0.00661776601880306,-0.00531880712742054,0.0206228356662874,0.247586366793812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39308,-0.00611278734403346,0.00528944289447823,-0.0164800954172108,0.00425452072914387,0.247846832138233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39241,0.00368046991455172,0.00319219803159777,-0.00257623822737991,0.00993717805648334,0.248953566395526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39259,-0.00600052544493475,0.00522064275649925,-0.0162329852476733,0.00423193435780378,0.250423290932179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41534,-0.00754757878640799,0.00657048468122287,-0.0204257287616048,0.00533057118878883,0.250696991737239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,41779,-0.00381880518842501,0.00332903853438972,-0.0103437207158289,0.00270611033897885,0.251353039096922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41590,-0.00529908017501667,0.00462423634639356,-0.014362583413948,0.0037644230639147,0.251842629805661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41465,0.0121791134912033,0.0106288473767513,-0.00865342736722923,0.0330116543496359,0.251876638908015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41740,0.00507194187338149,0.00444168612150609,-0.00363376292477046,0.0137776466715334,0.253518222384934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,41689,0.00913411352436919,0.00801307559834037,-0.00657151464837793,0.0248397416971163,0.254348373928211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41663,-0.00266555652184821,0.00233984467453584,-0.00725165208393846,0.00192053904024204,0.254639660499468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39655,-0.00325684173937604,0.00285913511002676,-0.00886074655502848,0.00234706307627641,0.254685992941553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39259,-0.00854629451803661,0.0075044165560312,-0.0232549509678578,0.00616236193178454,0.254797447224746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,41640,-0.0156782779944257,0.0137780093032829,-0.0426831762288601,0.0113266202400087,0.255174624664063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39308,0.00503276068604008,0.00443239976603151,-0.00365474285538169,0.0137202642274618,0.256212954437922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39250,0.00610670172587759,0.00537892003192214,-0.00443598153668979,0.016649384988445,0.256274115739412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39328,-0.0070684295138444,0.00623493797813436,-0.0192889079509878,0.00515204892329894,0.256953796659569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",41744,-0.0116029037331922,0.0102386578725343,-0.0316706731633594,0.008464865696975,0.257132219910027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39250,0.00801881069413631,0.00709030580142917,-0.00587818867666487,0.0219158100649375,0.258099861424848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39600,0.00600281873901079,0.00530870155694266,-0.00440223631259682,0.0164078737906184,0.258184629740495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39598,0.00576704100522011,0.00510156482276371,-0.00423202604739676,0.015766108057837,0.258313201945807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41836,0.00524459938228892,0.00464405272941891,-0.00385774396737215,0.01434694273195,0.258785353236396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41581,0.00527540819700043,0.00467347758022347,-0.00388460786023757,0.0144354242542384,0.25900427327556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39598,0.00342650409442723,0.00304142948544795,-0.00253469769705076,0.00938770588590522,0.259932098364374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,41636,-0.00513979467060199,0.00456538100718023,-0.0140879414446752,0.00380835210347126,0.260262681333618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39308,0.0123984339431181,0.0110179786652606,-0.00919680424079275,0.0339936721270289,0.260490897850329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41925,0.00332305988687034,0.0029553186704593,-0.00246936470722989,0.00911548448097058,0.260849340102042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,41740,-0.00784130274131378,0.00697355734821321,-0.0215094751438117,0.00582686966118411,0.260849631451502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39259,-0.00707793305750655,0.00629804903758915,-0.0194221091711813,0.00526624305616817,0.261110689848567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39633,-0.00327775905042865,0.00291770218311506,-0.00899645532933417,0.00244093722847687,0.261290286587963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39250,-0.00608051537036248,0.00542847675441851,-0.0167203298090228,0.0045592990682978,0.262690243621989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39328,0.0089401858303969,0.00799162022268347,-0.00672338980606271,0.0246037614668565,0.2632953140109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39542,0.00391566709354194,0.00350148524553214,-0.00294724398770105,0.0107785781747849,0.263468785112849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39328,0.0061651551888472,0.00551590579722931,-0.00464602017372226,0.0169763305514166,0.263718058876349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,41911,0.00762961427327667,0.00683576485725355,-0.00576848484694029,0.0210277133934936,0.264385886095499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39259,-0.00855692979031803,0.00767155297491473,-0.0235931736211509,0.00647931404051484,0.264699751457063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,41758,-0.00519513701908634,0.00466381402941695,-0.0143362125167435,0.00394593847857088,0.265331896586942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,41636,0.00391197618912942,0.00351994276516113,-0.0029871116305864,0.0108110640088452,0.266427490020576
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41465,0.00691645118390353,0.00623074750017863,-0.00529581391644659,0.0191287162842537,0.266997542778304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39589,0.00780470358870558,0.00703930431217856,-0.00599233286316439,0.0216017400405756,0.26756997670673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,39600,0.00721879855543822,0.00652678815710103,-0.00557370623247981,0.0200113033433562,0.268739377452013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39259,0.00572848970730674,0.00518117475144441,-0.0044266128055243,0.0158835922201378,0.268909358205177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41617,-0.00389318052806268,0.00352278306882004,-0.01079783534295,0.0030114742868246,0.269117874923657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39334,0.00566767088979125,0.00512870893128338,-0.00438459861552417,0.0157199403951067,0.269146550444781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,41865,0.00605268998991982,0.00547848424975676,-0.00468513913960343,0.0167905191194431,0.269261506036429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39598,0.00461125090156304,0.00417404587746769,-0.00356987901827363,0.0127923808213997,0.269294828450787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39250,0.00703235292242188,0.00637368898779562,-0.00546007749365753,0.0195247833385013,0.269904000958915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41466,-0.00540248640618364,0.00490027257804861,-0.0150070206591589,0.00420204784679164,0.27027066526763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41534,-0.00571043161902236,0.00518049961879424,-0.0158642108718591,0.00444334763381434,0.27035455752378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39408,-0.0042554476332821,0.00386377120806702,-0.0118284392010935,0.00331754393452926,0.270759514797098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39250,0.00777198631649263,0.00706968776269619,-0.0060846016983919,0.0216285743313772,0.271644901900541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,39589,0.0132904500651893,0.0121158325681945,-0.0104565817684719,0.0370374818988504,0.272687736685967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41521,-0.00708566313381545,0.00647383783333553,-0.0197743852871531,0.00560305901952219,0.273752925044831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39250,-0.00577325410918755,0.00528391470093202,-0.0161297269230143,0.00458321870463921,0.27459011157357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41465,-0.0103754358427578,0.00949673903666116,-0.0289890443546136,0.0082381726690981,0.274622356039015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41534,0.00500772953166647,0.00458572087216034,-0.00398028337776779,0.0139957424411007,0.274841715681781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,39600,-0.00520752849987458,0.00477252177447587,-0.0145616711778473,0.00414661417809812,0.275231580193126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39427,-0.00817076085573124,0.00751041135010465,-0.0228911671019364,0.00654964539047387,0.276652636006088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41466,0.00685382230136509,0.00632095785489868,-0.00553525509423633,0.0192428996969665,0.278251583204375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,39598,0.0108857110972124,0.010065497860895,-0.00884266471014187,0.0306140869045666,0.279503987517433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39308,-0.00623615370183658,0.00577612524074122,-0.0175573591736894,0.00508505177001622,0.28032546255698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39589,-0.011047818142772,0.0102514188209016,-0.0311405990317392,0.00904496274619517,0.281197233552466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39427,0.00754346399151608,0.0070231163033639,-0.00622184396307717,0.0213087719461093,0.282805963674911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39328,0.00365874083666448,0.00340991345669232,-0.00302468953845246,0.0103421712117814,0.28330792228856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41465,0.003729692318258,0.00347612269740218,-0.00308350816865029,0.0105428928051663,0.283315422141868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39259,0.00516710387691836,0.00481788388524021,-0.00427594853815246,0.0146101562919892,0.283526931051978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39250,0.00447870741499577,0.0041832236725691,-0.00372041098323967,0.0126778258132312,0.284357655333748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39334,0.00935445901458378,0.00874944999973734,-0.0077944629849014,0.026503381014069,0.285026922124642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39600,-0.00350200854059712,0.00328118122019772,-0.00993312373218464,0.0029291066509904,0.285859284959883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39583,-0.00809358385340123,0.00759195776490264,-0.0229738210726104,0.00678665336580794,0.286413919446229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39334,-0.00381054646429841,0.00357980979056692,-0.0108269736538096,0.00320588072521276,0.287146569311183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39308,0.0104373227271703,0.00981416485608295,-0.00879844039075229,0.0296730858450929,0.287581168359464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41689,0.0102984345430545,0.00970268765468353,-0.00871883326012524,0.0293157023462342,0.288527653129942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39589,-0.0102134818480261,0.00962957767653023,-0.0290874540940253,0.00866049039797318,0.288878424988653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41534,0.00544879102674753,0.005165536371881,-0.00467566026213924,0.0155732423156343,0.291520279125427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41465,0.00539348583198272,0.00511891215072606,-0.00463958198344036,0.0154265536474058,0.292067982942381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41798,-0.0065600598093833,0.00622663334508775,-0.0187642611657553,0.0056441415469887,0.292108995599029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39328,0.00546229589493865,0.00520284935791807,-0.00473528884658077,0.0156598806364581,0.293803264279396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39259,-0.00523084401281445,0.00498607165103584,-0.0150035444488447,0.0045418564232158,0.294159920500856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,39650,0.00268474654084219,0.00256558329000279,-0.00234379670756327,0.00771328978924765,0.29537766322996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39589,-0.00403074842867741,0.00386098008355687,-0.0115982693924489,0.00353677253509406,0.296522108263089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39334,-0.00351108164220858,0.00336326684934023,-0.0101030846669154,0.00308092138249826,0.296532140921379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39655,-0.00684433808950751,0.00656010260879655,-0.0197021392027488,0.00601346302373374,0.296819266830351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39589,0.00494589253219562,0.00474961263209348,-0.00436334822670761,0.0142551332910988,0.297747435868629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41466,-0.00550759303821025,0.00529278527456898,-0.0158814521763654,0.00486626609994495,0.298087742974462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39328,-0.00458451130270754,0.00441174316873749,-0.013231527913433,0.00406250530801793,0.298753299472434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,41636,-0.00135801674189233,0.00130973398272392,-0.00392509534803122,0.00120906186424655,0.299818217728285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39598,0.00508332703299845,0.00490899787375816,-0.00453830879956755,0.0147049628655644,0.300452554238675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41636,0.00376519357874949,0.00364055408897329,-0.00337029243563816,0.0109006795931371,0.301044843642305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,39630,-0.00250374001356925,0.00242891759165113,-0.00726441849320546,0.00225693846606696,0.302654949259362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,41720,0.00533697519789405,0.00518090922852816,-0.00481760689002114,0.0154915572858092,0.302971128509155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41521,-0.0124116719582356,0.0120490009183478,-0.0360277137581973,0.0112043698417261,0.302982498099327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,41689,0.00472637725056724,0.00459791359782891,-0.00428553340117742,0.0137382879023119,0.303997257528264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39427,-0.00431859192986951,0.00420360844804697,-0.0125576644880416,0.00392048062830255,0.30427698104955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41534,0.00851479908933695,0.00829128356896286,-0.00773611670583025,0.0247657148845041,0.304459497650003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39241,-0.00536629418686721,0.00522659000001757,-0.0156104105869017,0.00487782221316723,0.304571188185048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39408,0.00777977006049718,0.00757781429789354,-0.00707274596337415,0.0226322860843685,0.304607841222099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39259,0.00606297397395772,0.00590636983675217,-0.00551351090607654,0.017639458853992,0.304672450990461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,39633,-0.0093986343000389,0.00915966897823534,-0.0273515854973802,0.00855431689730237,0.304872196229393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39308,-0.00974031486261811,0.00949316807084291,-0.0283469242814702,0.008866294556234,0.304898652928299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,41925,-0.0027978225541763,0.00273226211340502,-0.00815305629645015,0.00255741118809755,0.305856258303212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39328,0.00396352417474949,0.00387096941947696,-0.00362357588742534,0.0115506242369243,0.305900888716194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39408,-0.0120608003723074,0.0117832092068402,-0.0351558904177143,0.0110342896730994,0.306066907036389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39625,0.0100781117226016,0.00988376022082607,-0.00929405831021754,0.0294502817554207,0.307910347326429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41466,0.00552233885440756,0.00542154478703497,-0.00510388892818098,0.0161485666369961,0.308416145273605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,41788,-0.0130942537808185,0.012864342484006,-0.0383083650494703,0.0121198574878332,0.308757470586961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41911,0.00306316425826101,0.00301031446462591,-0.00283705209240577,0.0089633806089278,0.308907388104584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,41877,0.00242336449974887,0.00238758761909028,-0.00225630723366808,0.00710303623316582,0.31013169683281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39615,0.00252027875013163,0.00248499091720443,-0.00235030344758905,0.0073908609478523,0.310509420523218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,41716,0.00976281755237946,0.00962948040052946,-0.00911096403265828,0.0286365991374172,0.31067457843765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,41805,0.00297543368442344,0.0029372715185849,-0.00278161849200296,0.00873248586084984,0.311082358017604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39250,0.00467527315330742,0.00461549256450458,-0.00437109227312155,0.0137216385797364,0.311106025304361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,41689,-0.00817404921001486,0.00809581878350856,-0.0240418540256916,0.00769375560566191,0.31267540758289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41466,0.00688532986044239,0.00683100202139497,-0.00650343410149176,0.0202740938223765,0.313495919803238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41124,-0.00322029171503043,0.0031962282489064,-0.00948489908288697,0.00304431565282611,0.313700234662864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41466,0.00400194822808252,0.00398085296270653,-0.00380052357882229,0.0118044200349873,0.314771714769174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",41805,0.0118383040418918,0.0117779429155943,-0.0112464640726731,0.0349230721564567,0.314855114889294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,39633,-0.0100371668393489,0.0100150851273998,-0.0296667336890526,0.0095924000103547,0.316266647551198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39259,0.00421713067626047,0.00422391028059492,-0.00406173347370558,0.0124959948262265,0.318110547488821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39427,-0.00924821143030411,0.00926427487204111,-0.0274061901795047,0.00890976731889645,0.318172656975504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39259,-0.00901449481029559,0.00904153192180067,-0.0267358973770249,0.00870690775643373,0.31878244594407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39600,0.00577439737616627,0.00580678548876177,-0.0056069021818068,0.0171556969341393,0.320039156653876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39334,0.00470239141528712,0.00473231485213564,-0.00457294569489874,0.013977728525473,0.320402646541708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39259,-0.00499028208240971,0.00504207593539445,-0.0148727509157828,0.00489218675096342,0.322329711342542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,41758,-0.00249688237696552,0.00252349917265699,-0.00744294075537322,0.00244917600144218,0.322460029757108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39655,-0.00304574700307543,0.00308712382086622,-0.00909650969197323,0.00300501568582237,0.323861849084185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41466,0.00541936285781395,0.005501300686459,-0.0053631864876457,0.0162019122032736,0.324590660961023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39221,-0.00570826485925441,0.0057988828122689,-0.0170740751713015,0.00565754545279263,0.324954470763168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39250,-0.00894503302389884,0.0090880997634207,-0.0267577085602034,0.00886764251240573,0.325011135194384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39241,-0.00649927341977181,0.0066049923073552,-0.019445058342188,0.00644651150264438,0.325140789048603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39408,-0.00930777798870975,0.00947854452106845,-0.0278857252500039,0.00927016927258441,0.326129767251281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39328,0.00648785380214805,0.00660806045020803,-0.0064639446802597,0.0194396522845558,0.326216050860754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39250,0.0103980438973689,0.0105993151274621,-0.0103766137524569,0.0311727015471947,0.326609640257522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,41740,0.00363950538365765,0.00371363745517513,-0.0036392240284856,0.0109182347958009,0.327085463361635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41466,0.00307734286432076,0.00314162564946754,-0.00308024340863562,0.00923492913727713,0.327332458066036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41758,-0.00306751973205278,0.00314232595196817,-0.0092264785979104,0.00309143913380484,0.328986283770997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39328,0.007362997777545,0.00756109153364072,-0.00745674162839081,0.0221827371834808,0.330177359887583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39427,-0.00648046183807179,0.00665973923101679,-0.0195335507308647,0.00657262705472112,0.330535074193172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39334,-0.00450271270582625,0.00463018798835995,-0.0135778811630118,0.00457245575135927,0.330839362223378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,41911,0.00384727494468551,0.00395681740487084,-0.00390808716886133,0.0116026370582324,0.330911276605638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39313,-0.00411134273752643,0.00423826108341627,-0.0124183344610223,0.00419564898596946,0.332041403317929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,41637,-0.00500104864168197,0.00516380577407224,-0.0151221079588635,0.00512001067549962,0.332822086353588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41614,-0.00268606422788413,0.00277638754050711,-0.00812778380727807,0.0027556553515098,0.333328446346039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39308,0.00809386783257722,0.00836958191508015,-0.00831051272097988,0.0244982483861343,0.333537078507745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41447,-0.00367948209849071,0.00380827509548392,-0.0111437012856392,0.00378473708865777,0.333971929420275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39308,0.00265989192927608,0.0027558931127694,-0.00274165857175193,0.0080614424303041,0.334483906703149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41617,-0.00833007871848354,0.00863112864583079,-0.0252470908643119,0.00858693342734481,0.334502417108295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41521,0.00869777412605014,0.00901657486875967,-0.00897471261671882,0.0263702608688191,0.334741802099319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41636,0.00312366079971186,0.00324441311411868,-0.00323538890396075,0.00948271050338447,0.335675064301965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39241,0.0065756808471985,0.00683777495836502,-0.00682635807119693,0.0199777197655939,0.336237409567307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41465,0.00385602661489808,0.00401534986488403,-0.00401405912027461,0.0117261123500708,0.33691150424577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39408,-0.0124567099023055,0.0129791391949345,-0.0378958227243771,0.0129824029197662,0.337203256129601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41465,0.00497250441208038,0.00520130625680382,-0.0052220558512551,0.0151670646754159,0.339084794540913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,41877,0.0061783536872614,0.00647043057904758,-0.00650369024767186,0.0188603976221947,0.339666014017749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39250,-0.00328769423218765,0.00344605624345576,-0.0100419644693609,0.00346657600498564,0.340082296788058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41581,0.00286539761613416,0.00300517000728265,-0.00302473559813983,0.00875553083040815,0.340359940590873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39600,0.00306065658140639,0.00321694314879029,-0.00324455199022257,0.00936586515303536,0.341413293695976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39308,0.00264067306676438,0.00277576090792038,-0.00279981831275956,0.00808116444628831,0.341456810994916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,41786,-0.00499556759147244,0.00525175764379421,-0.0152890125733091,0.0052978773903642,0.341511042595855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39334,0.00567607179048767,0.0059888084089023,-0.00606199269096084,0.0174141362719362,0.343262889163183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,41708,-0.0088350868639477,0.00932203322070987,-0.027106271976539,0.00943609824864365,0.343267117479882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39328,-0.00365521397883723,0.00387541724838445,-0.0112510317856708,0.0039406038279963,0.345610352890036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39328,-0.00686877529023549,0.00728948109292753,-0.0211561582323735,0.00741860765190246,0.346067500587187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41689,0.00247320493175105,0.00262868726327127,-0.00267902210426064,0.00762543196776273,0.346798215383316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39408,-0.0035107814306599,0.00374611901682308,-0.0108531747036331,0.00383161184231333,0.348687793691065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41465,0.00748331611864417,0.00799681526256675,-0.00819044179598665,0.023157074033275,0.34940040823072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,41743,-0.00656519009575504,0.00702761776750924,-0.0203393209200732,0.00720894072856307,0.350218663147545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41490,-0.00500335258756512,0.00535895903281157,-0.0155069122918758,0.00550020711674556,0.350505757589414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39334,0.00411075690651977,0.00441115288438689,-0.00453510274687853,0.0127566165599181,0.351408752987592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,41758,-0.00321735072778594,0.00345853920756911,-0.0099960875746214,0.00356138611904952,0.352252045875755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,39598,0.0069616005233212,0.00748818658560503,-0.00771524518446466,0.0216384462311071,0.352558357830829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39328,-0.00417719588916478,0.00449971440266956,-0.0129966361183971,0.00464224434006755,0.353260066332204
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,41683,-0.00363843079435848,0.00392690965136699,-0.0113351737110378,0.00405831212232083,0.354183578706717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39241,0.00376359628712301,0.00406339822391434,-0.00420066423174909,0.0117278568059951,0.354353230991182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39334,0.00442109854500498,0.0048043692705681,-0.00499546522530851,0.0138376623153185,0.35747610784137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,41808,-0.00269897913348842,0.00293952926121484,-0.00846045648546951,0.00306249821849267,0.358548142381871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39241,-0.00463648655164831,0.00505118710963538,-0.0145368132865337,0.00526384018323703,0.358691828255958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,41740,-0.0118634958519988,0.0129277485858957,-0.0372018830803544,0.0134748913763567,0.35880490379718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39427,-0.00419028991430472,0.00457394992864249,-0.013155231774444,0.00477465194583456,0.359624029821263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,41753,-0.0188408652754217,0.020680836220457,-0.0593753042675174,0.0216935737166739,0.362296184680585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41465,0.00659743000396953,0.00725181416148707,-0.00761612575254512,0.0208109857604842,0.362964715266403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,41836,0.00307223070487018,0.0033819163863696,-0.00355632541241423,0.00970078682215459,0.363668183235959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39259,-0.00328167405852378,0.00362446739943826,-0.0103856301614228,0.00382228204437521,0.365262105497164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,39600,-0.00367671562094552,0.00406084201260745,-0.0116359659656561,0.00428253472376509,0.365269529779758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,39589,0.00833204226103199,0.00921725453304655,-0.00973377662373925,0.0263978611458032,0.366035688261955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39493,-0.00307216399970852,0.00340201726180386,-0.00974011783284408,0.00359578983342704,0.366523646675555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,41862,0.00651897920901154,0.00730438900851866,-0.00779762324768504,0.0208355816657081,0.372154973948478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39334,0.0082720860063089,0.00928872041649988,-0.00993380601003087,0.0264779780226487,0.373189666129425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41465,0.00625659422894999,0.00702694039220139,-0.00751620893976473,0.0200293973976647,0.373282572945894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,39589,0.00375196104967426,0.00421888394181192,-0.0045170514762771,0.0120209735756256,0.373847640692044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,41865,0.00486980101210053,0.00547649960313342,-0.00586413821004098,0.015603740234242,0.373902155078036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,39655,0.00721025638048282,0.00811592330460921,-0.00869695329655122,0.0231174660575169,0.374340308999712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,39600,-0.00287854236337614,0.00325801532146346,-0.00926425239344452,0.00350716766669223,0.376971264763751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39328,0.00668974911378522,0.00758159926084508,-0.00817018543747113,0.0215496836650416,0.377598422033403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,41765,-0.0030183240192611,0.00342554093776005,-0.00973238425727079,0.00369573621874859,0.378267159625186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39328,0.0100333966865378,0.0113904902761442,-0.0122919642547048,0.0323587576277804,0.37841478595609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41521,-0.00880406248065567,0.00999928034281777,-0.0284026519525785,0.0107945269912672,0.378621336282262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41636,0.00750799234824273,0.00853104121514107,-0.00921284843343377,0.0242288331299192,0.378832603070244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41465,0.00300169702343678,0.00341255055855715,-0.00368690207133523,0.00969029611820879,0.379089681048158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39408,-0.0027483279816969,0.00313238176899437,-0.00888779624892586,0.00339114028553207,0.380293037848328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39427,-0.00398474057482714,0.0045447846809464,-0.0128925185494821,0.0049230373998278,0.38062986906061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39241,-0.00379600538905231,0.00433667622319026,-0.0122958907865052,0.0047038800084006,0.381416315951826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39328,0.00515194696081627,0.00588704601462167,-0.0063866632278422,0.0166905571494747,0.381521253454147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39334,0.00384304269933635,0.00439158274228723,-0.00476445947554662,0.0124505448742193,0.381542962043813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,41805,0.00610571139329001,0.00699224643922659,-0.0075990916275941,0.0198105144141741,0.382563577746077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,41740,0.0027671334608588,0.00316895407624874,-0.00344401652858873,0.00897828345030633,0.382569556734473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39195,0.00413885611441587,0.00474991309730154,-0.00517097355629515,0.0134486857851269,0.383580598848724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39328,-0.00508091271838515,0.00583911329058946,-0.0165255747679405,0.0063637493311702,0.38423712957312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39427,0.00425230187090626,0.00490176452033202,-0.0053551565889445,0.013859760330757,0.385684974839111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,41703,0.00818807135490234,0.00944401125226463,-0.0103221906995363,0.026698333409341,0.385951295627033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,41758,0.00397351469984489,0.00459719629815345,-0.00503699004453586,0.0129840194442256,0.387419998664425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,41728,0.00373503180580918,0.00432800988158146,-0.00474786756209047,0.0122179311737088,0.388158405100729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41534,0.00520670057878732,0.00603527294191893,-0.00662243438737378,0.0170358355449484,0.388311993717541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39625,0.00372266978332177,0.00431581825668586,-0.00473633399978252,0.0121816735664261,0.388395951196162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39427,-0.00813245077950089,0.0094642129725732,-0.0266823082057444,0.0104174066467426,0.390202640476434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,41805,0.00793299738466425,0.00923269343816571,-0.0101630817541405,0.026029076523469,0.390229817741748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39334,-0.00544897751519924,0.00634196639153433,-0.0178792316426065,0.00698127661220805,0.390252850078088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41447,-0.00498088635788568,0.00579910023025994,-0.0163471228091952,0.00638535009342381,0.39040798775268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39250,-0.00446371417844139,0.00521747778380451,-0.0146899706346982,0.00576254227781545,0.392276476274069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39408,0.00774752526146864,0.00905754552714884,-0.0100052639717431,0.0255003144946804,0.392366984977359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,41765,-0.00395522901713902,0.00463432866686663,-0.0130385132041976,0.00512805516991957,0.393418009421058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39259,-0.00975752309162609,0.011448122782929,-0.0321958437461669,0.0126807975629147,0.39405279485917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39625,0.00823481631368811,0.00967664014710314,-0.010731398374634,0.0272010310020103,0.39478809044495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39328,0.00560137719904411,0.00658465608490966,-0.00730454872737882,0.018507303125467,0.394971019345796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39328,0.00276056386594124,0.00325404440003682,-0.00361736315813092,0.0091384908900134,0.396262811554678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39250,-0.00557539115501101,0.0065807968627861,-0.0184737530060718,0.00732297069604974,0.396890831346262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,41740,0.00562880384518185,0.00666514892218592,-0.00743488804230256,0.0186924957326663,0.398398266672249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39334,-0.00507935639080957,0.00602227991278927,-0.0168830250198765,0.0067243122382574,0.399008201011332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39589,0.00360413960325965,0.00427543288913287,-0.00477570885944078,0.0119839880659601,0.39925337414563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39600,0.00587698253645004,0.00697500058918773,-0.00779401861835791,0.019547983691258,0.399482779344914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39328,0.00706429937636861,0.00839357192564449,-0.0093871015978946,0.0235157003506318,0.40001268842334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,41758,-0.00659940563512186,0.00784555998185929,-0.0219767031995661,0.00877789192932235,0.400271135765235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39334,0.00596051665648986,0.00708680974649921,-0.00792963044664858,0.0198506637596283,0.400326382353102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41617,0.00322197770793615,0.0038443744383743,-0.00431299619127749,0.0107569516071498,0.401988837145045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39600,0.00817891513724912,0.00979410797432479,-0.0110175364924275,0.0273753667669257,0.403687845637252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41689,0.00781028502949595,0.009374776991717,-0.0105642778742694,0.0261848479332613,0.404794011749019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39427,-0.00355557922218219,0.0042726520824466,-0.0119299773037775,0.00481881885941315,0.405330511501839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41437,-0.0067212342011314,0.00813807294049665,-0.0226718571645048,0.00922938876224204,0.408876186116505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39393,0.00326173891469995,0.00395446068340005,-0.00448900402476414,0.011012481854164,0.409489053222857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41780,0.00200943389720157,0.00243666066061322,-0.00276642099760035,0.00678528879200348,0.409575535258569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41465,-0.0033631044370214,0.00409065564482559,-0.0113807895008796,0.00465458062683675,0.411010677510156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41534,0.00375701203625613,0.00457202799833922,-0.00520416284048873,0.012718186913001,0.411240813704722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39259,0.00814809264078415,0.00993272549412653,-0.0113200493277039,0.0276162346092722,0.412047503914564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39600,0.00415109613047941,0.00506377805016576,-0.00577390884784547,0.0140761011088043,0.412369186725005
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39570,-0.00465493236207323,0.00568629180435167,-0.0158000642986025,0.00649019957445604,0.41301901073789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41466,-0.00752297594530816,0.00919076704753427,-0.0255368793584753,0.010490927467859,0.413066214656839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39589,0.0074215627287666,0.0090756385756534,-0.0103666888795141,0.0252098143370473,0.413520245752421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39328,0.0033097647113392,0.00405241807844748,-0.00463297472241786,0.0112525041450963,0.414096182729554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,41802,0.00298906129855632,0.00366189776726519,-0.00418825832528346,0.0101663809223961,0.414366076399986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39408,0.00524902943155359,0.00644970460599018,-0.00739239159618715,0.0178904504592943,0.41575438292581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,41689,0.0167168440517248,0.0205472446034948,-0.0235557553711251,0.0569894434745746,0.415899930362642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39259,0.00516113891096383,0.00635684177257315,-0.00729827096327955,0.0176205487852072,0.416865423087359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41465,0.00273878628942454,0.00337683972307872,-0.00387981956780974,0.00935739214665883,0.417351888137623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39427,0.00497112999400404,0.00613599041815027,-0.00705541122557048,0.0169976712135786,0.417866404380121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41521,-0.00274138995228532,0.00338398086740169,-0.00937399245239263,0.00389121254782198,0.41789302935674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39589,-0.00355754316447725,0.00439386211711175,-0.0121695129140163,0.00505442658506179,0.418151998063218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39259,-0.00302344421060836,0.00374179193339796,-0.0103573564000684,0.00431046797885163,0.419096871420567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39328,0.00297974645435997,0.00369466142640627,-0.00426178994139632,0.0102212828501163,0.419972171723809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39250,-0.00341386892665904,0.00423783996618879,-0.0117200352603891,0.00489229740707099,0.420509878139332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39408,-0.0109958365393088,0.0136787500055742,-0.0378061865502342,0.0158145134716165,0.42149396914119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39328,0.00511678187268362,0.00636635414101965,-0.00736127224371489,0.0175948359890821,0.421575082093224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41534,0.00419593576330565,0.00522081632301175,-0.00603686422979737,0.0144287357564087,0.421588821012993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39328,0.00480450466471248,0.00598454041952943,-0.00692519455756521,0.0165342038869902,0.422096959196987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39334,0.00362881253256391,0.00453427901721815,-0.00525837434118367,0.0125159994063115,0.423551005594257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,41805,0.00249733703349449,0.00312243385958826,-0.0036226333312985,0.00861730739828749,0.423838391697767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39250,-0.00493217643795028,0.00616988447813946,-0.0170251500151036,0.00716079713920307,0.424079083280182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",41728,-0.00944023705289661,0.0118150248029113,-0.0325976856666028,0.0137172115608096,0.424303284912925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39625,0.00260039863414899,0.00325623600741494,-0.00378182394038429,0.00898262120868228,0.424545190317843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39250,0.00397389199586244,0.00498366537208676,-0.00579409213342762,0.0137418761251525,0.425246179088424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,41765,-0.00254468370327105,0.00319670676193696,-0.00881022895666749,0.00372086155012539,0.426027275430999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,41636,-0.00894947818676037,0.0112553716680274,-0.0310100066560941,0.0131110502825734,0.42655264531498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41465,0.00397946712268548,0.00502131448665918,-0.00586230927116652,0.0138212435165375,0.428075054342158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41534,0.00987456021123889,0.0124632638337986,-0.0145534369030063,0.0343025573254841,0.428204218860215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39334,0.00146223510552387,0.00184701008639131,-0.00215790466380309,0.00508237487485083,0.428566624589369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41740,0.00817834145402055,0.0103370110481744,-0.0120822002004013,0.0284388831084424,0.428858600014425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,41865,-0.00555145715477719,0.00702308964805687,-0.0193167128649686,0.00821379855541427,0.429274492374528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41465,0.00679810882585318,0.00860550829479867,-0.0100686874319522,0.0236649050836586,0.429558801113025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41447,-0.00411989507534102,0.00522135692003129,-0.0143537546386023,0.00611396448792031,0.430099202980215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39328,-0.00523251513260998,0.00665891250845909,-0.0182839836491898,0.00781895338396983,0.432007152700695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,41847,-0.00356136402758732,0.00453528218712663,-0.0124505171143555,0.00532778905918088,0.432316694164333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39320,0.00236279628876041,0.00301372232809418,-0.00354409947430419,0.008269692051825,0.433050037431085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,39600,0.00295031562798578,0.00376863440519121,-0.004436207806189,0.0103368390621606,0.433725792888348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,41802,0.00599042767665003,0.00765600172646778,-0.00901533570722681,0.0209961910605269,0.433965027142353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,41802,0.00466240570081305,0.00596336647914283,-0.0070257925983069,0.016350603999933,0.43432191643978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,41865,0.00397542534669208,0.00509318253041192,-0.00600721241291529,0.0139580631062994,0.435087869171728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39334,0.00728877487700506,0.0093385736996134,-0.0110148295742372,0.0255923793282473,0.435112697900411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,39600,-0.00648975611447244,0.00832492173901572,-0.0228066027229433,0.00982709049399838,0.435668085400513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41689,-0.0039605806748774,0.005081897302822,-0.0139210993884085,0.00599993803865372,0.435787194317985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39589,-0.0033461773748598,0.0043177547132036,-0.0118089766127389,0.00511662186301926,0.438367629064081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,41826,-0.0129821307958544,0.0167704291594896,-0.045852171948454,0.0198879103567452,0.438880502208149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,39625,-0.00601692259956174,0.0077855144931905,-0.0212765310062151,0.00924268580709164,0.439636262030654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39250,0.00604168558747593,0.00784837564914821,-0.00934113068485456,0.0214245018598064,0.441435158810825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39328,0.00283001956557621,0.003690946685731,-0.00440423593845656,0.010064275069609,0.443249265797221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,41865,-0.00609198957216925,0.00794876694301651,-0.0216715727804816,0.00948759363614311,0.443447886142486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39334,0.00827306094185479,0.0108259364169867,-0.0129457744354391,0.0294918963191487,0.444771450611216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41598,-0.00534054602237299,0.00699304222082397,-0.019046908775188,0.00836581673044199,0.445063339270273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39250,0.00356247895080436,0.00466594114018881,-0.0055827656839657,0.0127077235855744,0.44517797287596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39224,-0.00400024991696522,0.00524177180383818,-0.0142741226524881,0.00627362281855761,0.445391825723861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,41740,0.00401132146545818,0.00526073222956514,-0.00629971370448949,0.0143223566354058,0.445773840044918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39334,0.00352172299381191,0.00462395953315595,-0.00554123769117375,0.0125846836787976,0.44630060625361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39259,-0.00465631066828346,0.00611807671507855,-0.0166477410298374,0.00733511969327049,0.446629554070791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,41708,-0.00637676546191417,0.00838439018029848,-0.0228101702152992,0.0100566392914708,0.446938326153879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39600,0.00541665821963802,0.00713273770525011,-0.00856350768265219,0.0193968241219282,0.44762479056827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41521,-0.00874633871146966,0.0115348660325706,-0.0313546761353081,0.0138619987123687,0.448313785998347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39241,-0.00488614426680982,0.00646994810005362,-0.0175672425429149,0.00779495400929528,0.450142044394666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,41758,-0.00260613346256079,0.0034540280598162,-0.00937602845980054,0.00416376153467896,0.450550507281847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,41812,0.00191812732771754,0.00254558091886235,-0.00307121127325267,0.00690746592868775,0.451155362596982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39625,0.0032749897193956,0.00434754983622118,-0.00524620795959792,0.0117961873983891,0.451288448912679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,41765,-0.00369519804359619,0.00494165357104167,-0.0133808390428379,0.00599044295564548,0.454614972687911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39600,-0.0103459812160266,0.0138364530339428,-0.0374654291625544,0.0167734667305013,0.454636827937555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39408,-0.00914481979867256,0.0122328262773692,-0.0331211593023162,0.0148315197049711,0.45473948662238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41534,0.00455185391717821,0.00609175760217076,-0.00738799098307648,0.0164916988174329,0.454947249505437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39308,0.00223808063904809,0.00299689845645121,-0.00363584033559627,0.00811200161369246,0.455201322193056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41465,0.00290616630312072,0.00389695397122447,-0.00473186348047925,0.0105441960867207,0.45583007743769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39250,-0.00600122528220266,0.00806633921892795,-0.0218112501513014,0.00980879958689612,0.456902721206721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,41752,-0.00249865711812514,0.00337312714867688,-0.00910998632953183,0.00411267209328155,0.458855891017421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39328,0.00621323279858756,0.00839362069217627,-0.0102382637580779,0.0226647293552531,0.459174987246958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39334,0.00457084868991501,0.0061750458128171,-0.00753224110320652,0.0166739384830365,0.459186999040383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,39598,0.00783725503126574,0.0105903539568638,-0.0129198387241873,0.0285943487867188,0.459293268263912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,39633,-0.00343745449441248,0.0046574700854918,-0.0125660958619764,0.00569118687315145,0.460498628612979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,39600,0.00180719253532062,0.00244976038747939,-0.00299433782413899,0.00660872289478022,0.460711441816979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39427,-0.00546605670196227,0.00741856355695492,-0.0200064412735939,0.00907432786966937,0.461255104969626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39250,0.00462776836752266,0.00628156834783446,-0.00768410559423288,0.0169396423292782,0.461307772264407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39259,-0.00765557597879319,0.0104121034575873,-0.0280632987556643,0.0127521467980779,0.462198932121303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41465,-0.0100059855701386,0.0136161470055368,-0.0366936337009908,0.0166816625607136,0.462437092192154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41863,0.00222968396245008,0.00304291051395705,-0.00373442064490574,0.00819378856980589,0.463725618863283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39241,0.00487009493467074,0.00668464214804358,-0.00823180367549467,0.0179719935448362,0.466293106555763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,41740,-0.00440752468939638,0.00608676295055007,-0.0163375800724745,0.00752253069368175,0.469007187436695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41534,0.00345834458602548,0.00478401411518431,-0.00591832307973577,0.0128350122517867,0.469756863049209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,39633,-0.00202901135558469,0.0028083868876506,-0.00753344965537987,0.00347542694421049,0.470012980513062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39241,-0.00242186733727303,0.00335876892882758,-0.00900505443777508,0.00416131976322902,0.470889647437227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39241,0.00651840995353187,0.00906514060309852,-0.0112492656285412,0.024286085535605,0.472117706023759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41466,-0.00822801935743205,0.0114476712901435,-0.0306654550861134,0.0142094163712493,0.472307720256433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39427,0.00337809112794563,0.00470128370493032,-0.00583642493371779,0.0125926071896091,0.47243586990282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39334,0.00687494088714862,0.0095876916057932,-0.0119169346602061,0.0256668164345033,0.473353273574783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39221,-0.00279883791802355,0.00390523229436256,-0.0104530932149742,0.00485541737892707,0.473581632906092
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41765,-0.00381758998871555,0.00533485765280777,-0.0142739109882188,0.00663873101078767,0.474255018151163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41534,0.00480815225920544,0.00671929301272788,-0.00836166204574121,0.0179779665641521,0.474267268979642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39334,-0.00348516778798882,0.00487047577068881,-0.0130313002985389,0.00606096472256124,0.474272285224846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39600,0.00351712218791957,0.00492441966661602,-0.00613474035864783,0.013168984734487,0.475105908013886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39625,0.00239035533690262,0.00334694543192911,-0.00416965770967843,0.00895036838348367,0.475124749350363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39600,0.00678650860461543,0.00952297170248612,-0.0118785159322574,0.0254515331414882,0.476079895987991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39318,-0.00278987004639164,0.0039250462137164,-0.0104829606252758,0.00490322053249251,0.477231984656244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,41911,0.00422841303499194,0.00595120802952024,-0.00743595470286773,0.0158927807728516,0.477398274018023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39308,0.00401406243978635,0.00566855735296148,-0.00709630997201815,0.0151244348515909,0.478881377144426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39259,0.004183581174305,0.00591036452374012,-0.00740073329222563,0.0157678956408356,0.479061282215677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,41925,-0.00424655168271665,0.0060350361656454,-0.0160752225673816,0.00758211920194833,0.481663216618858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,41865,0.0085260162117582,0.0121273773884439,-0.0152436434695919,0.0322956758931083,0.482043940456705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41466,0.00499962000040627,0.00711667985799586,-0.00894907252126562,0.0189483125220782,0.482366761420846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,41689,0.00144333555502139,0.0020559915593609,-0.00258640790132597,0.00547307901136875,0.48268270401817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39589,0.00265387940201563,0.00379345289289064,-0.00478128826805002,0.0100890470720813,0.484195284091444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39328,-0.0051515093215971,0.00737486966102817,-0.0196062538572123,0.0093032352140181,0.484865893468373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41466,0.00394134718298906,0.00564405994707372,-0.00712101031327543,0.0150037046792535,0.484991128726165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,41758,0.00316818586174256,0.00454461271971192,-0.00573925506889279,0.0120756267923779,0.485733758013805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39633,-0.00195244145865833,0.00280877224511776,-0.00745763505908914,0.00355275214177249,0.48699302414381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39334,-0.00657958604516126,0.00947175255029165,-0.0251442210437329,0.0119850489534104,0.487287511662693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41636,0.00600882916134632,0.008655641323967,-0.010956227833629,0.0229738861563216,0.487563154009267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,41689,0.00112883452152467,0.00162647290643473,-0.00205905237508741,0.00431672141813674,0.487670495729296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39328,0.00985905826239867,0.0142590523147187,-0.0180886842744501,0.0378068007992474,0.489313767295962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,41855,0.00449192274033132,0.00652226455066479,-0.00829171577897166,0.0172755612596343,0.491020352358732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39334,-0.00289808594619768,0.00423035344980138,-0.0111895787078084,0.00539340681541302,0.4933148846427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39427,-0.00533145414484633,0.00780381750706835,-0.0206269364587003,0.00996402816900762,0.494504318903157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39600,0.0122392017157215,0.017945033345924,-0.0229330636422896,0.0474114670737326,0.495229034422894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,41925,-0.00168050376837899,0.00246475257366709,-0.00651141881276649,0.0031504112760085,0.495368175242359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41559,-0.0123214076041672,0.0181428035686442,-0.0478813025987097,0.0232384873903754,0.497064641574643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41466,0.00238734883038941,0.00351847277286789,-0.00450885780443165,0.00928355546521048,0.497455208426463
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,39600,0.0189900686695651,0.0280702946452259,-0.0360277088350776,0.0740078461742078,0.498725840968771
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41534,0.00286875657091161,0.00425127973319694,-0.00546375170615439,0.0112012648479776,0.499815947209317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41636,-0.00419950174541846,0.00623285419228914,-0.0164158959623052,0.00801689247146825,0.500470355732692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,41877,0.0043415452870571,0.00646403687865902,-0.00832796699511458,0.0170110575692288,0.501820695939353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,39600,0.00381092297264899,0.00567700509130659,-0.00731600700631193,0.0149378529516099,0.502049201443253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39406,-0.00367011123092799,0.00547087746267017,-0.0143930310577615,0.00705280859590554,0.502333563627755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39259,-0.00523209914694433,0.00780127775187759,-0.0205226035406244,0.0100584052467357,0.502443986578918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39259,-0.00389578383672328,0.00580965031987858,-0.0152826984636853,0.00749113079023875,0.502508301591844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,41727,-0.0036059334081239,0.00537774118294508,-0.0141463061266963,0.00693443931044846,0.5025321865052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41819,-0.00817798089477297,0.0122741709423959,-0.032235355941869,0.015879394152323,0.505246570965728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39625,0.00233156109824993,0.00350058883000146,-0.00452959300855293,0.00919271520505279,0.505394189732043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39427,0.00383043675612837,0.00575156815293627,-0.00744263682362671,0.0151035103358835,0.505437250618672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39259,-0.00290324339893041,0.00436003919629964,-0.0114489202236777,0.00564243342581688,0.505505073741486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39562,-0.00195731202885872,0.00294087467551795,-0.00772142639287389,0.00380680233515646,0.505709975766975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39598,0.00386230019060828,0.00581672764531313,-0.00753848599420545,0.015263086375422,0.506704996931913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,41740,0.00495773248455595,0.00747587594456005,-0.00969498436678175,0.0196104493358936,0.507237099236754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39589,-0.0038283485505843,0.00578314051832443,-0.0151633039665002,0.00750660686533158,0.507995129075369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41534,0.00383727001441021,0.00579994592204608,-0.0075306239928001,0.0152051640216205,0.508236542742223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41534,0.00380518732955855,0.00576324186722522,-0.00749076673020287,0.01510114138932,0.50910440168815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39250,-0.00345387467073448,0.00523432311696319,-0.0137131479799823,0.00680539863851337,0.509363557763314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41466,-0.00348962342936107,0.00529413061972487,-0.0138661194440218,0.00688687258529967,0.509811583316984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",41758,0.00544017684123134,0.00826870345977839,-0.0107664819399343,0.021646835622397,0.510598603263538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39259,-0.00344535559164369,0.00524442563833914,-0.0137244298427884,0.00683371865950102,0.511223551667604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,41877,-0.00209214781776975,0.00318496765184583,-0.00833468441538758,0.00415038877984809,0.511268199392079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39259,-0.00396377199631232,0.00604506363204964,-0.0158120967151296,0.00788455272250497,0.512028790213539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,41734,-0.00167688888018124,0.0025660265750511,-0.0067063009672814,0.00335252320691891,0.513447812077738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,41805,0.00189975801365103,0.00290861348809535,-0.00380112442301585,0.00760064045031791,0.513671591807533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39334,0.00292532371645426,0.00447968262430552,-0.00585485422718457,0.0117055016600931,0.513757173809074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39328,0.00439808225166262,0.00674159485004983,-0.00881544365443505,0.0176116081577603,0.514169983092774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39589,-0.00504559099401305,0.00775018993524805,-0.0202359632670992,0.0101447812790731,0.515041996530061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,39589,-0.00246382077909565,0.00378934620531009,-0.00989093934150343,0.00496329778331214,0.515578699627662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39427,0.00211119046250065,0.00327586795621947,-0.00430951073168951,0.0085318916566908,0.519285973160535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39334,-0.00182214703780991,0.00283126393723448,-0.0073714243547895,0.00372713027916968,0.519861069755001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39535,0.00663436461514425,0.010309448561618,-0.013572154565627,0.0268408837959156,0.519898457594093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,41740,-0.00297041632222064,0.00461803096001742,-0.0120217570038548,0.00608092435941351,0.520091676154993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39259,-0.00218323765197418,0.00339901459853143,-0.00884530626509578,0.00447883096114743,0.520682569308434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39328,-0.00447969184908885,0.00698455532644715,-0.0181694202889253,0.00921003659074756,0.521295314412947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39266,0.00237887994704623,0.00372089561440179,-0.00491407545718127,0.00967183535127373,0.522622049211591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39625,-0.00680740342977905,0.0106506258838121,-0.0276826301620507,0.0140678233024926,0.5227352203769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39589,0.00368767974784778,0.00577450251545645,-0.00763034518244686,0.0150057046781424,0.523087200302651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41465,-0.0039037852216813,0.00612994424840858,-0.0159184759485621,0.00811090550519952,0.524241299994995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41466,0.00450946718250972,0.00708926147844868,-0.0093854853152497,0.0184044196802691,0.524723667697301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39250,-0.00402430079987756,0.00634601701171725,-0.0164624941428434,0.00841389254308825,0.525999216801364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39250,-0.00476430697173323,0.00752023035882692,-0.019503958475034,0.00997534453156753,0.526399861422691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39230,-0.00562224647678021,0.0088826818320634,-0.0230323028676245,0.0117878099140641,0.526783364925104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,39589,-0.00716342722485307,0.0113220962960154,-0.0293547359650432,0.015027881515337,0.526946374653917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39250,-0.00475393347123826,0.00752779876193942,-0.0195084190446395,0.010000552102163,0.527716040869273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,39579,0.00415912137235958,0.00659393570087488,-0.00876499260135517,0.0170832353460743,0.52821748398312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39250,-0.00347091379215875,0.0055113206765673,-0.0142731023182307,0.00733127473391316,0.528852724939399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39427,0.00269974011008303,0.00429495438510041,-0.00571837048471377,0.0111178507048798,0.529634621097261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39259,-0.00514638130439602,0.00819548197934191,-0.0212095259839062,0.0109167633751141,0.530047878244596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41534,0.0039047961893001,0.00622620223941064,-0.00829856019994475,0.016108152578545,0.530568463147844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39328,0.0018721049110228,0.00298766412399019,-0.00398371677199797,0.00772792659404357,0.530927214603432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41534,-0.00277643998092444,0.00444337325802464,-0.0114854515666527,0.00593257160480385,0.532080799451459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41465,-0.00364129408173475,0.00583360846807209,-0.0150751666791561,0.00779257851568655,0.53251230426126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,41758,0.00297335536378239,0.00476634200500373,-0.00636867496602492,0.0123153856935897,0.532754427383384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,41836,-0.00677259244909043,0.0108695827548725,-0.0280769746486405,0.0145317897504596,0.533244329975613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39408,0.00209536082022835,0.00336431560288326,-0.00449869776142284,0.00868941940187954,0.533416388971536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,39655,-0.00153501167811831,0.00246575808554906,-0.00636789752579446,0.00329787416955784,0.533605384713189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,41840,0.00410299607499241,0.00659280095782171,-0.00881889380233814,0.017024885952323,0.533725818244481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,41673,-0.00461151094048979,0.00742830874905101,-0.0191709960886298,0.0099479742076502,0.534740551671085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39427,-0.00530693239631313,0.00856069726502185,-0.0220858990357559,0.0114720342431297,0.535324661411853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39334,0.00710791952006366,0.0114927096904197,-0.015417791473159,0.0296336305132863,0.536277351206896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41865,0.00309903483485741,0.0050350015198767,-0.00676956814410092,0.0129676378138157,0.538236256556483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,41925,-0.00129871122667534,0.00211278644844394,-0.00543977266562547,0.00284235021227479,0.538769171632332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39308,0.00415910084789197,0.00676886935103564,-0.00910788308013788,0.0174260847759218,0.538934076939424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39259,0.0054436685796415,0.00886149981819998,-0.0119248710640305,0.0228122082233135,0.539026542599295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39250,-0.00325135729951715,0.00529376605824131,-0.0136271387736701,0.00712442417463583,0.539105505689834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41466,0.00389817764645722,0.00636738476005807,-0.0085818964832566,0.016378251776171,0.540409538907297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",41758,-0.00254653423937659,0.00416139596917321,-0.0107028703389561,0.00560980186020291,0.540586504163449
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41465,0.0019886922091987,0.00325607798854603,-0.00439322064835151,0.00837060506674892,0.541367230887086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,39600,-0.00228621541420357,0.0037574660750011,-0.00965084892120573,0.0050784180927986,0.542904236431047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,39600,-0.0101948212368747,0.0168964938274648,-0.0433119491387058,0.0229223066649564,0.546275655054948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,41728,0.0059461858548561,0.00986447643255718,-0.013388187952956,0.0252805596626682,0.546660289075735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39334,0.00283781009326633,0.00471294477476059,-0.00639956166526442,0.0120751818517971,0.547099667213346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,41762,-0.00234811889429758,0.00390053048457666,-0.00999315864406784,0.00529692085547268,0.547184585004433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41534,-0.00412299781622693,0.00685089952764453,-0.0175507608904102,0.00930476525795635,0.547305533215948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,39580,0.00557126165505333,0.00925862744629649,-0.0125756481396878,0.0237181714497944,0.547361428477402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39241,-0.00352258765202996,0.00586407861764318,-0.0150161817426106,0.00797100643855068,0.548048565799909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39589,-0.00312753318321769,0.00520655409215204,-0.0133323792038357,0.00707731283740031,0.548057819323785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39259,0.00324631937513502,0.00540638112388547,-0.0073501876276805,0.0138428263779505,0.548212013390175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39308,0.00573175535626276,0.00956342941903883,-0.0130125663050534,0.0244760770175789,0.548958192131869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39427,-0.00361118042893039,0.00602878126755917,-0.0154275917133464,0.00820523085548557,0.549192003688723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39250,-0.00416286168132661,0.00696127137734741,-0.0178069535809275,0.00948123021827432,0.54985059800236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39589,-0.0038178669985083,0.0063971988396687,-0.016356376724259,0.00872064272724234,0.550651257594099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,41805,-0.00233333757246258,0.00391628123350252,-0.0100092487901275,0.00534257364520236,0.551316118586338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39334,-0.00350408735853044,0.00588167674802348,-0.0150321737846565,0.00802399906759558,0.551345901559183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39522,0.00634077731529697,0.0106618949748931,-0.0145565368354935,0.0272380914660874,0.552047037545129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39241,-0.0019546158408325,0.00329095862526433,-0.00840489474635059,0.0044956630646856,0.552568146968725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39259,-0.00211698223155268,0.00356797428770574,-0.00911021183545594,0.00487624737235058,0.55297365580103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41465,0.00190706615916737,0.0032153690721711,-0.00439505722228799,0.00820918954062272,0.553118254038667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,39600,-0.00234673938468575,0.00395833757646419,-0.0101050810345556,0.00541160226518407,0.553287143751931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39250,-0.00257518088468022,0.00434500551008912,-0.0110913916844549,0.00594102991509445,0.553410528270018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39334,-0.00171044494684207,0.00289548764305867,-0.00738560072723706,0.00396471083355291,0.554715277943759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41521,0.00327042271826288,0.00557487005051048,-0.00765632258073766,0.0141971680172634,0.55745805605757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41465,0.00330871505127863,0.00566069739020666,-0.00778625183352643,0.0144036819360837,0.558889767833385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,41802,0.00386436225086972,0.00661347785249142,-0.00909805434001346,0.0168267788417529,0.559017578694981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,39655,0.00170004801130073,0.00291228506633216,-0.00400803071871031,0.00740812674131176,0.559400061334658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39334,-0.00179294487391435,0.0030767259211189,-0.00782332767930739,0.00423743793147869,0.56007760412396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41877,0.00210981863120016,0.00362077494008291,-0.00498690025136234,0.00920653751376266,0.560106456858667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41466,0.00511838100313811,0.00879785543112488,-0.0121254156418667,0.0223621776481429,0.56072777535396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41466,-0.00319920405623614,0.00549908293346674,-0.013977406605831,0.00757899849335868,0.560731490833609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,41925,0.00203473108522708,0.00352262886988776,-0.00486962149975293,0.0089390836702071,0.563532339960881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39408,0.00605463376834835,0.0104881794692026,-0.0145021979912888,0.0266114655279855,0.563761217913931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39334,-0.0023046262524755,0.00400388395633049,-0.0101522388068833,0.00554298630193225,0.564899226434867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41636,0.0057749383635557,0.0100528118520826,-0.0139285728665262,0.0254784495936376,0.565666469032964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41245,0.00199937664888617,0.00348862593758699,-0.00483833018878433,0.00883708348655668,0.566578420987107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39259,0.00216194201818334,0.00378343289764116,-0.00525358646119333,0.00957747049756001,0.567724732043465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,41698,0.00154516572921963,0.00270900580781048,-0.00376448565408891,0.00685481711252817,0.568429025412934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,39633,-0.00701369167478124,0.0123249902224295,-0.0311706725107431,0.0171432891611806,0.569325203818171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39576,0.00235389261057924,0.00414176136970693,-0.00576395967404634,0.0104717448952048,0.569821658191735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,41865,0.00224811945519124,0.00397397461636216,-0.00554087079287859,0.0100371097032611,0.571600115639555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,41836,-0.00165552578310917,0.00293691819362996,-0.0074118854426239,0.00410083387640556,0.572971344347028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39328,0.00379820038568689,0.00674630166498093,-0.00942455087767573,0.0170209516490495,0.573443364252534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,41715,0.00247603875249646,0.00442399304344782,-0.00619498761266128,0.0111470651176542,0.575704458734413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,39655,-0.00560129144160389,0.0100242807231321,-0.0252488816589428,0.0140462987757351,0.576328375751767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41534,-0.00187730995633004,0.00338496966713024,-0.00851185050390531,0.00475723059124524,0.579176710653578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39308,0.00440337600086334,0.00794478189346685,-0.0111683965103317,0.0199751485120584,0.579421006125248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41521,-0.00469550577093252,0.00847854658061632,-0.0213134570689405,0.0119224455270755,0.579718314654262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39427,0.00379794546979698,0.00687164128702594,-0.00967047145277387,0.0172663623923678,0.580481326842861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,41740,0.0028314629285029,0.00515863351314862,-0.00727945875726841,0.0129423846142742,0.583098172730777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39334,0.00213956175442741,0.0039185567046573,-0.0055408093867009,0.00981993289555572,0.585072058049461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39259,0.00435621139186615,0.00798387893442053,-0.0112921913195981,0.0200046141033304,0.585334512295773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41534,0.0021217404455163,0.00389435799790758,-0.00551120123038256,0.00975468212141516,0.585883832683413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39328,0.0023919447353393,0.00439068341663182,-0.00621379476125908,0.0109976842319377,0.585918004407444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39598,0.00214647875842301,0.00394562152501027,-0.00558693943059711,0.00987989694744314,0.586441923292394
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39420,-0.00591179979236922,0.0108678552349984,-0.027212796052966,0.0153891964682276,0.586472529028676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39241,-0.00274493510848667,0.00505211683772539,-0.0126470841104284,0.00715721389345509,0.586918290066461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41498,-0.00250327021979412,0.00461282148944718,-0.0115444003391106,0.00653785989952235,0.587361874178781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41466,0.00359223618811392,0.00662233873804026,-0.00938754773844499,0.0165720201146728,0.58752329018231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41414,-0.00338839637476552,0.00626724903979104,-0.015672204492756,0.00889541174322492,0.588757344980381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39241,-0.00148281071721046,0.002744070123078,-0.00686118815844333,0.00389556672402241,0.588953818851134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,41733,0.00383504427932926,0.00711765068984006,-0.0101155510727573,0.0177856396314158,0.590028752334637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41466,-0.00170750661300278,0.00317495247883926,-0.00793041347152772,0.00451540024552217,0.590720700188037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41805,0.00160188200735315,0.00298616998650226,-0.00425101116619127,0.00745477518089758,0.591667930307884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39250,-0.002758647825683,0.00514685277648625,-0.012846479267596,0.00732918361623005,0.591978507555953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39259,0.00280883587554992,0.00524492780418177,-0.00747122262064636,0.0130888943717462,0.592291996726214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,41765,-0.0039257387094312,0.00735660349502847,-0.018344681559687,0.0104932041408246,0.59360332278812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41764,-0.00199744306027737,0.00374313981067408,-0.00933399708919857,0.00533911096864383,0.593608154596169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39241,0.00430127818412628,0.00809445003408655,-0.0115638438826834,0.0201664002509359,0.595162347854314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,41865,-0.00160536114001103,0.00302339271644725,-0.00753121086424765,0.00432048858422558,0.595441511081842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,39600,-0.00374745221580471,0.00708902891468735,-0.0176419488885919,0.0101470444569825,0.597074879261666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39259,-0.00326473339625073,0.00617810122685152,-0.0153738118008797,0.00884434500837826,0.597207500479797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39241,-0.00365434322338206,0.00691600297771034,-0.0172097090596943,0.0099010226129302,0.597240056313274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39308,0.00440481871138868,0.008359606162509,-0.011980009367129,0.0207896467899063,0.598262133757564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41686,-0.00255459034293436,0.00490128670959133,-0.0121611122937334,0.00705193160786465,0.602230630591239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41577,0.00335818237046613,0.00644566255439675,-0.0092753162361515,0.0159916809770838,0.602376506336723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41447,-0.00340074121409321,0.00653156537495433,-0.0162026093490037,0.00940112692081727,0.602610869019471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39633,0.00779521906152294,0.0149845018468456,-0.0215744045582944,0.0371648426813403,0.602921545094715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41466,0.0029692086747483,0.00571342813171462,-0.00822911046341235,0.014167527812909,0.603288938835045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39427,0.00449607740496913,0.00866067769160987,-0.0124788508705862,0.0214710056805245,0.603675885968179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39600,-0.00640645767839733,0.0123551494078083,-0.0306225505177017,0.017809635160907,0.604102235655753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39427,0.00383414236859172,0.00739969024849998,-0.0106692505184682,0.0183375352556517,0.604364877399164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,41744,-0.00716226810473683,0.0138758404809559,-0.0343589154474104,0.0200343792379368,0.605745596011162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,39633,0.00472654860193656,0.00921268929849603,-0.0133303224231157,0.0227834196269888,0.607928261026289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39427,0.00196993461639593,0.00384730340973807,-0.00557078006669069,0.00951064929948254,0.608640484290294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39221,0.00475926315827391,0.00930240058132229,-0.0134734419811178,0.0229919682976656,0.608929956352513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39655,0.00136847133732613,0.00267695834606549,-0.00387836702096224,0.0066153096956145,0.609218552016167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39334,0.00487369452479686,0.00953814646104806,-0.0138210725388573,0.0235684615884511,0.609383466254598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39427,-0.0030944677203324,0.0060608885283711,-0.0149738092359398,0.00878487379527496,0.6096672341925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39427,-0.0015231079385058,0.00298905281253814,-0.00738165145108055,0.00433543557406894,0.610368688273709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,39589,-0.00145714685132694,0.00286751382381289,-0.00707747394600021,0.00416318024334633,0.611353534581267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39250,-0.00345023039074651,0.00681054501277047,-0.0167988986157766,0.00989843783428361,0.612445141912317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,41863,-0.00154738244189176,0.00305877144706222,-0.00754257447813371,0.0044478095943502,0.612946743526758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,41722,0.00260773210131356,0.00515904235227669,-0.00750399090914876,0.0127194551117759,0.613238484089485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39250,0.00367130093554896,0.00729057695838595,-0.0106182299028875,0.0179608317739854,0.614575430604186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41576,0.00379262802607861,0.00754496551800838,-0.0109955043892178,0.018580760441375,0.615204816473947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39625,-0.00285465615187029,0.00567980366151843,-0.0139870713284464,0.00827775902470583,0.61525719835246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,41786,0.0016555361329223,0.00331699895493402,-0.00484578181874839,0.00815685408459298,0.617712601473761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41465,-0.00170450126573887,0.00342419577508795,-0.00841592498491125,0.00500692245343351,0.618646573887267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39259,0.00628070427997955,0.0126497744207448,-0.0185128535846803,0.0310742621446394,0.619546836376258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,41738,0.00494559241340338,0.0100072325004876,-0.0146685832875524,0.0245597681143591,0.621171924323669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39334,0.00159996536080896,0.0032415698233948,-0.00475351149304484,0.00795344221466276,0.621614816622637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39334,-0.00189598901244162,0.00384804555424034,-0.00943815829875267,0.00564618027386944,0.622224193807859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39408,0.00384538896508668,0.00783007356600927,-0.0115015552242915,0.0191923331544649,0.623362094944521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39328,0.00212644580404398,0.004334416808553,-0.00636901114071989,0.0106219027488078,0.623722534866234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,41703,0.00549014632615302,0.0112197533519075,-0.0165005702435857,0.0274808628958918,0.624617259253119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39250,0.00180200142425894,0.00368578203338924,-0.00542213136118396,0.00902613420970185,0.624918224350843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39408,0.00194755000329537,0.00398359756251375,-0.00586030121923157,0.00975540122582232,0.624927897929555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,41765,-0.00213767487419709,0.00437716694264165,-0.0107169220817747,0.00644157233338054,0.625296268637154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41689,-0.00438143745149367,0.00899204611326971,-0.0220058478335023,0.013242972930515,0.626084373015142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39565,-0.00201382112717873,0.00414419117194655,-0.010136435824194,0.00610879356983651,0.627020637416241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,41697,-0.00308496986917778,0.00635620522060731,-0.0155431321015681,0.00937319236321255,0.627437811351427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41636,0.00363000249695741,0.00748417678023818,-0.0110389839923094,0.0182989889862242,0.627667742525932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41459,-0.00564680083575268,0.0116629267663257,-0.028506137297751,0.0172125356262457,0.62827580893342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39250,0.00341877527343336,0.00706712430564001,-0.0104327883656211,0.0172703389124878,0.62856783747624
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,41765,0.00202985582483296,0.00419684584860292,-0.00619596203842876,0.0102556736880947,0.62863364640349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41465,0.00240923702452705,0.00498422514534417,-0.00735984426034753,0.0121783183094016,0.628839545948795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41466,-0.00392999540604433,0.00813103592144467,-0.0198668258120759,0.0120068349999872,0.628867762380309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41740,-0.00443445717661478,0.00918604072949034,-0.0224390970064158,0.0135701826531863,0.629289337207449
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39328,0.00403588056047179,0.00836549891852742,-0.012360497319842,0.0204322584407855,0.629500770461728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39600,0.00894816218895298,0.0185836206768366,-0.0274757343376467,0.0453720587155526,0.630165067538479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,41861,0.00227019833432632,0.00471803496686483,-0.00697715020072873,0.0115175468693814,0.630400388901004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,39600,-0.00170239452627549,0.00354688596556961,-0.00865429101879193,0.00524950196624095,0.63125913679607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39625,0.00515693268030941,0.0107519496828908,-0.0159168886981566,0.0262307540587754,0.631501674609971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39259,0.00253094151300252,0.0052872751120225,-0.00783211770656158,0.0128940007325666,0.632172257572454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41689,-0.00274674322366502,0.00574205655289578,-0.0140011740673407,0.0085076876200107,0.632405327674199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39241,0.00289147515771364,0.006046332319323,-0.00895933618815944,0.0147422865035867,0.632503675097734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39334,-0.00210016148638981,0.00440197650579349,-0.010728035437745,0.00652771246496543,0.633304106223385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39241,-0.00281886071082455,0.00593955043433346,-0.0144603795621181,0.00882265814046903,0.63508783777912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,39600,0.00530621669242276,0.0111837050457963,-0.0166138451973381,0.0272262785821836,0.635181589154901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41521,-0.00389113288728625,0.00820394229075359,-0.0199708597771633,0.0121885940025908,0.635293740713985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39250,-0.00164378887518878,0.00346854115215695,-0.0084421295334164,0.00515455178303885,0.635571225163129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,41667,-0.00296805718300906,0.00626442971545866,-0.015246339425308,0.00931022505928991,0.635653822067139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39427,-0.00348283267568051,0.00739630556906521,-0.0179795915910483,0.0110139262396873,0.637730094503809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41521,-0.00426279165190161,0.00906863877016447,-0.022037323641424,0.0135117403376208,0.63832108397106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39259,0.00311798932128972,0.00665841134481466,-0.00993249691454701,0.0161684755571264,0.639595183748897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41765,-0.00415036530104406,0.00888816857361513,-0.0215711757053297,0.0132704451032416,0.640540562613876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41465,-0.00396813757516397,0.00849933737191626,-0.0206268388241198,0.0126905636737919,0.640596424248642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39259,-0.00263865217270361,0.00565253708857428,-0.0137176248663092,0.00844032052090197,0.640646458553262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41689,0.00105017816992535,0.00225249538167009,-0.00336471277814802,0.00546506911799872,0.641059510910494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39589,0.00222437446227264,0.00477242078168936,-0.0071295702698385,0.0115783191943838,0.641160789992134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39598,-0.00203287362188337,0.00437284803011115,-0.0106036557609012,0.00653790851713449,0.642022661755892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39259,0.00375072210101176,0.00811806309616035,-0.0121606815674625,0.019662125769486,0.644075118990527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39334,-0.00146843746462767,0.00319864257158776,-0.00773777690493967,0.00480090197568434,0.646184974181488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39241,0.00382560140271593,0.00835843237954378,-0.0125569260611899,0.0202081288666217,0.647181897539859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41689,0.00574592087348872,0.0125780566309506,-0.0189070701231744,0.0303989118701518,0.647807264505244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39334,-0.00100556645636953,0.0022124047955557,-0.00534187985565871,0.00333074694291964,0.649468920715267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39328,-0.00204982783434494,0.00452293010143644,-0.0109147708331604,0.00681511516447048,0.650408181557812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39600,-0.00506222747347173,0.0112478507961841,-0.0271080150339926,0.0169835600870491,0.652674781237771
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,41832,-0.0028334079985254,0.00631672631263525,-0.0152141915712905,0.00954737557423968,0.653759038677992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,41732,-0.00142605354109024,0.00318289646057872,-0.00766453060382453,0.00481242352164405,0.654134302378298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39250,-0.0015809316714433,0.00355824125548684,-0.0085550845321975,0.0053932211893109,0.656833696556845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39427,-0.00357656193293767,0.00805696399599249,-0.0193682113650829,0.0122150874992076,0.657116970203016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39328,0.00313224546846445,0.00706079768894726,-0.0107069180018722,0.0169714089388011,0.657333008215458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41662,-0.00136113310009113,0.00307117918657542,-0.00738064430577895,0.00465837810559669,0.657631601651199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41521,-0.00109221848120634,0.00247355700996425,-0.00594039022073626,0.00375595325832359,0.658816589695298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41534,0.00333518495110962,0.00760826617479953,-0.0115770167514975,0.0182473866537167,0.661130240288166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,41802,0.00517103306527726,0.0118366482914743,-0.0180287975860123,0.0283708637165668,0.662215438437787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,41819,0.00120501306749216,0.00276144914301228,-0.00420742725281191,0.00661745338779622,0.662575558146844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39361,0.00403224896546926,0.00925762560846143,-0.0141126972271151,0.0221771951580537,0.663164925377954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,41740,0.00321431292594497,0.00738192891705494,-0.0112542677514827,0.0176828936033726,0.663257528226865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39241,-0.00124498053647209,0.00287189726705788,-0.00687389917990554,0.00438393810696136,0.664657047795243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41466,-0.00318822255881008,0.00737815560805676,-0.0176494075506013,0.0112729624329812,0.66566400623792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41354,-0.00574708305095153,0.0133669263770828,-0.0319462587500338,0.0204520926481307,0.667240743199729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39408,0.00384118187126864,0.00901516476973141,-0.0138285410774049,0.0215109048199422,0.670058000363797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39308,0.00420774256346401,0.00988263399377933,-0.0151622200643435,0.0235777051912715,0.67028301173643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41466,0.00276404970752329,0.00650492108226304,-0.00998559561371226,0.0155136950287588,0.670904493939772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,41846,0.00171188805478607,0.00404690241212508,-0.00622004067297909,0.00964381678255123,0.672293414206518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,41740,0.0031107847596242,0.00741545513380709,-0.0114235073026377,0.0176450768218861,0.674857481576567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39598,-0.00252378823551233,0.00604404758217999,-0.0143701214965851,0.00932254502556044,0.676272676062684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,41805,-0.00396160384493304,0.00951522031572697,-0.0226114356637579,0.0146882279738918,0.67716514676187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39328,0.00162510777085837,0.00392242085401538,-0.00606283710301177,0.00931305264472851,0.678653584903515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,41740,0.00247207059255697,0.00597348037517805,-0.00923595094279202,0.014180092127906,0.67899737067913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39633,-0.00282331227774903,0.00682383758689178,-0.0161980339480569,0.0105514093925589,0.679070670097626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39259,-0.00144330681407444,0.00349276964657149,-0.00828913532135455,0.00540252169320568,0.679448601484695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39625,-0.00119325662566023,0.00288983810439804,-0.00685733931028038,0.00447082605895992,0.6796771424687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,41765,-0.00147818523031487,0.00359830807546549,-0.00853086905822722,0.00557449859759749,0.681225823525655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39334,0.00274099461623031,0.00667256564983477,-0.0103372340574458,0.0158192232899065,0.681237872420453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",41805,0.00123388305515796,0.00301084086860736,-0.00466736504731247,0.0071351311576284,0.681949453772407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39241,-0.00276111526345255,0.0067380552380147,-0.0159677035299614,0.0104454730030563,0.681976133261007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,41744,0.00120993925066147,0.00295822267544348,-0.00458817719320776,0.0070080556945307,0.68253983138501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39334,0.00282175052048144,0.00693914762966992,-0.0107789788336716,0.0164224798746345,0.684278877698943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39328,0.00161207726731827,0.00397686886547947,-0.00618258570902149,0.00940674024365803,0.685218459573431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39625,0.00269848044123135,0.00666100208037985,-0.0103570836363132,0.0157540445187759,0.685399894137043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39600,-0.00131120876105099,0.00325402973257657,-0.00768910703690107,0.00506668951479908,0.686993408207675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39259,0.00187918729123829,0.0047176655600896,-0.00736743720653733,0.0111258117890139,0.690394994983393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,39650,-0.00063913362696068,0.00160478293275353,-0.00378450817515759,0.00250624092123623,0.690440368998238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39598,0.00118526249227553,0.00298549926728038,-0.00466631607159402,0.00703684105614507,0.691370401303542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,41802,0.00105556786441641,0.00266013048939406,-0.00415828789479595,0.00626942362362876,0.691513578330352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,41925,0.00376071285830197,0.0094857891879645,-0.0148314339501084,0.0223528596667124,0.691773857317469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39600,-0.0035452691961746,0.0091325557330376,-0.0214450784329283,0.0143545400405791,0.697874649339555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39241,-0.00272760019609547,0.00705864756253571,-0.0165625494186655,0.0111073490264745,0.699193617869937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39259,0.00180034943964381,0.0046641167505148,-0.00734131939136519,0.0109420182706528,0.69950431331082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41465,0.00370203310684963,0.00959926764393281,-0.0151125314752587,0.0225165976889579,0.699756445433606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41899,-0.00158471206296289,0.00413761817629574,-0.00969444368850254,0.00652501956257676,0.701725114638162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39241,0.00151138383935974,0.00394868864044252,-0.0062280458959076,0.00925081357462709,0.701908414152302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39250,0.00144622607812485,0.0037897137069479,-0.00598161278749303,0.00887406494374274,0.702751734907673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,39598,-0.000890994272359356,0.00235701352838451,-0.005510740787993,0.00372875224327429,0.705424286956589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39334,-0.00417191130643085,0.0110407125177788,-0.0258117078412773,0.0174678852284156,0.705537516458312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41521,-0.00229077202625201,0.00607922139839067,-0.0142060459670977,0.00962450191459372,0.70631358669255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39589,-0.00156204777638258,0.00415421276930306,-0.00970430480421659,0.00658020925145142,0.7069127415669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39241,0.00286911446973013,0.00768441041205256,-0.0121923299378929,0.0179305588773531,0.708881862782116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39250,0.00224247851349961,0.0060169494083377,-0.00955074232684229,0.0140356993538415,0.709383919614754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39241,0.00368965760814611,0.00992722206128634,-0.0157676976319751,0.0231470128482673,0.710145440324014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,39633,0.00172639092484582,0.00466492673697708,-0.00741686547962925,0.0108696473293209,0.711330811632291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41764,0.0012515507638373,0.003410606156701,-0.00543323730329666,0.00793633883097125,0.713655906294527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,41765,-0.0010653099979009,0.00291461040701185,-0.00677794639564412,0.00464732639984232,0.714738984783485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,41740,0.00146939799226052,0.00402398236851218,-0.00641760745002335,0.00935640343454439,0.714997742652421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39308,-0.000923257761010025,0.00254435154744049,-0.00591018679399338,0.00406367127197333,0.716712414766776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39308,0.00287097037780631,0.00793819746081277,-0.0126878966453867,0.0184298374009993,0.717609314451199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39385,-0.00406467528730315,0.0112431173773555,-0.0261011853469199,0.0179718347723136,0.717713617929061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41465,-0.00209966659860304,0.00581041004776972,-0.0134880702922317,0.00928873709502562,0.7178341158603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,41765,0.00262210135855655,0.00726141513721674,-0.0116102723103883,0.0168544750275014,0.718030039443456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39427,0.0027669662183258,0.00767576736159109,-0.0122775378103927,0.0178114702470443,0.718494697093703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,41877,0.00429692369031587,0.0119404870075415,-0.0191064308444654,0.0277002782250972,0.718956299987682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39427,0.0015572268554699,0.00433200125622543,-0.00693349560673194,0.0100479493176718,0.719250118939833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39259,0.0031731708545813,0.00892702236323939,-0.0143237929773679,0.0206701346865305,0.72225443241203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39259,0.00278568196536965,0.00787820040508303,-0.0126555908285931,0.0182269547593324,0.723650395817404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39259,0.0028183735817475,0.00798788728410003,-0.0128378854950886,0.0184746326585836,0.724222182040992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,41836,0.00253555850998864,0.00718745290826203,-0.0115518491902049,0.0166229662101822,0.724262243023047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39328,0.00192690202020288,0.00546855587559295,-0.0087914674959593,0.0126452715363651,0.724574988527308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41614,0.00127174802842321,0.00362605414844386,-0.00583531810252676,0.00837881415937318,0.72580030628153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39250,-0.00148030746644765,0.00422701873991429,-0.00976526419667966,0.00680464926378436,0.726194555199313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39241,-0.00323473955820253,0.00923861119541444,-0.0213424175012148,0.0148729383848098,0.726246067371573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,41805,-0.000810003289328958,0.00233188710866145,-0.00538050202230539,0.00376049544364748,0.728326743437756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39328,-0.00181136402200906,0.00521888763941155,-0.0120403837952557,0.00841765575123757,0.728539105987664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39600,0.00294130358048064,0.00847677321148637,-0.0136731719140326,0.0195557790749939,0.728610073877978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39250,0.00136535205395827,0.00395456222713935,-0.00638558991123485,0.0091162940191514,0.729905752921363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,41758,-0.00131111957959538,0.00381380871037452,-0.00878618465192945,0.00616394549273868,0.731015574645864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39328,-0.00104910958260724,0.00305354089937491,-0.00703404974538207,0.00493583058016758,0.73117530484318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39328,-0.00148959432458254,0.00433806902196277,-0.00999220960762956,0.00701302095846449,0.731321381141976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41666,0.00122964367322413,0.0035864545235905,-0.00579980719301326,0.00825909453946152,0.731711005020903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41562,-0.00125251969999618,0.00365847886704736,-0.00842313827940901,0.00591809887941666,0.732084946670185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39625,0.00395580749733325,0.0115711516673956,-0.018723649770762,0.0266352647654285,0.732456682239143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,39589,0.00170917281850323,0.00500096024680619,-0.00809270926523691,0.0115110549022434,0.732531330743319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,41925,0.00127465927296586,0.0037431078516367,-0.00606183211624206,0.00861115066217378,0.733459029965003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41534,-0.00137403397202261,0.00405156444639411,-0.00931510028695507,0.00656703234290985,0.734512299839822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41328,0.00307110968572827,0.00909082317441777,-0.0147469037361306,0.0208891231075871,0.735500445851749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,41758,0.000892867086214733,0.00264406080366952,-0.00428949208897752,0.00607522626140699,0.735603853375512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39589,-0.00273921886909417,0.00817643802973857,-0.0187650374073818,0.0132865996691934,0.737621135833255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41865,0.00100617209807705,0.00301081006685417,-0.00489501563295712,0.00690735982911122,0.738244108554788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39259,-0.00212158701578779,0.00637837759405422,-0.0146232071001341,0.0103800330685585,0.739426376471107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39250,-0.00139631914569369,0.00420771376880565,-0.00964343813255276,0.00685079984116538,0.740010971773489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39625,0.00101962771451191,0.00307468452032729,-0.00500675394532956,0.00704600937435339,0.740182314098871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,41758,-0.0012138667055411,0.00366672575852115,-0.00840064919224254,0.00597291578116035,0.740612578402593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41521,0.00117037986569018,0.00356271538387072,-0.00581254228669643,0.00815330201807678,0.742533055736648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39334,-0.00106420861589494,0.0032399817814522,-0.00741457290754125,0.00528615567575136,0.742569310649289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39250,0.00169751432462996,0.00519286789915626,-0.00848050675771631,0.0118755354069762,0.743754925499652
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39600,-0.00237776262888843,0.00728988772854794,-0.0166659425768424,0.0119104173190655,0.744299872462219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39259,0.00326047581202005,0.00999980931315816,-0.0163391504417699,0.02286010206581,0.744390052684689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41534,0.00483649383706625,0.0148583610362884,-0.024285893794059,0.0339588814681915,0.744802991668341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39328,0.00176819969361269,0.00543460977651242,-0.00888363546835167,0.012420034855577,0.744915658690238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41802,-0.00122586594853832,0.0037771344851665,-0.00862904953946465,0.00617731764238802,0.745527427444759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,39589,-0.00199923088721894,0.00617134763283419,-0.0140950722475739,0.0100966104731361,0.745979254332932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39600,-0.00172643467697309,0.00533381488589315,-0.0121807118533237,0.00872784249937748,0.746188529425053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39334,0.00242204681333136,0.00751106575701936,-0.0122996420704266,0.0171437356970893,0.747107637207579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39241,-0.00204431035880778,0.00634350480826202,-0.0144775797830013,0.0103889590653858,0.747255795144617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,41740,0.00229772350396468,0.0071411116075998,-0.0116988552469309,0.0162943022548603,0.747639697744148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39589,-0.00215339518577007,0.00670575759166819,-0.0152966800654397,0.0109898896938996,0.748120780382023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39427,-0.00165106652374377,0.00515755974409027,-0.0117598836221607,0.00845775057467315,0.748879353798116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39650,-0.000564851173609595,0.00178240627665511,-0.00405836747585361,0.00292866512863442,0.751322648605049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,39589,0.0014512161694896,0.0046058260773691,-0.00757620294215383,0.010478635281133,0.752704837253773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39241,-0.00171249151903322,0.00544976312255626,-0.0123940272392435,0.00896904420117704,0.753350783941507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41465,-0.00543906136801295,0.0174165921146968,-0.0395755819128187,0.0286974591767928,0.754823725007072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39334,-0.00198253694984321,0.00636840768189841,-0.0144646160063641,0.0104995421066777,0.755572449110253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41758,-0.00103653022344526,0.00334320522169234,-0.00758921245796225,0.00551615201107172,0.756534794260387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39328,0.00169507844614656,0.00548555561255686,-0.00905661055446489,0.012446767446758,0.757321736299454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,41765,0.000948646538889306,0.00307029834707693,-0.00506913822138147,0.00696643129916008,0.757345159109789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,41765,0.00427925702352147,0.0139239122662574,-0.0230116110183431,0.031570125065386,0.758595912946114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39600,-0.00180588159282185,0.00587803754810659,-0.0133268351871108,0.00971507200146707,0.758677738567155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,39596,-0.00102785706639471,0.00335142702383737,-0.00759665403311595,0.00554093990032654,0.759083351962321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41465,0.00277983221562752,0.00908717627540219,-0.0150310332841608,0.0205906977154158,0.7596802899816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39408,-0.0014325921521749,0.0047043903472729,-0.0106531972328298,0.00778801292847999,0.760735807008374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39250,-0.00346025685533028,0.0114253645298648,-0.0258539713338653,0.0189334576232048,0.762004408449455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41911,-0.00129535971508025,0.00428733183421363,-0.00969853011013896,0.00710781067997846,0.762552679497941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39427,-0.00130392582384808,0.00433536468713156,-0.00980124061062595,0.00719338896292978,0.763599498357878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39633,0.00272114703427584,0.00906362010094658,-0.0150435483635795,0.0204858424321311,0.764009368073301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39408,0.00282264162315214,0.00942693549696759,-0.0156541519509043,0.0212994351972086,0.76462304718577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,39589,0.00249741160796636,0.00837750639922346,-0.0139225009345116,0.0189173241504443,0.765625467220301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39427,-0.00143845630586634,0.00483421403423475,-0.0109135158129664,0.00803660320123377,0.766046678095337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41637,-0.00188465783830727,0.006340960367477,-0.0143129401585622,0.0105436244819476,0.766303578247697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41534,0.00162329218318003,0.00552613828835912,-0.00920793886200385,0.0124545232283639,0.76895517044525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41466,0.000876799664461015,0.00300584197686423,-0.00501465061019288,0.00676824993911491,0.770521841532808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39259,0.00235770437075122,0.00812307652675438,-0.0135635256216874,0.0182789343631898,0.771632384290383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39625,-0.00110762233626541,0.0038340158168346,-0.00862229333726122,0.00640704866473041,0.772668292011348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41465,-0.00150096137818723,0.00521063269756732,-0.0117138014654192,0.00871187870904471,0.773307430840748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41466,-0.00122224320695243,0.00430271620189935,-0.00965556696267516,0.00721108054877029,0.776366541520082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39308,-0.0018784205924531,0.00661668408016114,-0.0148471213895689,0.0110902802046627,0.776498993550743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39625,0.00217287955069763,0.00767919571953034,-0.0128783440595818,0.0172241031609771,0.777215374555408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41465,-0.00238296255132289,0.00842793127011771,-0.0189017078407536,0.0141357827381078,0.777376218944955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39241,0.00190397493855952,0.0068069063737945,-0.0114375615540777,0.0152455114311967,0.779703733723577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41521,0.00231602351182424,0.00830079517368284,-0.0139535350285941,0.0185855820522426,0.780239891590302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39427,0.00153877935312175,0.00557688262776527,-0.00939191059729817,0.0124694693035417,0.782613965886649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39598,0.00114425889961215,0.00415326238136369,-0.00699613536786069,0.00928465316708499,0.782930807269869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41465,0.00231205086891665,0.00847718321632948,-0.0143032282350891,0.0189273299729224,0.785058920177658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,41650,0.00136292399481207,0.0049987998976854,-0.00843472380465132,0.0111605717942755,0.785126401989552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,41747,-0.0022444527416256,0.00828480986824954,-0.0184826800833947,0.0139937746001435,0.786463123398083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39328,0.0019654559469236,0.00726786939893205,-0.0122795680749832,0.0162104799688304,0.786834027375255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39328,-0.00174782966873595,0.00648838084319791,-0.0144650561214039,0.0109693967839319,0.787643684778338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39334,0.00121445929710726,0.00454102642293782,-0.00768595249185087,0.0101148710860654,0.78913432426904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,41786,-0.00251009153880408,0.00940064382632007,-0.0209353534383914,0.0159151703607833,0.789463538041276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41465,-0.00149338587817553,0.0055957116901309,-0.0124609807908321,0.00947420903448104,0.78956551126795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39598,-0.00306810557423185,0.0115764611010891,-0.0257579693323666,0.0196217581839029,0.790991578428238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39259,-0.00154367982184728,0.00583722778527616,-0.0129846462809885,0.00989728663729399,0.791435009875209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41521,0.00133663809176405,0.00514012346820263,-0.00873800390591312,0.0114112800894412,0.794837004662794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39308,0.00120508831685981,0.00472241888143442,-0.00805085269075166,0.0104610293244713,0.798585467705064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41466,-0.00105960495776697,0.00418529685137493,-0.00926278678646185,0.0071435768709279,0.800138427468132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,41786,-0.00089049713248189,0.00352151049175776,-0.00779265769632711,0.00601166343136333,0.80036981129816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39241,-0.00180492845228987,0.0071499820973314,-0.0158188933630594,0.0122090364584797,0.800707269491612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,41689,-0.000777427054279129,0.00308758803858424,-0.00682909960990424,0.00527424550134598,0.801206523644419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39241,0.00146052255914095,0.00582013914152147,-0.00994695015824113,0.012867995276523,0.80186310588627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,41865,0.000791291240461032,0.00315692349075155,-0.00539627880141201,0.00697886128233408,0.802086553590332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39259,0.00292521651050575,0.0117216599434084,-0.0200492369785748,0.0258996699995863,0.802935145780911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,41765,0.00216862259301622,0.0086970194881863,-0.0148775356038289,0.0192147807898614,0.803092099746865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39241,-0.00140459348307789,0.00563318169368689,-0.0124456296027042,0.00963644263654842,0.803100413935699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,41758,0.00080783668268758,0.00325358232455786,-0.00556918467344582,0.00718485803882098,0.803912786280022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39259,-0.00146567872179377,0.0059287084627444,-0.0130859473087728,0.0101545898651853,0.804744893930843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39250,-0.00266177085538029,0.0109151699186438,-0.0240555038959221,0.0187319621851615,0.807344122664194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41686,-0.000779009973542348,0.00320091991324122,-0.00705281300349514,0.00549479305641044,0.807722089733774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39399,0.000548457831744014,0.00227159240742464,-0.00390386328680829,0.00500077895029631,0.809217142127601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39600,-0.00231638318700179,0.00960210542798688,-0.0211365098258561,0.0165037434518525,0.809375925528627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39655,0.00096445498495754,0.00400118892404017,-0.00687787530616119,0.00880678527607627,0.809526956529721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39301,0.00173685052332648,0.00720882415507592,-0.0123924448206223,0.0158661458672753,0.809610919779599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,41896,0.00134589977161833,0.00562239805101773,-0.00967400040837642,0.0123657999516131,0.810813230300401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,41925,0.000837828229099565,0.00351106105357678,-0.00604385143591092,0.00771950789411005,0.811399763540069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39334,-0.00077264285848271,0.00326158353036759,-0.00716534657800318,0.00562006086103776,0.812745141508642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,41740,0.000880507003533348,0.00372974515546939,-0.00642979350118666,0.00819080750825335,0.813376609435311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41534,0.00129260364938369,0.00549207034950047,-0.00947185423563722,0.0120570615344046,0.813934472678869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39241,-0.000981943080298551,0.00421285454341701,-0.00923913798539589,0.00727525182479878,0.81570175100913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39328,-0.00092244228935794,0.00397044807730095,-0.00870452052086781,0.00685963594215193,0.816288474978284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39334,0.000671123420979918,0.00289102114930409,-0.0049952780316561,0.00633752487361593,0.816433227381095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39334,0.00136184765301497,0.00588101533707878,-0.0101649424076594,0.0128886377136894,0.816878943299441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39259,-0.00228073589397536,0.00987857462497587,-0.0216427421589281,0.0170812703709773,0.817414773231944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39600,0.00118491872835828,0.00519230891433686,-0.00899200674374197,0.0113618442004585,0.819489937691985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39241,-0.00129085902906249,0.00566697468605146,-0.0123981294137233,0.00981641135559837,0.819816777097266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39250,-0.000991417955984606,0.00438325639678371,-0.00958260049368067,0.00759976458171146,0.821063454896443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,39600,-0.0015105928969432,0.00674182679824023,-0.014724573421494,0.0117033876276077,0.822712563650733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39063,0.000581541378257391,0.00261286814303917,-0.00453968018209938,0.00570276293861416,0.823875927088591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39427,-0.00183058503505231,0.00825619808372319,-0.0180127332791498,0.0143515632090451,0.824534080518432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,39600,0.00188543922805408,0.00851411254708607,-0.0148022213642346,0.0185730998203428,0.824747180298782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39193,0.000821265246346681,0.00370969208412324,-0.00644973123853488,0.00809226173122824,0.824797973986783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39250,-0.000942740537118922,0.00426361368493657,-0.0092994233595946,0.00741394228535676,0.825008664413959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39250,-0.00078474018777374,0.0035621553756251,-0.00776656472399893,0.00619708434845145,0.825642320252596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39600,0.000571860272075479,0.0026082979757921,-0.00454040376047703,0.00568412430462798,0.826462081740048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41466,-0.00131434769783727,0.00599799980843291,-0.0130704273223658,0.0104417319266912,0.826551478797721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41617,-0.00229245579143082,0.0104693220614599,-0.0228123270318922,0.0182274154490305,0.826677717812964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39328,-0.00152110772027191,0.00696702097462619,-0.0151764688305393,0.0121342533899954,0.827176374608174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39545,0.00111319547306274,0.00510772836512957,-0.00889795212259123,0.0111243430687167,0.827477306980471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,41740,0.00210538107200115,0.00966886560427708,-0.0168455955123819,0.0210563576563842,0.827628446547717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41521,-0.00112852495820252,0.0052400770245748,-0.0113990759263691,0.00914202600996409,0.829486784189702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39397,0.000763973516617196,0.00360566078029167,-0.00630312161275449,0.00783106864598888,0.832203331236871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41636,0.00226460250605471,0.0107446137034999,-0.0187948403528052,0.0233240453649146,0.833072928568228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,41636,0.00127041017711974,0.0060621583531166,-0.0106114201949888,0.0131522405492283,0.834011251175549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,41694,-0.000985471836052522,0.00472518279197472,-0.010246830108323,0.00827588643621793,0.834797013288278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39328,-0.000704992794142834,0.0033889765809016,-0.00734738689270996,0.00593740130442429,0.835213179252248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,41836,0.000660734898976211,0.00318118135553687,-0.00557438055787605,0.00689585035582847,0.835465546301609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,41925,0.00160540828950775,0.00773892018534386,-0.0135628752737662,0.0167736918527817,0.835664705588933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41689,0.000761185371395637,0.00367928664798945,-0.00645021645866368,0.00797258720145495,0.836103706030818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39250,0.000845120610395168,0.00413813465222606,-0.00726562330796791,0.00895586452875825,0.838179678372108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,41802,-0.00173167665658959,0.00857387687055403,-0.0185364753228755,0.0150731220096963,0.839942309582663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41465,-0.00288880375151247,0.01435121000518,-0.0310171753616652,0.0252395678586403,0.840472351023534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39308,-0.000463266735598424,0.00231823161681361,-0.0050070007045531,0.00408046723335625,0.841612436734281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39408,0.00225629848208205,0.0113451903826644,-0.0199802746679401,0.0244928716321042,0.842362629632353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39259,-0.00213009391082389,0.0107160886264245,-0.023133627618616,0.0188734397969682,0.842442296227722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,41805,0.000890218764305399,0.00447964832024149,-0.00788989194336793,0.00967032947197873,0.842480812430566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41689,-0.00154861013063089,0.00780509188554569,-0.0168465902263004,0.0137493699650387,0.842727190151085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39381,0.00109783472158998,0.00557461510249682,-0.0098284108793038,0.0120240803224837,0.843882411528689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39427,-0.00146957851561385,0.00749567162440555,-0.0161610948994487,0.013221937868221,0.844569270776106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41466,-0.00230343290900894,0.0120077951486904,-0.0258387114004422,0.0212318455824243,0.847879861522348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41465,0.00156475631082185,0.00820053794353972,-0.014508298058516,0.0176378106801597,0.848676350091061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39259,0.00152323877145872,0.00805956747995451,-0.0142735134892521,0.0173199910321696,0.85009830968703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,41750,-0.000625747676678418,0.00338974306201079,-0.00726964407821958,0.00601814872486274,0.853545376338207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39598,0.00197648651997703,0.0107106548921421,-0.0190163970686215,0.0229693701085755,0.853597481153166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,39598,-0.000568522224562999,0.00310788794624283,-0.00665998259919895,0.00552293815007295,0.854857253880373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39334,0.00146076948602213,0.00800709181455378,-0.0142331304705033,0.0171546694425475,0.855245228126722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39259,-0.00121349050714417,0.00665975401586969,-0.0142666083782488,0.0118396273639604,0.855419419443197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39334,0.00121944300906281,0.00672508774978886,-0.0119617289805234,0.014400614998649,0.856113985217926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,39625,0.000579030567989528,0.00325243356020486,-0.005795739210012,0.00695380034599105,0.858702729470748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,41765,0.00124276973154635,0.00712144117747165,-0.0127152549762981,0.0152007944393908,0.861466580015282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39250,0.00093831112972134,0.00539805641728547,-0.00964187944815817,0.0115185017076009,0.862007177523634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39334,-0.0013005837576338,0.00776245395706537,-0.0165149935134819,0.0139138259982143,0.866942026673421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41802,0.00128922346852979,0.00774907427845723,-0.0138989621172464,0.016477409054306,0.867867315670584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39427,0.00124663529826386,0.0075818517257842,-0.0136137940842732,0.0161070646808009,0.869400761564588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41521,0.000479493838038568,0.00296949353096026,-0.00534071348264353,0.00629970115872067,0.871723185204539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,39598,0.00147389165773226,0.00915731230719488,-0.0164744404643697,0.0194222237798342,0.872133824547691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41765,-0.000556419883303801,0.00347629680482795,-0.00736996162076658,0.00625712185415898,0.872835401006294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39259,-0.0016788685325308,0.0105104406509958,-0.0222793322084827,0.0189215951434211,0.873094107525276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39598,0.00171905416228888,0.0107872659615074,-0.0194239871222656,0.0228620954468434,0.873388509445698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39334,0.000871034157739971,0.00551925829815952,-0.00994671210665269,0.0116887804221326,0.874603775283876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39328,-0.00175008563529942,0.0112254151743792,-0.0237518993770826,0.0202517281064837,0.876111730449218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39250,-0.000793620921723673,0.00509586988955347,-0.0107815259052485,0.00919428406180113,0.876242442454473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39082,0.00118339095154725,0.00763620461814527,-0.0137835701000175,0.016150352003112,0.876847092753664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39408,-0.000439187530826062,0.00284450750115741,-0.00601442223309458,0.00513604717144246,0.877298463704052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,41925,0.000389526097922288,0.00252863441880773,-0.00456659736294087,0.00534564955878544,0.87757577352963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41350,0.000437030093493448,0.00284394761952411,-0.00513710724077381,0.0060111674277607,0.877872188534201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41597,-0.00092387231750354,0.00601408683325147,-0.0127114825106764,0.0108637378756693,0.877913285627731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41840,0.000502638191262744,0.00327239728505116,-0.00591126048743754,0.00691653686996302,0.877927967402021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41805,-0.000721060065890822,0.0047273693606682,-0.00998670401280049,0.00854458388101885,0.878772192401739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39600,-0.000553482518147459,0.00365438603038617,-0.00771607913770435,0.00660911410140944,0.879617968540665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41534,-0.000551795185271812,0.0036572160417039,-0.00771993862701146,0.00661634825646784,0.880073932118118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39328,-0.000509815063055906,0.00339085843345628,-0.00715589759263022,0.00613626746651841,0.880491430435444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,41865,-0.00111196728031007,0.00742473740182011,-0.0156644525878775,0.0134405180272573,0.88095214307826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41521,0.000752065707054545,0.00504216655901297,-0.00913058074861088,0.01063471216272,0.881433443407306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39259,-0.00084445021910967,0.00566414904552769,-0.011946182348344,0.0102572819101246,0.881487911412937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39633,-0.000484162107971684,0.00327023361184276,-0.0068938199871835,0.00592549577124013,0.882305043670839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,39604,-0.0005112418102099,0.00349422402420922,-0.00735992089765997,0.00633743727724017,0.883678924343293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41408,0.00100139622858843,0.00685212432225185,-0.0124287674430252,0.014431559900202,0.883810084623514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,41704,0.00041528433914352,0.00286660257565216,-0.0052032567091347,0.00603382538742174,0.884815844601853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39241,0.000651023850616869,0.00454371157944792,-0.00825465084510106,0.0095566985463348,0.886071614821598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39259,0.0010289146609062,0.00722364214618159,-0.0131294239456097,0.0151872532674221,0.886737449280641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39250,-0.000686476057895564,0.00483845630943409,-0.0101698504243864,0.00879689830859525,0.887178148982687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39258,-0.000848706528822172,0.00604942818321516,-0.0127055857679239,0.0110081727102796,0.888429304374442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41465,-0.000755352711914138,0.00540886126458117,-0.0113567207904932,0.00984601536666495,0.888937954506489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,38964,-0.00166053527001244,0.0119985915240718,-0.0251777746571931,0.0218567041171683,0.889931582867127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39600,0.00126832428473424,0.00921343308367725,-0.0167900045592732,0.0193266531287416,0.89051138854212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,41744,-0.000345458884847443,0.00253227194925599,-0.00530871190538919,0.0046177941356943,0.89148937219775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41465,-0.000519147231605778,0.00383445797127411,-0.00803468485530303,0.00699639039209147,0.892305655179334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39259,-0.000869151936620272,0.00643136138164263,-0.0134746202446398,0.0117363163713993,0.892501553366625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41617,0.00105385230938361,0.00802724362488173,-0.0146795451953846,0.0167872498141518,0.895552316863121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39250,0.000883718937252499,0.00676662894636293,-0.0123788737976189,0.0141463116721238,0.896094537106653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39250,-0.000886006597578129,0.00680395780948427,-0.0142217639041673,0.012449750709011,0.896395387731097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41465,0.000725952599598016,0.00563778598354891,-0.0103241079281579,0.0117760131273539,0.89754518036349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39598,0.000659802628845086,0.00517275275185372,-0.00947879276478821,0.0107983980224784,0.898504677727778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39427,-0.000779926564776805,0.00626158674343459,-0.0130526365819086,0.011492783452355,0.900876318449347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41689,0.00113053167257378,0.00913037204128545,-0.0167649975283457,0.0190260608734933,0.901458916184313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41689,0.000460111889761842,0.00373541164427344,-0.00686129493301411,0.00778151871253779,0.901969870329492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39476,-0.000746457295543206,0.0060655672577509,-0.012634969120735,0.0111420545296486,0.902058127481084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39241,-0.000413638577415324,0.00337419281828265,-0.00702705650124932,0.00619977934641867,0.9024349617079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41511,-0.00115889613440658,0.00954640005885024,-0.0198698402497531,0.0175520479809399,0.903379161930202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39334,-0.000381841339913866,0.00318021037214704,-0.00661505366932207,0.00585137098949434,0.904431568006961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,41802,-0.000545166105017434,0.00454287480586593,-0.00944920072451466,0.00835886851447979,0.904481289793345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39600,0.000483924238443339,0.00404404909308285,-0.00744241198399905,0.00841026046088573,0.904752063236088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41466,-0.000712366973855321,0.005962706619626,-0.0123992719483223,0.0109745380006116,0.904904550885341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41447,-0.00059745661869708,0.00503997725971638,-0.0104758120477412,0.00928089881034702,0.905638871709845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39408,0.000390553536961647,0.00330601718284102,-0.00608924014140676,0.00687034721533005,0.905963558687051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41534,0.000477395448890635,0.00404831359016533,-0.00745729918783342,0.00841209008561469,0.906129293464915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39427,0.000801364046269481,0.00684303953941001,-0.0126109934509741,0.0142137215435131,0.906777873152077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39259,-0.000437507042552559,0.00373739489839893,-0.00776280104341446,0.00688778695830934,0.906813102118408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41521,0.00061080310643983,0.00523166547131103,-0.00964326121732978,0.0108648674302094,0.907059047927254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39420,-0.00123604771772435,0.0107278661447869,-0.0222626653615067,0.019790569926058,0.908274142023131
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39241,-0.000901393701653628,0.00789270389597801,-0.0163710933377705,0.0145683059344633,0.909076694510117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,39598,0.00032418931255079,0.00287665383829291,-0.00531405221050331,0.00596243083560489,0.910273097037018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39598,-0.000306608823239312,0.00274295652786643,-0.00568280361785752,0.00506958597137889,0.910999555422725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39600,0.000798279436637734,0.0071714545510756,-0.0132577714834704,0.0148543303567459,0.911369811181881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39334,0.000678770242475527,0.00615996982013341,-0.0113947706049859,0.012752311089937,0.912260344942675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39250,-0.000551099614980189,0.00508356476491523,-0.010514886554214,0.00941268732425366,0.913674015641391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,41865,0.000325649419670509,0.00306247719778104,-0.00567680588798033,0.00632810472732135,0.915317936037572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39259,0.000598727721005696,0.00565587397189694,-0.0104867852639123,0.0116842407059237,0.915695857631176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39595,0.000223890727458042,0.00215174544887878,-0.00399353035234437,0.00444131180726046,0.917130972343847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39427,0.0005039715635404,0.00485015227822957,-0.00900232690178956,0.0100102700288704,0.917243965453498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41744,-0.000432051958098506,0.00427729215613497,-0.00881554458412304,0.00795144066792603,0.919543565693149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39250,0.000463164822884122,0.00460128648731377,-0.00855535669225087,0.00948168633801912,0.919822376640546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39250,-0.000422310643614208,0.00428243806393191,-0.00881588924892076,0.00797126796169234,0.921446183950627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39241,0.00081428974298054,0.00843710306418878,-0.0157224322628295,0.0173510117487905,0.923115003394559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39427,0.000776241215361606,0.00805613873441394,-0.0150137907040897,0.0165662731348129,0.923241205751738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41466,0.000759334573065333,0.00792974041871311,-0.0147829566476124,0.016301625793743,0.923714417739881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41466,0.000427039401876863,0.00450150341148302,-0.00839590728462986,0.00924998608838359,0.924422779045532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39250,0.000934914064068965,0.00996273655131229,-0.0185920495765031,0.0204618777046411,0.925237155330482
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39334,-0.000248433540611654,0.00279409407926962,-0.00572485793598011,0.0052279908547568,0.929152069693865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39250,-0.000489623708661271,0.00551145740542377,-0.0112920802232919,0.0103128328059693,0.929212781246308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41070,0.00039316790654615,0.00452764462885304,-0.0084810155660058,0.0092673513790981,0.930802325494066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41534,-0.000871569595153772,0.010144368266926,-0.0207545313983287,0.0190113922080211,0.931534048070749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39408,0.000262110599454396,0.00306456754051151,-0.00574444177994816,0.00626866297885695,0.931842113632222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39334,-0.000351946220550664,0.00412663116736915,-0.0084401433085942,0.00773625086749288,0.932035158314464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39589,-0.000328993879529497,0.00390665305317911,-0.00798603386376056,0.00732804610470157,0.932888025007489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39427,0.000370014800218107,0.00444103402326916,-0.00833441188538944,0.00907444148582565,0.933600814315491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,41740,-0.000819045718404451,0.00986904682096549,-0.0201623774874968,0.0185242860506879,0.933859665662651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,41689,0.00040354414652716,0.0048665866769747,-0.00913496574034325,0.00994205403339757,0.933915311445461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,41805,-0.00112231140713713,0.0137812986315123,-0.0281336567249013,0.025889033910627,0.935095440559537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,41838,0.000558411278107796,0.00685884205728952,-0.0128849191541797,0.0140017417103953,0.935113307525704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,41740,-0.000479510893410353,0.00606872766398261,-0.0123742171148163,0.0114151953279956,0.937023156499802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39427,-0.000547992581744684,0.00720265913896221,-0.0146652044941106,0.0135692193306212,0.939355280721735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41925,-0.00054211950674478,0.00754832165392821,-0.0153368299484441,0.0142525909349545,0.942746334723348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39241,-0.000280101420524627,0.00393299101593233,-0.00798876381175198,0.00742856097070273,0.943225257050669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41466,-0.000231150487419574,0.00325742663806923,-0.00661570669803526,0.00615340572319611,0.94342984000954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39334,0.000185902596501831,0.00266191723133274,-0.00503145517691033,0.005403260369914,0.944324015673425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39308,0.000890808143596475,0.0127583286654544,-0.0241155160406942,0.0258971323278872,0.944336882327717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41466,-0.000290121820675366,0.00415896067254576,-0.00844168473886506,0.00786144109751433,0.944387161536526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39328,0.000519275154061725,0.00749999214219684,-0.0141807094446441,0.0152192597527675,0.944802453666176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41534,-0.000228051033585129,0.00334008475026193,-0.00677461714409852,0.00631851507692826,0.945566172166266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,41758,0.000322964240784187,0.00481096834160559,-0.00910653370876278,0.00975246219033115,0.946478579860836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,41802,0.000496199921926069,0.00740678021658627,-0.014021089302583,0.0150134891464352,0.946588559586088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39334,0.000350936720015132,0.00529357746214474,-0.0100244751057886,0.0107263485458188,0.947144348610216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41534,0.000198897594767855,0.00304780518726812,-0.00577480057227767,0.00617259576181338,0.947968565701532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39241,-0.000231490110711745,0.00363302045011642,-0.00735221019293994,0.00688922997151645,0.949195680857158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39328,0.00032577993120637,0.00512246584828509,-0.0097142531314324,0.0103658129938451,0.949291299602275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39589,-0.000378839482067074,0.00648856974325723,-0.0130964361788512,0.0123387572147171,0.953442491778496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41466,-0.000425850386498896,0.00742979115678206,-0.0149882410537917,0.0141365402807939,0.954293885269072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39427,-0.000140195816767298,0.00251339646442919,-0.00506645288704851,0.00478606125351392,0.95551855284993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41740,0.00057830456052871,0.0107143840025872,-0.0204218880845422,0.0215784972055996,0.956956223790052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39169,-0.000483198891668725,0.00900040439661,-0.0181239915090243,0.0171575937256869,0.957186070167288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39328,-0.000261738412597296,0.00493779561603777,-0.00993981782003132,0.00941634099483672,0.957727207535814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,41840,0.000391509643379369,0.00748404041856186,-0.0142772095770019,0.0150602288637606,0.958280399660566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39600,-0.00031325688177585,0.00606984721648617,-0.0122101574260887,0.011583643662537,0.958841429622743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,39598,-0.000504193637823912,0.0102634609363098,-0.0206205770729911,0.0196121897973433,0.960820485472104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,39650,8.75914383166601e-05,0.00201873421279432,-0.0038691276187602,0.00404431049539352,0.965392001301439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39250,0.000180017304530437,0.00425983882540629,-0.0081692667932659,0.00852930140232677,0.966292876382261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39241,0.000181473537643005,0.00431957971603608,-0.00828490270578772,0.00864784978107373,0.966490039272809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,41765,0.000303457865774783,0.00734844878035021,-0.0140995017437116,0.0147064174752612,0.967060946803107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,41840,-0.00032028961154836,0.00785205563978028,-0.0157103186655177,0.015069739442421,0.9674634938941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,41720,0.000180882524623715,0.00471767673305299,-0.00906576387216014,0.00942752892140757,0.96941603318693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41521,-0.000175212110004071,0.0046864857037085,-0.00936072408927273,0.00901029986926459,0.970177275959619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39334,-0.000250192048113418,0.00678683693054187,-0.0135523924319755,0.0130520083357487,0.970593883856087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39250,0.00016017176887596,0.00438335231095718,-0.00843119876060011,0.00875154229835203,0.970851728112391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41744,-0.000215053057460921,0.0063280394708643,-0.012618010420355,0.0121879043054331,0.972890304024177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,41740,-0.000157030991585645,0.00481430978575155,-0.00959307817165868,0.00927901618848739,0.97398006957071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39250,0.000159869635795766,0.00523991621059568,-0.0101103661369718,0.0104301054085633,0.975660921574722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,41614,-0.000166463045648259,0.00558580369838963,-0.0111146382944919,0.0107817122031954,0.97622614544559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,41758,0.000195878420726302,0.00664083765774789,-0.0128201633884596,0.0132119202299122,0.976469423626502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41534,0.000277971100221759,0.00999824506161215,-0.019318589220538,0.0198745314209816,0.977820508434968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39328,-9.76232731584124e-05,0.00392704842565487,-0.00779463818744195,0.00759939164112513,0.980167735049715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39250,-0.000144444720870339,0.00597172438671476,-0.0118490245188313,0.0115601350770906,0.980703016097975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39308,-0.000100042388293667,0.0044211737251151,-0.00876554288951926,0.00856545811293193,0.981947417902754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,41802,-0.000191166317856478,0.00902800631580621,-0.0178860586968367,0.0175037260611237,0.983106528536358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,39655,5.39150354346789e-05,0.00261276397125557,-0.00506710234822623,0.00517493241909559,0.983536994124078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41689,0.000123204056882607,0.00612678119099646,-0.0118852870774704,0.0121316951912357,0.983956647216752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,41805,7.21581340993358e-05,0.00413692775459961,-0.00803622026491591,0.00818053653311458,0.986083911743695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41466,0.000275970357573862,0.016044581533623,-0.0311714094483273,0.031723350163475,0.986277152123526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41689,5.44510657538021e-05,0.00341051949572323,-0.00663016714586373,0.00673906927737133,0.987262061051296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39589,6.36639328404743e-05,0.00404517737122558,-0.00786488371476166,0.0079922115804426,0.987443513156448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,39600,-7.00093086994894e-05,0.00473852373375477,-0.00935751582685884,0.00921749720945986,0.988212353075105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,41723,-0.000173562311216856,0.0121421252451931,-0.0239721277917954,0.0236250031693617,0.988595461545502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41466,-5.68831487213155e-05,0.00508369530254419,-0.0100209259417079,0.00990715964426529,0.991072565439856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39250,-5.7127708504363e-05,0.00513800920231028,-0.0101276257450325,0.0100133703280238,0.991128994590098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39259,-4.7504980864938e-05,0.00489268514889612,-0.00963716787270133,0.00954215791097145,0.992253332255445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,41744,-2.28741516744977e-05,0.00252708279116121,-0.00497595642235048,0.00493020811900148,0.992778101230754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,41708,-5.00091517916391e-05,0.00713608065866399,-0.0140367272427731,0.0139367089391898,0.994408633478674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39589,-7.34614116529022e-05,0.010814381770467,-0.0212696496817682,0.0211227268584624,0.994580185611896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41521,-4.81862309567039e-05,0.00758282530046073,-0.0149105238198597,0.0148141513579463,0.994929851928794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39633,1.36569649015934e-05,0.00293758595699704,-0.0057440115108126,0.00577132544061578,0.996290697382716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39334,1.45909317005837e-05,0.00319024022839935,-0.00623827991596214,0.00626746177936331,0.996350880633968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,41911,3.30131001565801e-06,0.000993327063404801,-0.00194361973425775,0.00195022235428907,0.997348295371723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39250,-8.43150674845048e-06,0.00503172044826812,-0.00987060358535396,0.00985374057185706,0.998663040194311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41465,-3.39736523045074e-06,0.00432893800793291,-0.00848811586077896,0.00848132113031806,0.999373829723113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,39600,3.43230040251004e-06,0.00671807680094897,-0.0131639982294575,0.0131708628302625,0.999592365907468
